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Abstract
The formation of lipid-membrane compartments is one of the distinguishing features of
eukaryotic cells. Inspired by the complexity of cellular functional modules and com-
partments, scientists have concentrated on developing synthetic compartments for the
bottom-up assembly of cellular functions. This cumulative thesis bridges the gap between
the development of droplet-based microfluidic technology, and its application towards
the creation of synthetic cells. Towards this end, polymer-based water-in-oil droplets
and microfluidic devices were optimized to achieve stable retention of encapsulated bio-
molecules within the droplet-based compartments. The outcomes of this research pro-
vided crucial information for the successful reconstitution of microtubule networks, rep-
resenting a minimal cytoskeleton model system. Furthermore, in an attempt to combine
the properties of biological lipid membranes with the advantages of droplet-based mi-
crofluidics, a new compartment system termed droplet-stabilized Giant Unilamellar Vesicles
(dsGUVs) was developed. Importantly, the enhanced stability of dsGUVs and the imple-
mentation of ’pico-injection’ microfluidic technology enabled the sequential and precise
loading of dsGUVs with biomolecules and membrane proteins without compromising
their functionality. In order to expand the potential of this technology, a new microfluidic
device was developed for the release of the assembled protocells into a physiological envi-
ronment. Finally, Fluorescence Correlation Spectroscopy (FCS) was reconceptualized as a
new analysis tool, allowing for the efficient monitoring of the high-throughput generation
process of droplet-based synthetic cells in the kHz-range.
Zusammenfassung
Jede lebende Zelle besitzt eine Hülle aus einer Biomembran. Um die komplexen Eigen-
schaften und Funktionen von Zellbestandteilen nachzubilden, sind Wissenschaftler auf
der Suche nach synthetischen Hüllen, die den Aufbau einer minimalen synthetischen
Zelle aus ihren fundamentalen Bestandteilen ermöglichen sollen. Diese kumulative Ar-
beit verbindet die Entwicklung von tröpfchen-basierter Mikrofluidik-Technologie und
deren Anwendung für den Aufbau von synthetischen Zellen. Dafür wurde zunächst die
grundsätzliche Eignung mikrofluidischer Tropfen als künstliche Hülle untersucht, wobei
die Stabilität der Tropfen sowie die Fähigkeit, Fluorophore und Biomoleküle langfristig
einzukapseln, verbessert wurde. Diese Ergebnisse machten es möglich, die Selbstor-
ganisation von Mikrotubuli-Netzwerken zu untersuchen, was ein minimales Modellsys-
tem des Cytoskeletts darstellt. Um die Eigenschaften von biologischen Lipidmembra-
nen mit den Vorteilen der tröpfchen-basierten Mikrofluidik zu kombinieren, wurde ein
neuartiges Kompartiment entwickelt, das droplet-stabilized Giant Unilamellar Vesicle (ds-
GUV) genannt wurde. Es konnte gezeigt werden, dass sich nach der Herstellung der ds-
GUVs weitere funktionale Biomoleküle über ein mikrofluidisches ‚Piko-Injektionssystem’
vollautomatisch und kontrollierbar injizieren lassen. Um das Potential dieser Technolo-
gie noch zu erweitern, wurde eine Methode entwickelt, mit der sich die aufgebauten
Minimalzellen mitsamt ihrer Lipidmembran aus der stabilisierenden Polymerschicht in
eine wässrige Umgebung überführen lassen. Darüber hinaus wurde die Fluoreszenz-
Korrelations-Spektroskopie (FCS) als Analysemethode neu konzipiert, um eine Kontrolle
der effizienten Herstellung von tröpfchen-basierten synthetischen Zellen im kHz-Bereich
zu ermöglichen.

Cell and tissue, shell and bone, leaf and flower,
are so many portions of matter,
and it is in obedience to the laws of physics
that their particles have been moved, moulded and conformed.
D’Arcy Thompson, Cambridge 1917
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CHAPTER 1
Introduction
2 Introduction
1.1 What is Life?
The question ’What is Life?’ is one of the most fundamental and most striking questions
to ask. The world around us is full of life in multifaceted forms, dimensions, complexities
and developments: The length scale of living systems goes from several 10 7m diameter
(bacteria, archaea) [1] up to 102m length of the Sequoiadendron giganteum (Giant Sequoia
tree) [2]. Simple unicellular organisms like bacteria, archaea or protozoa can individu-
ally and independently execute all vital functions to survive. Multicellular organisms
consist of specialized and interdependent cells allow for the formation of higher-ranking
functional units such as tissue and organs. This enables an effective sharing of specific
tasks and allows for the performance of more complex functions [3]. Life is adopted to
miscellaneous and extreme environmental conditions [4, 5], for example to extreme tem-
peratures (thermophile), to acidic (acidophile) or alkaline conditions (alkaliphile) or even
to high pressure in the underground or deep down in the ocean (piezophile). And yet
this is only the occurrence and facets of life as we know it on earth. Since there is no
comparable system it is hard to judge whether essential features of life on Earth already
include all possible aspects of life or whether they are just a specific occurrence adopted
to this environment [6].
In the past philosophers and scientists from diverse research fields made different at-
tempts to explain and define life. They developed manifold theories, which strongly
influenced the way of thinking and the social relations in their times. Their attempts
reach back to the beginnings of philosophical thinking: The philosopher Empedocles (ca
430 BC) developed the concept of four elementary and eternal elements, earth, water, air
and fire, from which everything in the universe is made up [7]. In his theory, life can
be reduced to different combinations and arrangements of the four elements and is thus
merely matter (materialism). On the other hand, Aristotle (ca. 350 BC) introduced in his
book De anima [8] the soul as the entity which allows to identify a natural body as a living
thing (Hylomorphism). Different kinds of living things possess different faculties of the
soul, like reproduction and growth for plants, self-motion and sensation for animals and
intellect, thought and reflection for humans. Thus, the soul is an immaterial principle
necessary for all living things (idealism).
Based on these ideas two controversial philosophical concepts of the definition of life
were developed: Mechanical Philosophy [9], assuming that life is nothing but matter
influenced by mechanical principles. These principles can be described by natural laws,
making it theoretically possible to determine the state of a living organism at any time
by knowing the exact state of the system at a given time (determinism). In this case a
living organism is often compared to a machine (see Figure 1.1). In contrast to this con-
cept, Vitalism explains life by an immaterial principle, some non-physical or non-natural
element. All living things are characterized by a purposeful ’vital force’ (vis vitalis) [10,
11].
Scientific models try to identify the building components of life and the universal pro-
cesses, that drive a living organism. In this context, the Physicist E. Schroedinger defined
life as a system being able to maintain or decrease its internal entropy [12]. This means
that a living organism is able to delay its decay into the thermodynamic equilibrium for
a sufficiently long time. A system that ’feeds on negative energy’, does not contradict the
second law of thermodynamics, since it is an open system: The creation of ordered struc-
tures within the organism is possible by the uptake of free energy from the environment
and by a subsequent increase of disorder outside the system. Therefore, the definition of
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Figure 1.1 – This drawing by Fritz Kuhn from 1926 demonstrates the me-
chanical ideology, which also reflects the way how a living organism was
considered to function. Organic functions and living procedures are com-
pared to mechanical or industrial processes. Dr. Fritz Kahn, Der Mensch
als Industriepalast, 1926, drawing.
life in this context is concentrated on the energy requirements of the system.
The wide range of different scientific approaches to explain life culminated in the creation
of a whole new research field, Biology (bios-logia), the ’study of life’. Biology as an inde-
pendent research field aims for the phenomenological description of living organisms
on earth and analyzes their interaction with each other, with other organisms and with
their environment. In order to define life, Biologists describe, dissect and investigate the
different forms and characteristics of living organisms. Resulting from these findings,
essential principles necessary for life as it is known on Earth have been identified. D.
Koshland lists seven features of life on Earth [13] : Program (an organized plan, imple-
mented by DNA), Improvisation (response to environment, evolution), Compartmentaliza-
tion (to maintain the concentrations and arrangement of the interior), Energy (movement
and metabolism), Regeneration (compensation for metabolism), Adaptability (immediate
response to stimuli), and Seclusion (chemical control and selectivity). Other authors try to
define life by the things life on earth needs and consumes: energy, liquid water, carbon
and a small amount of other elements. [6]
However, there are obviously living organisms that do not fulfill these criteria, e.g. a
mule, which is the offspring of a female horse and a male donkey, is unable to reproduce
itself and to undergo an evolutionary development. Another example are viruses, which
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are particles containing all information for reproduction and proliferation, however they
do not possess an individual metabolism and need a host cell to actually replicate. On
the other hand these criteria are not exclusive characteristics for life, since e.g. fire also
fulfills most of them. Furthermore the features would also apply to robots or computer
programs, which is at least a matter of debates. Finally, these definitions could exclude
forms of possible extraterrestrial life and also possible forms of future synthetic life on
earth.
Summarizing the above, it can be said that till now there is no clear, general definition
of life. In order to approach this issue, scientists try nowadays to develop a fundamen-
tal theory similar to e.g. the quantum theory or the standard model, which describes
how matter is constructed internally. To achieve a fundamental understanding of life,
scientists want to dissect the complex varieties of life on earth into the smallest common
building units. The understanding of what these building units are composed off and
how they dynamically interact could lead to a fundamental understanding of life.
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1.2 Fundamental Building Blocks of Life
Chemists use the periodic table of the elements to explain the composition and construc-
tion of matter. Nowadays, Biologist strive for a similar construct by identifying the ele-
mentary building blocks of living organisms. Jamey D. Marth [14] identified 68 funda-
mental molecular building blocks, which can be grouped into the four macromolecular
units of all cells (see Figure 1.2):
 Lipids: hydrophobic and amphipathic molecules, 8 molecular building blocks
 Proteins: polymers consisting of combinations of 20 natural amino acids
 Nucleic Acid: DNA and RNA being produced from 8 nucleosides
 Glycans: polysaccharides and simple sugars, 32 molecular building blocks
Figure 1.2 – This sketch represents the elementary building blocks of a
living cell, as identified by J. Marth [14]. DNA and RNA are composed
of eight nucleosides (red color). Combinations of the twenty amino acids
(green) allow for the formation of proteins. The class of glycans includes
32 saccharides, which are often attached to lipids and proteins (blue). Fi-
nally, lipids have been categorized into eight groups, as indicated in pur-
ple. Taken with Permission from J. Marth [14].
These fundamental molecular building blocks form a variety of approximately 105 dif-
ferent (macro-) molecules in a single eukariotic cell [15]. Not only the amount of these
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molecules is remarkable, also the complexity and variety of their functions is astonish-
ing. Furthermore, the composed molecules assemble again into higher functional units.
This self-organization of molecules into functional units depends on the concentration
of the components, the environment, the size of their confinement and much more [16].
Despite the fact that the functions of the major cellular units are known, the chemical and
physical mechanisms behind the self-organization of the molecules into functional units
is only partly understood.
In this thesis, the self-assembly process of selected bio-molecules was experimentally
studied under defined and well-controlled conditions. The following section provides
a general overview of the most important molecular building units and highlights the
specific functions of bio-molecules used in the context of this thesis.
1.2.1 Lipids
Lipids are hydrophobic or amphiphilic molecules [16], having a high amount of C-H
bonds (carbon - hydrogen). The simplest constructs are fatty acids, having a carboxyl
group at one end and long hydrocarbon chains on the other, usually containing 16 or
18 carbon atoms. Saturated fatty acids have straight hydrocarbon chains (see Figure 1.3,
octadecanoic acid), while unsaturated fatty acids contain at least one double bond be-
tween the carbon atoms, thus showing a king in their hydrocarbon chain (see Figure 1.3,
oleic acid). Three fatty acids can be combined with glycerol to triglyceride, the main con-
stituents of fat in the body. They serve mainly as energy storage and form fat droplets in
an aqueous environment since they are insoluble in water. [16].
Phospholipids represent the most abundant lipid types in cellular membranes [15]. They
consist of a hydrophilic head and two fatty acids forming a hydrophobic tail. In case of
glycerophospholipids, the two fatty acids are connected via glycerol, however the third
carbon atom binds to a phosphate group, which can bind another small polar molecule.
Both the polar head group as well as the two hydrophobic tail can be varied, allowing for
different combinations with different physical properties, see Figure 1.3, right column.
When the connecting glycerol is replaced by serine, the resulting complex is a so-called
sphingomyelin.
In contrast to phospholipids, steroids consist of four very hydrophobic hydrocarbon
rings. In case of cholesterol a hydroxylic OH - group is attached to one end, making
the molecule amphipathic.
Amphipathic lipids exposed to water can exist as monomers up to a specific lipid con-
centration. When reaching the critical micelle concentration (CMC) the lipids start to
assemble into aggregates. In order to reduce the free energy of the system, lipids ex-
pose the hydrophilic heads to the aqueous environment and thus minimize the contact
of the hydrophobic tails to water [17]. Further increase of the lipid concentration will not
increase the concentration of lipid monomers, but will increase the concentration of the
aggregates. The CMC depends on the physical properties of the amphipathic lipids, e.g.
the length of the hydrocarbon chains [18].
Additionally, the exact arrangement of the aggregates can be described by the critical
packing parameter CPP [16, 19]
CPP =
V
a0:lc
(1.1)
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Figure 1.3 – Left side: Chemical structure of octadecanoic acid (top)
and oleic acid (bottom). The double bound leads to a kink in the
spatial configuration. Right side: Different phospholipids. DOPS
(1,2-dioleoyl-sn-glycero-3-phospho-L-serine) and DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine) have the same hydrophobic tails and differ by
their head group. DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine) has
the same head group as DOPC, however the hydrophobic tails consist of
only saturated fatty acids. In contrast to DSPC, DPPC (1,2-dipalmitoyl-sn-
glycero-3-phosphocholine) has 16 instead of 18 C-Atoms. Chemical struc-
tures are taken from https://avantilipids.com/ and were drawn with
ChemDraw 15 (Perkin Elmer, USA)
with V : volume of the hydrocarbon tail, a0: optimum surface area of the head group and
lc: critical length of the hydrocarbon chains [20, 21].
The packing parameter roughly describes the structure of the molecule and thus deter-
mines the possible geometrical arrangements. In case of only one hydrophobic tail the
amphipathic lipid has a cone shape with CPP  0:5 (see Figure 1.4, left side). Therefore
the lipids tend to form circular micelles. In contrast, lipids having two hydrophobic tails
such as phospholipids, form a more or less cylindrical molecule with CPP  1:0 (see
Figure 1.4, right side). Therefore, these lipids arrange into a bilayer-like structure after
reaching the CMC.
Figure 1.4 – The chemical composition and the structure of phospholipids
determines the spatial expansion and orientation of lipid arrangements.
The arrangement of phospholipids into a lipid bilayer is a self-assembly process driven
by need to decrease the system’s free energy [22]. In an aqueous environment the lipids
normally arrange into a liposome, i.e. an enclosed lipid bilayer shell. Lipid bilayers have
a thickness of roughly 4 nm [16]. Due to thermal movement, single lipid monomers can
rotate freely around their longitudinal axis as well as diffuse laterally within the plane of
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the bilayer. The latter movement is described by the diffusion coefficient and can be up
to several m2=s at room temperature [23]. This means that lipid monomers change their
position with their neighbors millions of times per second and travel several m in the
same time.
The mobility of the lipids is strongly influenced by the phase of the lipid, which de-
pends on the phase transition temperature [24, 25]. At temperatures below the transition
temperature, lipids are in the ordered gel phase, where the hydrocarbon chains are fully
stretched out and thus closely packed [26]. Here, lipids show a slow lateral diffusion,
leading to a higher rigidity of the lipid bilayer. For temperatures higher than the transi-
tion temperature, lipids are in the disordered liquid phase, showing a random orientation of
the hydrocarbon chains and thus a greater mobility. The transition temperature depends
on the physical properties of the lipids, e.g. longer hydrocarbon chains increase the van
der Waals interactions between the lipids and thus require more energy i.e. higher tem-
perature for the transition. Mixtures of lipids with different phase transition tempera-
tures can lead to a phase separation, where ordered gel phases and disordered liquid
phases coexist in a lipid bilayer and spatially separated patches in the respective phases
are observable [27].
The presence of lipid bilayer compartments is a distinguishing feature of living cells.
Every cell is confined by a lipid bilayer and this so-called plasma membrane acts as a phys-
ical barrier between the extracellular aqueous environment and the interior of the cell
[16]. In case of eukariotic cells, lipids additionally form specific subcompartments, the
organelles. The composition of the plasma membrane and the organelles is a mixture
of hundreds of different types of lipids as well as numerous membrane and transmem-
brane proteins [16]. The compartmentalization allows for a physical separation of differ-
ent molecules, ions or other cellular components, thus allowing several metabolic activ-
ities at the same time inside living systems. Furthermore, it enables the establishment
of different micro-environments inside the cell, in which specific biochemical reactions
and other processes take place. Finally, transmembrane proteins enable a selective per-
meability for molecules and ions and thus the creation of transmembrane concentration
gradients. Such gradients can drive other molecules to perform specific tasks such as the
synthesis of ATP (see Section 1.2.2).
All in all, the formation of lipid bilayer compartments is considered to be an essential step
in the origin and the evolution of life and therefore a fundamental piece of the puzzle to
the question ’What is life?’.
1.2.2 Proteins
Each protein is composed of several amino acid groups or polypeptides and thus has a
distinct amino acid sequence. This specific sequence is called the primary structure of the
protein (see Figure 1.5) [16]. Small proteins consist of something around 100 amino acids.
Regarding the large number of 20 amino acids as building blocks, the total amount of
different combination (20100) seems to be overwhelmingly high (higher than the number
of atoms known in the universe [28]). However, only a small fraction of combinations
can form stable three-dimensional structures. This is because the polar groups of the
amino acid sequence can form hydrogen bonds with each other, resulting in two different
three-dimensional arrangements (secondary structure): In an alpha-helix hydrogen bonds
are formed between two nearby separated amino acids along one individual chain, thus
pulling the chain into a coil. The second structure is the beta-sheet, where hydrogen bonds
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are formed between two individual chains, thus allowing for the linkage of many chains
side-by-side (see Figure 1.5).
Figure 1.5 – The basic structural arrangement of the protein Tubulin (see
Section 1.2.2), composed of two subunits -TB and -TB. a) represents
an extract of the amino acid sequence (primary structure). The sequence
of B2 (yellow) corresponds to a beta sheet, the sequence H2 to an alpha
helix. The chemical structures of these sequences are presented in b).
c) shows the corresponding three-dimensional arrangements (secondary
structure). These parts are marked with the same color in the globular
protein (tertiary structure), presented in d). Together with the  part, the
tubulin dimer is formed (quaternary structure). Adopted with Permission
from [29]
Finally the hydrophobic interactions between distinct amino acids drive the arrangement
into the tertiary structure, which is the final folded shape of a globular protein (see Fig-
ure 1.5). In the end, this three-dimensional arrangement is already defined by chemical
nature of the side groups of the primary structure. Hydrophobic interactions between dif-
ferent amino acids are believed to be the dominant driving force for protein folding [30].
Thus the native conformation of the three dimensional protein structure is driven by the
system to minimize the free energy. Some proteins consist of more than one polypeptide
chain as a base. The different tertiary structure of the single chains cluster into the qua-
ternary structure and form a singe functional protein.
Due to the diverse structures, proteins are able to fulfill various functions and tasks like:
 Transport: proteins can transport small molecules and ions, e.g. hemoglobin can
transport oxygen in the blood
 Support: Fibrous proteins like collagen form structural units
 Motion: contractile proteins can move materials within cells, e.g. actin and myosin
cause muscular movement through sliding motion
 Regulation: Proteins can regulate intracellular processes as well as intercellular
processes via hormones
 Defense: Foreign microbes or other invaders such as cancer cells can be recognized
by globular proteins like antibodies
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 Enzyme catalysis: Proteins can facilitate chemical reactions e.g. for metabolism
The following section introduces the proteins Tubulin and ATPsynthase, which were
studied in the context of a bottom-up synthetic cell approach in this thesis.
Tubulin
Tubulins are spherical proteins existing in all eukariotic cells [29]. They can be divided
into six major groups, , , , , " and , all of them having a molecular weight of roughly
55 kDa and consisting of around 450 amino acids [31].  and  tubulin form a dimer (see
Figure 1.5 and 1.6) by binding two molecules of Guanosine-triphosphate (GTP) [32]. Sev-
eral dimers can attach to each other, thus forming a long protofilament. In turn, these
protofilaments attach to each other side by side and form a stiff, hollow cylinder with a
base of 13 protofilaments. This structure is called microtubule. Microtubules have an
outer diameter of 25 nm, an inner diameter of 14 nm and a length of up to 50 m.
The GTP molecule of the -tubulin shifts into the inner part of the microtubule, whereas
the GTP of the -tubulin is accessible at the outside. The microtubule can grow in both
directions, however the presence of the GTP molecules at the -subunits leads to an in-
creased growth speed. Thus, the microtubule is directional, having a fast growing plus
end (-subunits) and a slower growing minus end (-subunits).
Figure 1.6 – Structural arrangement of microtubules being composed of 
and  tubulin. a) shows the combination of tubulin dimers to a protofil-
ament. These protofilaments arrange to a hollow cylinder-like structure,
called microtubule, b). The stability and formation of microtubules de-
pends on the tubulin concentration and is a highly dynamic process, as
schematically shown in c). Taken with Permission from [32]
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Additionally, the accessible GTP at the -subunit can be hydrolyzed, leading to a de-
formed guanosine diphosphate (GDP) structure and thus resulting in a destabilization
of the microtubule. This process regulates the elongation of the microtubules and is the
reason for the so-called dynamic instability of microtubules.
The growth of microtubules depends on the concentration of free tubulin dimers. In case
of an excess of free tubulin dimers the polymerization is faster than the GTP hydrolysis,
leading to a GTP-Cap at the plus end of the microtubule. When the concentration of free
tubulin dimers is reduced, polymerization is slower than hydrolysis, resulting in a loss of
the GTP-Cap and thus in a fast depolymerization. This process is called catastrophe. The
tubulin concentration, at which polymerization and depolymerization balance equally, is
the critical concentration, which is around 20 M [33], corresponding to half of the total
tubulin concentration in a cell. Typically the half-life time of a microtubule is 5-10 min
[34]. However, so-called microtubule-associated proteins MAPs regulate the polymeriza-
tion and depolymerization velocity, as well as the occurrence of the catastrophes.
In eukariotic cells microtubule-organizing centers (MTOC) serve as nucleation points
and organize the arrangement of microtubules [35]. The centrosome is the main MTOC,
bundling the minus ends of the microtubules at its center and thus forming a star-like
structure. The plus ends reach into the cellular interior and up to the cellular membrane,
stabilizing the physical shape of the cell. Due to these attributes, microtubules are one
of the main components of the cytoskeleton. Beside their function as backbones of the
cell, the microtubules serve as guiding structures for motor proteins, which can transport
organelles or vesicles to the plus end (kinesin) [36] or to the minus end (dynein) [37]. Dur-
ing cell migration the dynamic behavior of the microtubules plays a central roll, e.g. as
regulators of G-proteins (such as RhoA and Rac1) or to trigger focal adhesion disassem-
bly. Additionally microtubules are involved in the cellular division by inducing forces to
the cell. During mitosis microtubules mechanically separate the replicated chromosomes
into two new nuclei, forming a structure which is called mitotic spindle [38]. The origin
of this formation remains unclear, currently two models describe the organization:
1. Search and capture model: Microtubules nucleate from two bipolar centrosomes,
get in contact with the two chromosomes in a ’search and capture’ manner and
finally adopt the stabilized spindle structure [39–41].
2. Self assembly model: Microtubules nucleate from the two chromosomes, are moved
and organized into anti-parallel bundles via motor proteins and finally adopt the
mitotic spindle formation [42].
In the context of this thesis, the self-assembly of tubulin into microtubule structures in a
compartment under controlled conditions was investigated.
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ATP synthase
ATP synthases (also called H+ -ATPase, F-ATPase or F0F1-ATPase) are transmembrane
proteins with a molecular mass of roughly 550 kDa [43, 44]. They synthesize the central
molecule for chemical energy within the cells: Adenosine triphosphate (ATP). Many cel-
lular functions like movement, cellular division, synthesis of proteins etc. are driven by
the hydrolysis of ATP into ADP (Adenosine diphosphate) or AMP (Adenosine monophos-
phate). The recoupment of ATP from ADP and phosphate (Pi) plays a central roll: The
human body contains on average only 250g pure ATP, whereas the total need of ATP each
day is equivalent to the human body weight.
ATP synthases catalyze the reaction of ATP from ADP and Pi. According to the chemios-
motic theory, proposed by P. Mitchell 1961 [45], the electron transport chain of the cellular
respiration is responsible for the pumping of protons from the matrix of the mitochon-
drion (in case of eukariotic cells) across the stroma, thus creating a transmembrane elec-
trochemical gradient H+ between the two compartments. This gradient consists of
two components: The difference in transmembrane proton concentration pH and the
difference in the transmembrane electric potential . The resulting flux of the protons
back into the mitochondrion is the driving force for the activity of ATP-synthase.
Figure 1.7 – a) schematic representation of the structural arrangement of
the transmembrane protein ATPsynthase. c-, - and " - parts can perform
a rotation, driven by a transmembrane electrochemical gradient. The 
and  units allow for the synthesis of ATP from ADP and Pi. b) illistrates
the top view of the protein, demonstrating the synthesis process. Adopted
with Permission from [46].
ATP-synthases consist of two main parts (see Figure 1.7). The hydrophobic F0-part is
incorporated into the cellular membrane of the mitochondrion and can be divided in
three subparts: one a-part, facilitating the flow of the protons, two b-parts, stabilizing
the protein and twelve c-parts, forming a rotational ring [46, 47]. The hydrophilic F1-part
consists of five subunits: three -parts and three -parts, forming a catalytic hexamer, one
-part and one "-part, connected to the c12-ring and one -part, connected to the b-part.
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The whole complex can additionally be divided into a rotation unit (rotor), consisting of
the c12 ring, the -part and the "-part and a stator (other parts).
The flow of the protons through the contact area of the part a and the c12-ring forces
the latter into a continuous rotation. Since the -part and the "-part are connected to the
c12-ring, they follow the rotation. However, the -part is asymmetric and extended up
into the -hexamer. Thus, the continuous rotation of the c12-part is converted into a
step-wise rotation of 120. As a result, the conformation of the  part changes cyclically,
allowing for the synthesis of ATP.
Every active binding side of the three  parts passes sequentially through three different
phases (see Figure 1.7): During the Loose-binding-phase (L), the conformation of the -part
has a high affinity to bind ADP and Pi; in the Tight-phase (T) the conformation of the -
part changes, shielding ADP and Pi from water and thus allowing the synthesis to ATP;
finally, in the Open-phase (O) the conformation of the -part changes again, opening the
active binding side for a release of the synthesized ATP.
The generation of ATP plays a critical role in providing energy for a living organism.
Therefore, in this thesis, the possible implementation of an ATP-generating unit for a
synthetic cell was investigated.
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1.3 Synthetic Biology
The previous chapter gave an insight into the fundamental building units, which are
required to form complex biological systems. However the original question ’What is
Life?’ still remains unanswered. Moreover, there are several scientific questions that de-
rive from the original one: How do fundamental building units interact and form a living
system? What is the minimum amount of fundamental building units to form a living
system? Where is the difference between a non-living assembly of fundamental building
units and a living cell? How is the organization of the fundamental building units con-
trolled, both spatially and temporally? Or, in short: What are the minimum requirements
for a functional assembly of fundamental building units to form a living system? In the
last few years a new interdisciplinary research field arose to answer these questions: syn-
thetic biology.
This new field aims to not only observe and describe biological systems but to mimic
them synthetically and even to construct them in new ways. A major motivation is the
application of engineering principles to biological systems [48]. The famous words of the
Physicist Richard Feynman became the new guiding principle of this research field:
’What I cannot create I do not understand’
The underlying hope is that synthetic biological systems might allow the study of self-
organization processes of molecular building units and the pattern and shape formation
under defined conditions. Following this motif, two methodological approaches in syn-
thetic biology can be distinguished: Top-Down and Bottom-Up approaches [49].
1.3.1 Top-Down vs Bottom-Up approach
The top-down approach emanates from an existing living organism. As described in
Section 1.2, even ’simple’ organisms such as unicellular bacteria are composed of a mul-
titude of different molecules, which have to be organized and conducted in defined ways
to perform specific tasks. Researcher following the top-down approach try to simplify
and reduce the living organism step by step until only a minimal system remains, which
however is still able to perform fundamental tasks (see Figure 1.8). As an example, Venter
et al. presented a synthetic bacterium called Mycoplasma mycoides JCVI-syn3.0, a minimal
living system that needs only 473 genes (532kbp) to survive [50]. Remarkably, still 149 of
the genes being essential to survive cannot be assigned to a specific biological task. Such
a reduced system can provide information about the fundamental building blocks and
their functional interactions. Additionally a reduced cell can serve as a base or platform
to build and construct new synthetic cells, being able to perform predefined metabolic
tasks. These cells can be genetically transformed to serve as molecular factories produc-
ing specific materials and chemical products. As an example, Jay Keasling et al. [51, 52]
showed, that the bacterium Escherichia coli can be genetically modified to produce the
malaria medication Artemisinin.
In contrast, the bottom-up approach emanates from fundamental building blocks such as
genes, proteins or even small functional units. They can be either isolated from living sys-
tems or produced synthetically. In an engineering-like manner these building blocks can
be arranged to fulfill specific tasks, therewith mimicking a living organism (see Figure
1.8).
Towards this goal, engineering principles have to be applied to biological systems [54].
The first one is the definition and classification of unique, well-defined and functional
building units or modules. They can be genes, proteins or even large macromolecular
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Figure 1.8 – This sketch demonstrates the working principles of the dif-
ferent approaches in Synthetic Biology. The Top-down approach emerges
form a living organism such as bacteria. The controlled deactivation of
different units leads to a minimal functional cell, might providing infor-
mation about the essential components to survive and their working prin-
ciples. On the other hand, the Bottom-up approach emerges from isolated
cellular components. The combination of these components might lead to
functional modules. Taken from [53], cSchwille, P., 2015. Originally pub-
lished in JCB. https://doi.org/10.1083/jcb.201506125.
arrangements. In a second step these modules have to be characterized thoughtfully and
their functions have to be described. Ideally, mathematical models and simulations pro-
vide insight in their functions, how they could be manipulated and how they behave in
different environments. Thirdly the modules should be standardized in a way they can be
used for broad applications, i.e. independent of their ’natural’ environment. This might
allow for a general construction and combination of several modules and also a possible
substitution of the modules. Finally, the mentioned procedures might enable the combi-
nation of these modules in order to form functional cellular units, being able to perform
specific tasks. A combination of different functional cellular units can ultimately lead to a
complex synthetic cell, being able to perform specific tasks and thus to mimic a living cell.
For such an assembly, an appropriate compartment plays a crucial roll. Compartments
allow for the accumulation of molecular components and, additionally, serve to create
physical barriers to establish chemical and potential gradients, which are necessary for
metabolism and energy production.
In my research , I used the bottom-up approach to study the behavior and self-assembly
of different proteins (see Section 1.2.2) in defined and controlled compartments. The
following section will introduce the most common model systems for synthetic compart-
ments.
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1.3.2 Model Systems and Compartments for Synthetic Biology
Supported Lipid Bilayer
Supported lipid bilayer (SLB) are planar lipid structures supported by a hydrophilic sub-
strate such as glass or silica [55, 56]. The most common method to produce SLB is the
fusion of liposomes (see Section 1.2.1) with the supporting substrate [57]. The fusion pro-
cess involves initially an adhesion of the liposomes to the substrate followed by a rupture
and fusion of the lipids. These processes depend on van der Waals and electrostatic inter-
actions and thus on the physical properties of the lipids, the supporting surface and the
aqueous environment. Negatively charged lipids rupture and fuse best for low pH and
high ionic strength, i.e. a minimum of roughly 5 mM of bivalent cations such as Mg2+ or
Ca2+ [58, 59]. After rupturing the liposomes fuse and form disconnected patches, which
can then merge to form a full coverage, depending on a sufficient high lipid concentration
[60].
Figure 1.9 – Top panel represents schematically the formation process of
Supported Lipid Bilayer (SLB). Liposomes adhere to the substrate and
rupture, thus forming lipid bilayer patches. These patches can fuse and
form a continuous lipid bilayer, supported by the substrate. Lower panel
shows time-lapse AFM measurements of the lipid bilayer formation pro-
cess and the fusion of patches over time. Adapted from Attwood et al.[60]
licensed under CC BY 3.0
SLB have the advantages of a high stability due to the supporting substrate and a ac-
cessibility to optical and analytic tools, such as Atomic Force Microscopy (AFM), quartz
crystal microbalance with dissipation monitoring (QCM-D) or total internal reflection
fluorescence microscopy (TIRF) [57, 61]. This allows for the characterization and analysis
of the lipid bilayer formation process. Additionally, the mobility of lipids can be inves-
tigated using fluorescence recovery after photobleaching (FRAP) measurements. Fur-
thermore, transmembrane proteins can be incorporated into the lipid bilayer and their
activity and functionality can be studied in vitro [62, 63].
However, the use of SLBs as a model system has certain limitations: Both lipids and in-
corporated transmembrane proteins can be subject to perturbations of the substrate, since
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they are separated only by a thin gap of water of around 10 Å [64]. Additionally, one side
of the lipid bilayer is not accessible for experiments due to the supporting substrate and
thus it is also difficult to create a transmembrane gradient. Finally, a SLB model system
is not a confined compartment and thus not suitable to mimic a living cell [65].
To summarize, SLB are a good tool to analyze specific molecular building blocks in
vitro, especially lipids and transmembrane proteins. However, to assemble the molec-
ular building units in a synthetic bottom-up approach, a suitable compartment is crucial
(see Section 1.3.1). Synthetic in vitro compartments should fulfill the following criteria:
 The size of the compartment should mimic the dimensions of a natural cell
 The formation, composition as well as the physical and chemical properties of the
compartment should be controllable
 The compartment should be stable enough to allow for the encapsulation of biomole-
cules under physiological conditions
 The compartment should be manipulatable, i.e. they should enable the loading
with molecules or functional units
Currently there are three major types of compartments in synthetic biology [65, 66],
which are introduced in the following section and which are schematically shown in
Figure 1.10.
Figure 1.10 – Schematic representation of the most commonly used com-
partments in bottom-up synthetic biology. a) Giant Unilamellar Vesi-
cle (GUVs) consist of naturally occurring lipids, such as phospholipids,
which arrange into an enclosed lipid bilayer compartment. b) Polymer-
somes consist of synthetic amphiphilic block copolymers. In an aque-
ous environment, the copolymers arrange in a bilayer-like structure. c)
Copolymers are also used to stabilize water-in-oil droplets, where the en-
capsulated aqueous interior is surrounded by an oil phase.
Lipid Vesicles
Lipid vesicles are three-dimensional water-in-water lipid bilayer structures. Depending
on their production technique, they can be unilamellar (a single bilayer) or multilamellar
(several bilayer) [67]. When a film of dried lipids is exposed to water, multilamellar vesi-
cles (MLV) are formed spontaneously. These vesicles can be transformed into unilamellar
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vesicles of an uniform diameter using techniques such as sonication or extrusion through
a membrane [68]. The resulting vesicles can be categorized by their size: vesicles smaller
than 100 nm are called small unilamellar vesicles (SUVs), vesicles with a diameter between
100 nm and a few micrometer are called large unilamellar vesicles (LUVs) [66].
Giant unilamellar vesicles (GUVs) are vesicles with a diameter of several tens of microm-
eters. Due to their cell-sized dimensions they are the most common compartments for
many synthetic biology applications [69, 70]. Several techniques to form GUVs have
been developed, like spontaneous swelling [71, 72], electroformation [73, 74], emulsion
methods [75] or microfluidic methods [76–78].
However, GUVs as model systems for synthetic compartments have disadvantages main-
ly due to their mechanical and chemical instabilities. Furthermore, the controlled injec-
tion of additional bio-molecules into assembled GUVs represents a challenge, since pre-
cise and efficient technology is still missing [59, 79, 80]. Additionally, the most common
formation methods result in a polydisperse size distribution of the GUVs, making repro-
ducible experiments impossible.
Polymersomes
Polymersomes are water-in-water constructs composed of synthetic amphiphilic block
copolymers [81, 82]. In an aqueous phase, the hydrophobic parts of diblock copolymers
face eachother in order to minimize energy, thus forming a bilayer-like structure. The
formation techniques of polymersomes are similar to lipid vesicles. The most commonly
used techniques nowadays are electroformation, gel hydration and microfluidic-based
double emulsion techniques [83]. In contrast to lipid vesicles, polymersomes exhibit a
higher stability, a tunable rigidity and a longer lifetime. Due to the controllable syn-
thetic components of the polymers the properties of polymersomes such as thickness
and permeability can be adjusted to specific needs. Additionally, it is possible to engi-
neer polymersomes having transmembrane channels or allowing the incooperation of
transmembrane proteins [84, 85]. However, a controlled encapsulation of biomolecules
and an additional manipulation of polymersomes is still a challenging task.
Water-in-oil Droplets
In contrast to polymersomes, water-in-oil droplets are cell-sized aqueous compartments
surrounded by a continuous oil phase. In order to prevent fusion with neighboring
droplets, they are stabilized by synthetic amphiphilic block copolymers [86]. The most
common way to produce droplets is by microfluidic-based techniques, allowing for a
very controllable production and manipulation at high-throughput rates [87] (see Sec-
tion 1.4.2). Droplets can provide stable containers for the assembly of biomolecules [88,
89]. Additionally, the hydrophilic parts of the stabilizing amphiphilic block copolymers,
which face into the droplets interior, can be modified for specific biological applications
[90]. Several microfluidic techniques can be used to handle, proceed and manipulate
the compartments and their content (see Section 1.4.4). Moreover, microfluidics allows
for the sequential loading of the created droplets with biomolecules by means of pico-
injection technology [91]. However, droplets fail to mimic the biophysical properties of
cellular lipid membranes due to the stabilizing synthetic amphiphilic block copolymers
and the surrounding continuous oil phase.
In this work, the use of microfluidic water-in-oil droplets as compartments for the bottom-
up assembly of minimal synthetic cells was investigated. Therefore, the next section
provides theoretical background and an overview of microfluidic techniques and appli-
cations.
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1.4 Microfluidics
Microfluidics is a research field that investigates both the behavior of fluids in small con-
straints ranging typically from 0.1 to 100 m as well as their controlled handling and
manipulation [92, 93]. The development of soft lithography methods allowed for the fab-
rication of micrometer scaled structures, neccesary for the microfluidic channel forma-
tion. The arrangement of such microchannels allows a guidance, mixing, separation or
other manipulations of the fluids in an automated high-throughput manner [94]. The ma-
jor advantages of down-scaling the size and volume of the fluids are a reduced amount
of necessary reactants, faster processing times and a parallelization of processes. The ul-
timate goal is the integration of various lab processes into one single microfluidic device,
so-called lab-on-chip technology [95].
However, since the physics of microfluidics happens on much smaller scales than our
direct, daily experience, the behavior of fluids is different and has to be considered for
designing devices and planning experiments on a micrometer scale. The next section
covers the properties of fluids in these regimes.
1.4.1 Fluid Dynamics of Microfluidic Systems
Laminar flow vs. turbulent flow
The flow dynamics of viscous fluids under the influence of friction depends on their ve-
locity and on their physical constraints. For low velocities, stream lines do not mix and
the viscous forces are dominant. This flow regime is called laminar flow. For high veloci-
ties turbulent flow dominates, characterized by chaotic vortices and eddies. The method-
ology to differentiate between these flow regimes was first developed by G. Stokes 1851
[96], but popularized by O. Reynolds in 1883 [97]. Following the theory the Reynolds-
Number Re is defined as:
Re =
inertial forces
viscous forces
=
Fi
Fv
(1.2)
Applying dimension analysis leads to: Fi = ma = (L3)(Ut ) and Fv = 
U
LA. Thus, the
Reynolds-Number can be written as:
Re =
(L3)(Ut )
ULA
=
UL

(1.3)
where U is the mean velocity of the liquid, L the characteristic linear dimension, t the
time,  the dynamic viscosity and  the density of the fluid.
The Reynolds number is not an intrinsic property of the fluid, but a combination of fluid
properties (density and dynamic viscosity) as well as geometric properties of the system
and the flow velocity. The characteristic linear dimension depends on the geometry of
the system. In case of flow in a pipe, equation 1.3 transfers to:
Re =
UDH

(1.4)
with DH being the hydraulic diameter. In case of a circular pipe, DH equals the inner
diameter of the pipe. For this geometric configuration, the transition between the two
regimes occurs for Re  2400, however there is a wide transition range.
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For many biological system on micrometer scale such as e.g. blood circulation, the flow
takes place in laminar regime. The same is true for all microfluidic devices. As an exam-
ple the Reynolds number is calculated for the flow of water (at 20C) in a microfluidic
device, assuming a circular pipe with a diameter of 30 m and the corresponding cross
section A = r2 = 707m2 at a volumetric flow rate of UV = 500L=h. This leads to a
mean velocity of U = UV =A = 50010
 9m3
3600s =(707m
2) = 0:20m=s. With  = 1000kg=m3
and  = 1:002mPas = 1:002  10 3kg=(ms) it follows:
Re =
UDH

=
1000kg=m3  0:20m=s  30  10 6m
1:002  10 3kg=(ms)  5:9 (1.5)
The result indicates that in microfluidic devices water behaves as a viscous fluid. This
means that the fluid flows in parallel layers (or laminae) without a lateral mixing. How-
ever, mixing due to diffusion between the layers does exist. But the time scale of diffusive
mixing is much lower than that of turbulent mixing.
Flow profile
The Navier-Stokes equation for an incompressible fluid describes the relevant forces on
a water parcel and is given by:
@u
@t
+ (u  r) u  

r2u =  rw + g (1.6)
The first term describes the temporal variation of the flow velocity u, the second term
the mean convection, the third term the friction, with : viscosity and : density of the
liquid, the forth term the internal force, whereasrw  r(p=0) = (1=0)rp, and the last
term the external force.
In microfluidic devices the solution of the Navier-Stokes equation can be derived for
a fully developed and stationary flow: @uz=@z = 0 and @u=@t = 0. In case of flow
through a circular pipe, three-dimensional cylindrical coordinates can be applied. For
this confinement no radial flows or swirls can occur, thus ur = u = 0. Furthermore, the
flow is axisymmetric. With these specifications equation 1.6 simplifies to:
rw = 

r2u() 1
r
@
@r

r
@uz
@r

=
1

@p
@z
(1.7)
In the circular pipe, boundary conditions require the velocity of the fluid at the inner pipe
wall to be zero: uz = 0 at r = a with a: radius of the pipe. This leads to the following
solution, also called Hagen-Poiseuille law:
u(r) =
1
4
 
a2   r2 @p
@z
(1.8)
The pressure gradient @p=@z along the pipe is roughly constant for most microfluidic
flows. The flow field describes a parabolic velocity profile along the flow direction. This
means that the velocity is maximal in the middle of the pipe and decays to zero at the
boarders, i.e. the walls of the pipe. In microfluidics it is common to use the volumetric
flow rate Q:
Q = 2
Z a
0
u(r)rdr =
a4
8
@p
@z
(1.9)
It is worth mentioning here that the volumetric flow rate and the pressure change is pro-
portional to the fourth power of the radius, leading to an enormous increase in pressure
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for small changes in the channel diameter at the same flow rates.
To conclude this section, microfluidic devices allow to scale down lab processes and to
reduce the amount of reactants. However the parabolic velocity profile can lead to an
axial dispersion of the reactants in the liquid (see Equation 1.8) and the laminar flow
prohibits rapid mixing of fluids (see Equation 1.5), thus limiting the use of microfluidic
devices for several lab-on-chip applications. To overcome these problems, microfluidic
water-in-oil droplets have become popular.
1.4.2 Droplet-based Microfluidics
The concept to use water-in-oil droplets as compartments for chemical and biological
applications dates back to 1954, when Lederberg encapsulated cells in individual water
droplets [98]. However, the use of droplet compartments was limited due to the wide
size distribution resulting from the production methods. Variances in size lead to vari-
ability in reaction conditions and concentrations and thus to an uncontrolled behavior.
The use of microfluidic devices to produce water-in-oil droplets allows to exploit the
maximum potential of droplets as compartments. Microfluidic devices allow the con-
trolled production of uniform, monodispers droplets (< 1% in diameter) at rates up to
the MHz range [99, 100]. The possibility to manipulate and analyze the droplets in an
automated way opens the door for many applications. It also allows to overcome the
problems addressed in the last paragraph, since each droplet can be considered as an
individual controllable reaction chamber and microfluidic channel designs enable pro-
cessing steps like a fast mixing of the reagents (see Figure 1.12)) [101, 102]. Therefore it
is no surprise, that droplet-based microfluidics has arrived in many disciplines such as
biology, chemistry, material science, physics and other fields.
In this thesis the use of polymer-stabilized, microfluidic water-in-oil droplets as com-
partments for a bottom-up assembly of synthetic cells was investigated. The following
section gives a background on the physics behind droplet formation and manipulation
in microfluidic devices.
Generation of Droplets using Microfluidic Devices
The production of microfluidic droplets requires two immiscible phases: one phase be-
ing the carrier phase, often referred to continuous phase and another phase inside the
droplets, so-called dispersed phase. In order to create water-in-oil droplets, oil is used
as the continuous phase and mixed with a dispersed aqueous phase [103]. According to
Equation 1.3 the micrometer-dimensions of microfluidic devices lead to laminar flows.
Thus, in order to break the co-stream of the two immiscible phases and to form droplets,
different geometries were designed to generate droplets. Most designs allow a passive
production of droplets, where the flow field of the two phases deforms their interface,
thus forming a droplet that eventually pinches off due to free surface instability [103].
Today the most commonly used designs are the T-junction (cross-flowing streams [104])
and the cross-junction (flow focusing [87]), depicted in Figure 1.11.
The formation process depends on an individual control of the flows of the two immis-
cible liquids. The flow can either be gas pressure driven, where the imposed pressure is
controlled by a regulatory unit or driven by constant volumetric flow rates imposed by
syringe pumps. A general physical model for the formation process of droplets is still
subject to investigations and so far only partially understood [103]. This is mainly due to
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Figure 1.11 – a) shows the production of microfluidic water-in-oil droplets
using a T-junction. Aqueous phase is shown in blue, the continuous oil
phase in orange. b) shows a microfluidic production device, using flow-
focusing geometry. A sketch of the whole device is shown in I, in which
the oil channels are colored in orange and the aqueous channels in blue.
The extract II shows the production unit, where the aqueous phase is
ripped of by the crossing oil phase. Part III shows a photograph of the
whole device. Adopted from [105].
the manifold geometric designs to produce droplets but also to different break up modes
of the droplets. In total, five fundamental modes for droplet generation have been iden-
tified, as summarized by Zhu 2017 [103]. The three major modes are squeezing mode, with
monodisperse droplets larger than the channel dimension, dripping mode, with monodis-
perse droplets smaller than the channel dimension and jetting mode, with polydisperse
droplets.
The physical differentiation between these modes requires to identify the forces involved
in the formation process. During droplet production, generally four forces are involved:
inertial force (force due to the momentum of the liquid, (v)v), viscous force, gravity
and capillary force. In order to compare the influence of the forces, they can be unified
in the form of stress, the force per unit area. A volume of fluid with the velocity us in
a microfluidic device with the characteristic length L is then exposed to the following
stresses: inertial stress fi  u2, viscous stress fv  u=L, gravity stress fg  gL and
capillary pressure f  =L, with : density of the fluid, : dynamic shear viscosity, g:
gravitational acceleration, : interfacial tension.
From these considerations, dimensionless numbers can be defined to characterize the
fluid. The Reynolds number Re can be used to define the laminar or turbulent regime
and is given as the ratio of inertial and viscous force (see Section 1.4.1).
During the droplet formation process the interfacial tension plays the crucial roll. There-
fore the ratio of f to the other three forces is considered to be most important one for the
description of droplet production. The capillary number Ca is defined as:
Ca = fv=f =
u

(1.10)
The ratio of fi to f is defined as Weber number We:
We = fi=f =
u2L

(1.11)
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Finally, the Bond number Bo is:
Bo = fg=f =
gL

(1.12)
In microfluidic devices, the length scale L is small, therefore both fv and f are enhanced,
whereas fi is not influenced by L and fg is even reciprocally. Thus, the capillary num-
ber has the most impact in describing and characterizing droplet generation. These di-
mensionless numbers allow for a characterization of the droplet production modes, as
described by Zhu 2017 [103]:
Squeezing Ca < 10 2
Dripping 10 2 < Ca < 1 and We < 1
Jetting Ca + We > 1
Therefore, mainly changes in the capillary number of the continuous or dispersed phase
lead to transitions between the different modes and thus to modifications of the droplet
size. As an example ( see [106] and [104]), the droplet diameter D in dripping mode for a
flow focusing device can be estimated by balancing the capillary pressure and the viscous
stress:

D
=
u
L
() D
L
=

u
= Ca 1 (1.13)
whereas in this case the characteristic length corresponds to the diameter of the nozzle.
Therefore, in dripping mode with Ca < O(1), the produced droplets are larger than the
diameter of the nozzle but smaller than the diameter of the channel.
To conclude, the size of the droplets depends on the flow rates, the densities, the viscos-
ity and the interfacial tension of the dispersed and the continuous phase as well as the
microfluidic device geometry. The diameter of the droplets can be adapted to a range
from 1 to 200 m, corresponding to volumes from femtoliters to nanoliters. The lower
limit is mainly defined by the current limitations in soft lithography methods, necessary
to produce microfluidic devices.
1.4.3 Surfactants
So far, the introduced methods for microfluidic droplet production would lead to the fu-
sion of droplets as soon as they come in contact with each other, driven by the aim to
minimize the surface energy. Therefore, to prevent droplet coalescence, so-called ’sur-
factants’ are used to stabilize the droplets. The word ’surfactant’ is the short form of
’surface active agent’ and describes a class of amphiphilic molecules. These molecules
consist mostly of two groups with attractions for different phases, such as water and
oil in the case of microfluidic droplets. In this case surfactants have a hydrophilic part
(’head’) attached to one or two hydrophobic groups (’tail’). Due to these properties, the
surfactants are driven towards the interface of the two immiscible phases, i.e. to the pe-
riphery of the droplets. When surfactants accumulate at the interface, the surface tension
between the phases is decreased and thus the surface free energy is reduced, as given by
the Gibbs adsorption isotherm for dilute solutions [86]:
  =   c
RT
d
dc
(1.14)
With  : Surface concentration, T : temperature, R: gas constant and c: surfactant bulk
concentration. Additionally, the interface becomes more rigid after the adsorption of
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surfactants. Therefore, the addition of surfactants provides the energy to stabilize the
droplets in a metastable state. The coalescence of droplets is then hindered by the steric
repulsion of the surfactants.
In order to use microfluidic water-in-oil droplets as compartments for a bottom-up as-
sembly of synthetic cells, the whole emulsification system, i.e. the combination of aque-
ous phase, oil phase and surfactants, must be bio-compatible. This means on the one
hand that the droplets should form a stable and sealed container, where molecular ex-
change both between droplets and between the continuous phase is minimized. On the
other hand, the water-oil-interface should be inert to the content inside the droplets, i.e.
the attraction or adsorption of proteins to the interface should be hindered. In order to
address the second point, a variety of different head groups have been tested. Most com-
monly, surfactants with a hydrophilic group composed of polyethylene glycol (PEG) are
used [89]. PEG molecules form a passivation layer at the droplets’ inner interface and
therefore minimize unspecific interactions of proteins or other molecules. Additionally,
the PEG groups can be chemically modified leading to anchoring points at the droplets
inner periphery and a functionalization of the interface [90].
The hydrophobic tail can be adopted to the chemical composition of the surrounding
oil. Many biological applications are performed in droplets surrounded by fluorinated
oils. These types of oil show a good bio-compatibility and most organic compounds,
i.e. the composition of biological structures, are insoluble in fluorinated oil. Therefore,
surfactants with (per)fluorinated carbon chains are the preferred choice. Additionally
it could be shown that fluoro-based surfactants are more efficient in stabilizing droplets
compared to e.g. hydrocarbon based surfactants, even for the same chain length and
the same head group. However, the stability of the droplets depends not only on the
chemical composition of the surfactants, but also on the physical properties. In order to
assess the stability, the hydrophilic-lipophilic balance (HLB) can be considered:
HLB = 20
HW
HW + LW
(1.15)
where Hw and LW are the molecular weights of the hydrophilic and the hydrophobic
part, respectively. Therefore, HLB = 0 represents a pure hydrophobic and HLB = 20 a
pure hydrophilic molecule. A HLB value between 1 and 10 for the surfactants allows for
the stable production of water-in-oil droplets.
Furthermore, surfactants can be synthesized as Triblock- or Diblock copolymer surfac-
tants, having two or one hydrophobic chains, respectively. All these properties can influ-
ence the stability of the droplets.
One crucial requirement for the compartments in a bottom-up synthetic cell approach is
the ability to encapsulate and retain bio-molecules, buffers, ions etc. Therefore the first
publication in this thesis comprised a thorough investigation of the retention ability of
diverse molecules in microfluidic droplets, stabilized by different surfactant types and
compositions.
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1.4.4 Microfluidic Devices for Droplet Manipulation and Analysis
Microfluidic devices allow not only for the production of monodisperse droplets at high
productions rates in the kHz range, but also their manipulation and analysis in multiple
ways. The following section provides an overview of the most commonly used microflu-
idic methods and techniques used in this work.
One major advantage for the production of water-in-oil droplets using a microfluidic
device is not only their uniform size but also their periodic flow within the channels. The
single droplets are separated from each other by an equal oil spacing, thus allowing for
automated operations on the droplets (see Figure 1.12, a).
Figure 1.12 – a) In this device, droplets are produced with two aqueous-
phase inlet channels. The upper phase is visualized by black inc.
The highly-periodical flow of the droplets after production can be ob-
served. The subsequent zigzag-mixing unit allows for a fast mixing of the
droplet’s content [107]. b) Combined fluorescence and brightfield image
of a trapping structures for long term observation of microfluidic droplets
[108]. Different approaches to merge droplets are shown in c) and d). The
common principle is to slow down one droplet, thus enabling the subse-
quent droplet to come into close contact and to merge. Droplets can be
decelerated by enlarged channels (c) or pillar structures (d).
Figure c) taken with Permission from [109], Figure d) taken with Permis-
sion from [110].
Mixing
Droplets flowing in a microfluidic device are often in contact with the channel walls and
are therefore subject to friction boundary conditions. This induces a circular flow pattern
inside the droplets, being symmetric identical to an axis parallel to the movement velocity
of the droplet [101]. Therefore, the content in the two circulating halves of a flowing
droplet is spatially separated. In many biological applications, two different aqueous
phases e.g. with different chemical reactants are used and merged only shortly before
the production of the dropelts. In order to mix them rapidly, special channel designs
are necessary. One way to perform fast mixing is the use of zigzag structures [102, 107],
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which break the symmetry of the flow profile inside the droplet and thus allow for a fast
mixing of the reagents (see Figure 1.12 a).
Droplet Storage
For some applications time lapse visualization and analysis of the droplets’ content has
to be performed. Towards this end, microfluidic trapping or storage structure are neces-
sary. One example for a droplet trapping structure is shown in Figure 1.12, b). The traps
have a small opening, allowing the oil to pass through the structure when no droplets
are trapped [108]. However, when the array is flushed with droplets, the trapping struc-
tures are filled with these droplets. A trapped droplet blocks the opening, therefore the
resulting steam-lines of the continuous oil phase move around the trap so that no other
droplets can enter. In this configuration, droplets can be stored for long-term observa-
tions and are available for analytically methods such as microscopic investigations.
Droplet Fusion/Merging
One main requirement for the performance of biological or chemical reactions inside
water-in-oil droplets is the ability to add reactants to the system, i.e. to merge and mix
different liquids. One possibility is the fusion of two individual droplets into one single
droplet. The use of surfactants (see Section 1.4.3) actually hinders the fusion of droplets.
However, for low surfactant concentrations, droplets fuse when they are in close contact
to each other. In this case, droplet coalescence can be achieved using optimized channel
geometry to slow down the droplets. In that case, the subsequent droplet can come into
close contact with the leading droplet and finally merge. Several channel designs allow
for the deceleration of droplets such as narrowed channels, which increase the fluid resis-
tance [111], enlarged channels, where the continuous phase can flow around the droplet
[109] (see Figure 1.12, c), pillar structures [110] (see Figure 1.12, d) or even pockets, where
the droplet is physically entrapped by narrowing channel walls [112].
For higher surfactant concentrations coalescence of the droplets can be induced by elec-
trical fields. In this case an inhomogeneous or homogeneous electrical field in the range
of 1-100 kV/m is applied across two droplets being in close contact [113, 114]. The in-
duced dipoles of the droplets align, thus creating an attractive Coulomb force between
them, which can overcome the energy barrier of the steric repulsion of the surfactants
(see 1.4.3) and finally lead to the fusion of the droplets.
The major limitations of the droplet fusion methods for the controlled addition of com-
ponents are the necessary alternating alignment of droplets with different contents and
their controlled combination. Furthermore the added volume equals almost the volume
of the original droplet and cannot be adequately controlled. In order to overcome these
limitations, the ’Pico-Injection’ technology was developed.
Pico-Injection
The pico-injection technology allows for a sequential addition of reactants into the drop-
lets in a controlled and automated fashion. The concept was first developed and demon-
strated by Abate et al. [91]. Preformed droplets are reintroduced into a microfluidic
device, separated by an orthogonal oil channel and thus aligned to an uniform, periodic
and adjustable droplet - oil - pattern. The oil spacing between the droplets hinders the
uncontrolled fusion of subsequent droplets. In a next step, droplets reach the injection
unit, where a pressurized injection channel with a narrowing tip is attached orthogonal to
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Figure 1.13 – This figure shows the microfluidic pico-injection unit. a)
shows an overview of the device, where oil channels are indicated by an
orange color, aqueous channels by a blue one and electrodes by a green
one. b) shows the droplet separation unit, allowing to separate the reintro-
duced droplets to equivalent distances. In the injection unit c), microelec-
trodes apply an electrical field to the droplets, leading to electroporation
of the surfactant layer. This allows for the injection of liquids through the
attached injection channel. d) shows a photograph of the actual device.
Adopted from [105]
the main channel. Since the connection between the injection channel and the main chan-
nel is only a small slit, a high pressure difference is created, which can be approximated
by the Laplace pressure:
Pin   Pout = 2=r (1.16)
With Pin: pressure of the injection fluid, Pout: pressure in the main flow channel, : sur-
face tension of water and oil and r: radius of the curvature of the interface at the slit.
In this configuration nothing will be injected into the droplets, even for a high pressure
on the injection channel. This is due to the surface tension of the remaining oil film be-
tween the interior of the droplets and the injection fluid and the small radius of the cur-
vature. However, optimized micro-electrodes, usually attached to the opposing sides of
the injection channel, are used to generate electrical fields, which rupture the surfactant
layer at the water-oil-water interface (see Section 1.4.4 and Figure 1.13, c). This enables
the injection fluid to stream into the droplet. After the droplet has passed the injection
unit, surfactants reassemble and the droplet is sealed again. It is worth to emphasize that
this is a fully automated technique operating at several hundreds of droplets per second,
where only the pressures of the droplet-inlet channel, the spacing oil channel and the
injection channel have to be adjusted to control the injected volume. Depending on the
specific need, the injection volume can be adjusted from 0.1 pL to several tenth of pL.
Additionally, several injection units can be placed in a row, thus allowing for serial and
combinatorial injections. In the latter case ground electrodes in between the injection
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units shield the electrical field of the neighboring electrodes, thus enabling an indepen-
dent combination of the injections.
The controllable injection of fluids, reactants, biomolecules or even cells into the droplets
opens the door for many applications. The ability of pico-injection technology for a
bottom-up synthetic cell approaches was a major investigation in this thesis.
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1.5 Research Objectives of the Thesis
The major goal of my research was to progress and to further develop methods and tech-
nology for bottom-up synthetic cell approaches with the ultimate goal to investigate and
better understand fundamental processes of life. More concrete, I aimed for the develop-
ment of a model system with reduced complexity in order to experimentally study the
formation and self-organization of microtubule networks as well as to create an synthetic
ATP-generating module. Towards this end, I used microfluidic water-in-oil droplets
as compartments, taking advantage of the highly-controllable and adjustable produc-
tion methods as well as the variety of manipulation and analysis tools. The underlying
methodological principles were introduced in Section 1.4. Since the results achieved in
this context were published in several publications, the present thesis is written in cumu-
lative form. The following section provides an overview of the results presented in the
corresponding publications:
In a first step, the use of microfluidic water-in-oil droplets as compartments for biologi-
cal applications was investigated. Towards this end, the stability of droplets for different
surfactant types and concentrations was analyzed, as well as the ability of the droplets to
encapsulate and retain selected fluorophores and bio-molecules. The results are crucial
for the selection of proper and adjusted fluorescent dyes in order to label and to visualize
bio-molecules in future synthetic cell applications and are represented in Publication 1:
Key Factors for Stable Retention of Fluorophores and Labeled Biomolecules in Drop-
let-Based Microfluidics [115].
In a second step, the use of microfluidic water-in-oil droplets as compartments for micro-
tubule polymerization under confined and controlled conditions was investigated. Dif-
ferent strategies to initiate the polymerization of tubulin were compared and the resulting
microtubule networks and arrangements were analyzed. These results are summarized
in Appendix A. Based on these results, the influence of additional motor proteins on the
microtubule self-organization in microfluidic droplets was investigated and the achieved
results were published in Publication 2:
Spherical Network Contraction Forms Microtubule Asters in Confinement.
So far however, the investigation of microfluidic water-in-oil droplets as compartments
for synthetic cell applications had one major drawback: The inability to mimic the cellular
bio-membrane with regard to both the continuous oil phase, surrounding the droplets’
aqueous interior as well as the polymeric surfactants at the interface between oil and
aqueous phase. To overcome this problem, a fundamental new approach was investi-
gated.
The basic idea behind the newly-developed system was to use the microfluidic drop-
lets only as stabilizing compartments and to set up the synthetic cell inside the droplets,
including a lipid bilayer and thus a bio-membrane. Towards this goal, different possibil-
ities to form an enclosed lipid bilayer system at the inner periphery inside water-in-oil
droplets were investigated. It turned out, that the encapsulation of vesicles under spe-
cific ionic conditions enabled the formation of the desired structures, which were termed:
droplet-stabilized Giant Unilamellar Vesicles (dsGUVs). A thorough and comprehensive
analysis of the system allowed for an understanding of the formation process and the
conclusion, that the structure is indeed an enclosed, unilamellar lipid bilayer showing
full mobility of the lipids and incorporated transmembrane proteins (see also Appendix
A.2). Furthermore it was demonstrated, that the lipids are fully available for functional-
ization and that microfluidic tools such as pico-injection technology in particular can be
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applied to the system.
In order to demonstrate the capabilities of the developed system to serve as a compart-
ment for synthetic cell applications, microtubule polymerization was performed inside
dsGUVs. It was shown, that the interactions of tubulin with the surfactant layer were
reduced in the presence of a shielding lipid bilayer. Furthermore, the functional recon-
stitution of the transmembrane protein ATPase into the dsGUVs was achieved, allowing
for the creation of a minimal, ATP-generating system. Finally, to exploit the maximum
potential of the newly developed system, different approaches were investigated to re-
lease the assembled synthetic cells from the stabilizing droplet shell into a continuous
aqueous phase and thus into a physiologically relevant environment (see Appendix A.3).
One approach included the design and the construction of a novel microfluidic device,
allowing to include the release process into future lab-on-chip applications. These find-
ings are represented in Publication 3:
Sequential Bottom-up Assembly of Mechanically Stabilized Synthetic Cells by Microflu-
idics [116].
The analysis of the formation process of the dsGUV system included the use of an optical
microscope setup with a defined, confocal fluorescent detection-volume. This procedure
enabled the detection of fluorescently labeled lipids, which were encapsulated into mi-
crofluidic droplets. Due to the fast (MHz) sampling rates of the setup, the lipid-bilayer
formation process could be analyzed for flowing droplets in a microfluidic device (see
Appendix A.4). Based on these results, the idea arose to analyze periodically passing
droplets by Fluorescence Correlation Spectroscopy (FCS), allowing to correlate the con-
tent of thousands of microfluidic droplets. The developed method represents a suitable
tool to monitor the flow of microfluidic droplets and thus to analyze and control the pro-
duction of of several thousand droplet-based synthetic cells per second. These findings
were published in Publication 4:
Reconceptualizing fluorescence correlation spectroscopy for monitoring and analyzing
periodically passing objects [117].
CHAPTER 2
Publications

General information on publications
This thesis is written in cumulative form, i.e in the form of a series of publications. Fol-
lowing the requirements of the Faculty for Physics and Astronomy of the Heidelberg
University, I am the principle author of two of the submitted publications (Publication
1 and Publication 3), as confirmed by all participating authors and the co-author of two
additional publications (Publication 2 and Publication 4). All four publications are con-
tributions in international, peer-reviewed journals and are published online (Publication
1, Publication 3 and Publication 4) or accepted (Publication 2) to the date of submission
of this thesis. The publications have not been used in other dissertations. Permissions to
reprint the publications are given in Appendix B. The author contributions to the respec-
tive publications are given on the following page.
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Based Microfluidics’
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Eberhard Bodenschatz, Jean-Christophe Baret, Tanja Vidakovic-Koch, Kai Sundmacher, Ilia Platz-
man, and Joachim P. Spatz
Nature Materials, Published online: 16 October 2017
doi:10.1038/nmat5005
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Eli Zamir, Christoph Frey, Marian Weiss, Silvia Antona, Johannes P. Frohnmayer, Jan-Willi Ja-
niesch, Ilia Platzman, and Joachim P. Spatz
Analytical Chemistry Article ASAP
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Author contributions to the respective publications
Publication 1:
Key Factors for Stable Retention of Fluorophores and Labeled Biomolecules in Droplet-
Based Microfluidics
The idea behind the retention analysis of different fluorophores originated from obser-
vations made by Jan-Willi Janiesch. In close cooperation with him, I performed and
analyzed the droplet stability experiments as well as the retention experiments. I de-
veloped the analysis method for the categorization of the fluorophore retention and per-
formed the droplet stability analysis. I identified and applied the method to estimate
the hydrophilicity of the fluorophores by calculating the LogD value. Furthermore I per-
formed the experiments with fluorescently labeled tubulin and antibodies and wrote the
manuscript. Synthesis and analysis (FTIR measurements and interfacial tension mea-
surements) of the different surfactants were performed by Jan-Willi Janiesch and Gerri
Kannenberg. Labeled tubulin was provided by Jonathon Hannabuss and Thomas Surrey.
Ilia Platzman and Joachim P. Spatz designed, supervised and managed the experiments
and wrote the manuscript.
Publication 2:
Spherical Network Contraction Forms Microtubule Asters in Confinement
The investigation of microtubule self-organization in microfluidic droplets was performed
in cooperation with Thomas Surrey and Michael Juniper. In this context, I performed
preliminary experiments, demonstrating a successful polymerization of tubulin inside
microfluidic droplets as summarized in Appendix A.1. These results paved the road
towards the results achieved by Michael Juniper in Publication 2. For this publication
I produced the microfluidic droplet production device, installed and assisted with the
droplet-based microfluidics, evaluated the droplet size distribution and wrote parts of
the manuscript. Michael Juniper performed and analyzed the tubulin polymerization
experiments, Thomas Surrey designed the study and wrote the manuscript. Ilia Platz-
man and Joachim P. Spatz assisted with the polymer stabilized droplet microfluidics and
designed, supervised and managed the experiments.
Publication 3:
Sequential Bottom-up Assembly of Mechanically Stabilized Synthetic Cells by Mi-
crofluidics
In this publication, I realized experimentally the general concept of dsGUVs by microflu-
idic technology and identified and analyzed the mechanism of the dsGUV formation
process. In close cooperation with Johannes Frohnmayer, I developed and performed
analysis strategies for dsGUV characterization - this includes FRAP measurements, in-
tensity analysis and the establishment of pico-injection technology and its application
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towards a sequential loading of dsGUVs. Furthermore, I wrote the manuscript, inves-
tigated phase-separated dsGUVs (see Appendix A.2), assessed the functionality of ds-
GUVs by his-tagged GFP, performed the assembly of microtubules inside dsGUVs and
performed the reconstitution of ATPsynthase inside dsGUVs. For the latter, I devel-
oped different strategies to create and monitor a pH gradient to drive the synthesis of
ATP and developed and demonstrated different strategies to measure the produced ATP.
Additionally, I demonstrated the successful bulk release approach (see also Appendix
A.3) and designed and tested the microfluidic release device. For the latter, the appli-
cation to release GUVs from dsGUV was performed by Johannes Frohnmayer. He also
reconstituted functional integrin in liposomes and dsGUV and performed the release
of integrin-containing GUVs into a water phase. Lucia Benk optimized the release of
GUVs from oil to water phase, in particular the release of integrin functionalized GUVs,
performed adhesion experiments of integrin functionalized GUVs to different matrices,
and wrote parts of the manuscript. Barbara Haller performed the experiments of ds-
GUVs with F-actin and its release from oil to water phase and performed Raman spec-
troscopy analysis. Jan-Willi Janiesch performed the experiments of dsGUVs with F-actin
and synthesized polymer-based surfactants. Thomas Heitkamp and Michael Börsch pre-
pared the labeled FoF1-ATP synthase. Rafael B. Lira, Rumiana Dimova and Reinhard
Lipowsky discussed lipid bilayer formation using droplets. Eberhard Bodenschatz and
Jean-Christophe Baret helped install the pico-injection technology. Tanja Vidakovic-Koch
and Kai Sundmacher supported the reconstitution of FoF1-ATP synthase. Ilia Platzman
designed and supervised the experiments, and wrote the manuscript. Joachim P. Spatz
invented the concept of synthetic cell formation by sequential bottom-up assembly in
droplet-stabilized compartments, designed, supervised and managed the experiments,
and wrote the manuscript.
Publication 4:
Reconceptualizing Fluorescence Correlation Spectroscopy for Monitoring and Ana-
lyzing Periodically Passing Objects
Based on the results achieved in Appendix A.4 and together with Eli Zamir, I devel-
oped the general concept of applying FCS to droplet-based microfluidic and performed
first experiments with fluorescently labeled droplets. Furthermore, I measured the auto-
fluorescence of the carrier oil phase and wrote parts of the manuscript. Christoph Frey
performed other droplet-based experiments and measured the droplet production rate
with a high-speed camera. Eli Zamir analyzed and interpreted the data, performed the
simulations and wrote the manuscript. Silvia Antona performed the experiments with
encapsulated cells. Johannes P. Frohnmayer designed the microfluidic production de-
vice. Jan-Willi Janiesch synthesized the surfactants. Ilia Platzman and Joachim P. Spatz
designed, supervised and managed the experiments and wrote the manuscript.
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ABSTRACT: Water-in-oil emulsion droplets created in droplet-
based microﬂuidic devices have been tested and used recently as well-
deﬁned picoliter-sized 3D compartments for various biochemical and
biomedical applications. In many of these applications, ﬂuorescence
measurements are applied to reveal the protein content, spatial
distribution, and dynamics in the droplets. However, emulsion
droplets do not always provide entirely sealed compartments, and
partitioning of dyes or labeled molecules to the oil phase is frequently
observed. Therefore, stable molecular retention in the droplets
represents a challenge, and many physical and chemical key factors of
microﬂuidic system components have to be considered. In this study,
we investigated the retention of 12 commonly used water-soluble
dyes in droplets having six diﬀerent aqueous phase conditions. We demonstrate that the physicochemical properties of the dyes
have a major inﬂuence on the retention level. In particular, hydrophilicity has a strong inﬂuence on retention, with highly
hydrophilic dyes (LogD < −7) showing stable, buﬀer/medium independent retention. In the case of less hydrophilic dyes, we
showed that retention can be improved by adjusting the surfactants physical properties, such as geometry, length, and
concentration. Furthermore, we analyzed the retention stability of labeled biomolecules such as antibodies, streptavidin, and
tubulin proteins and showed that stable retention can be strongly dependent on dye and surfactants selection.
Over the past decade, water-in-oil emulsion dropletscreated in droplet-based microﬂuidic devices have
become widely used as a screening tool for biological and
chemical applications.1,2 Using ﬂexibly designed microﬂuidic
devices, the formation speed and diameter size of monodisperse
droplets can be controlled during their creation: the ﬁrst may
be varied from a slow drip to over 1 MHz,3 and the latter is
variable upward of 2 μm (diameter diﬀerence <1%).4 The soft
and dynamic nature of these biocompatible droplets, their
ultrafast generation, and the well-controlled environment add
up to a system that combines the necessary functions of
microcompartments for various biochemical and biomedical
applications, including high-throughput cellular investiga-
tions,5−8 polymerase chain reaction-assays (PCR),9−11 and in
vitro protein expression analyses.12−14
In most of these applications, ﬂuorescence measurements are
applied to reveal the content of droplets and to gauge success
and eﬃciency. For example, ﬂuorescently labeled proteins were
used to characterize their localization within the droplets for
amyloidosis investigation,15 protein crystallization,16 and
immunological5 and digital PCR applications.17 Moreover, a
high-throughput ﬂuorescence-activated droplet sorting technol-
ogy was developed to monitor and sort droplets according to
their ﬂuorescence signal.18
Emulsion droplets do not always provide entirely sealed
microcompartments, and the release of dyes or ﬂuorescently
labeled proteins is observed.19 Diﬀusion-driven20,21 and
micellar-induced22,23 mechanisms have been proposed to
describe the molecular transport to the oil phase. To minimize
the transport due to diﬀusion and to reduce the solubility of
biomolecules and ﬂuorophores in the oil phase to a minimum,
ﬂuorinated oil became the most prominent choice in droplet-
based microﬂuidics.24 However, the proper conditions for
reduction of the micellar-induced transport are not as clear as in
the case of diﬀusion. Molecular retention depends strongly on
the surfactant’s concentration: lower surfactant concentration
reduces the creation of reverse micelles but also aﬀects droplet
stability. An addition of biomolecules leading to the formation
of a passivation (protection) layer at the inner periphery of the
droplets can improve molecular retention.25 However, it will
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prevent the interactions between biointerfaces, the biomole-
cules, and the droplet periphery, as required in certain studies.
Therefore, surfactant concentration and its type as well as the
aqueous phase conditions have to be chosen carefully in order
to avoid molecular partitioning into the oil phase.
Here, we describe a detailed study of the retention of 12
water-soluble dyes, which are extensively used in biochemical
and biomedical droplet-based microﬂuidic applications. We also
describe the inﬂuence of concentration, geometry, and
molecular weight of commonly used ﬂuorinated surfactants
on the molecular stability within the droplets. Moreover, the
inﬂuence of the four most commonly used buﬀers and of two
cell culture media is presented. We demonstrate that with the
right choice of ﬂuorophores and optimized surfactant
physicochemical properties the partitioning to the oil phase
can be minimized or avoided. Additionally, we analyzed the
encapsulation stability of labeled biomolecules such as
antibodies, streptavidin, and tubulin proteins and showed that
stable encapsulation can be strongly dependent on dye and
surfactant selection. These ﬁndings are important and can help
one choose the appropriate key factors for the stable retention
of ﬂuorescently labeled biomolecules in the droplets.
Synthesis of PFPE−PEG−PFPE (5600g/mol, (TRI2500)),
PFPE−PEG−PFPE (15400g/mol, (TRI7000)), PFPE−PEG
(7750g/mol, (DI7000)), and PFPE−PEG−gold (DI-Au)
surfactants followed the procedure reported earlier5 (see
Supporting Information, Section 1). Fourier transform infrared
(FT-IR) spectroscopy was used to conﬁrm the success of the
surfactant synthesis and to assess the purity of the product (see
Supporting Information, Section 1.1). Following synthesis, the
surfactants were dissolved in ﬂuorinated oil (FC-40, Acros
Organics, Germany) at diﬀerent concentrations, ranging from
0.5 to 50 mM. Interfacial tension measurements between the
aqueous and the oil phase were performed to obtain the CMC
values of 0.01 and 0.05 mM for TRI2500 and TRI7000
surfactants, respectively (see Supporting Information, Section
1.4). Twelve diﬀerent dyes were dissolved in two culture media
(DMEM and RPMI 1604) and four diﬀerent buﬀers (PBS,
PIPES, HEPES, and TRIS) at a concentration of 5 μM and
used as aqueous phase to create droplets in a microﬂuidic
device (see Supporting Information, Section 2). Hydrophilicity
of ﬂuorophores with a hydrolyzed active group was analyzed
using the calculated distribution coeﬃcient, LogD, which is a
measure of the expected ratio of the sum of concentrations of
all forms of the ﬂuorophore (ionized plus unionized) in water
and in a nonpolar solvent (octanol) (see Supporting
Information, Section 2). Negative LogD values correspond to
hydrophilic ﬂuorophores and positive values to hydrophobic
ones. A droplet-based microﬂuidic device made of PDMS was
used to create the droplets, and an analysis chamber was used
to monitor the droplets content (see Supporting Information,
Section 3). Time-lapse analysis of the droplets content was
performed using brightﬁeld and ﬂuorescence microscopy (see
Supporting Information, Section 4). Fluorescence intensities I0,
It0, and It24 correspond to the emission values obtained in an
aqueous phase inside the microﬂuidic channels (ﬂuorophore
solution prior to droplets creation), 1 min and 24 h after
droplets insertion into the analysis chamber, respectively.
Retention of ﬂuorophores was categorized according to
Figure 1 shows a retention summary of 12 ﬂuorophores in
the droplets produced with TRI2500 (10 mM) surfactants.
Note: Similar results were observed with and without addition
of 3 μM gold-linked surfactants. These gold-linked surfactants
were used in our previous studies to provide anchoring points
for bioactive molecules in biomedical applications.5,26,27
As expected, stable retention in all buﬀers and media was
observed with highly hydrophilic (LogD < −7) Alexa 488,
Alexa 647, and ATTO 488 dyes. However, less hydrophilic
ﬂuorophores with distribution coeﬃcients of around −4
presented buﬀer/medium-dependent retention. In the case of
Alexa 532 and ATTO 532 ﬂuorophores, high pH values
reduced the protonation state of secondary amines and,
therefore, moderate retention was observed. In the case of
hydrophobic dyes (LogD > 0), no retention was observed with
the exception of RPMI medium, where moderate retention was
detected. Surprisingly, stable retention was not observed in any
of the slightly hydrophilic dyes (−1 < LogD < 0). Furthermore,
no retention was observed with ATTO 495 dye (LogD =
−0.81). This behavior can be attributed to the relatively small
molecular weight and planar structure of the ATTO 495 dye
and, therefore, to a small energetic barrier to be transported
through the surfactant layer.28 In the case of ATTO 565 and
655 dyes, moderate retention was observed only in 50% of the
buﬀer/medium choices. In an attempt to improve retention, we
investigated the inﬂuence of the physical properties of the
surfactants (i.e., molecular weight and geometry) on the
stability of the ﬂuorophores within the droplets.
Figure 2 shows a retention summary of the 12 ﬂuorophores
in the droplets produced with TRI2500, TRI7000, and DI7000
(10 mM) surfactants. Detailed analysis revealed that DI7000 is
the best among the tested surfactants for stable ﬂuorophore
encapsulation. However, emulsions formed with this surfactant
consisted of droplets that were highly polydisperse in size.
Stable retention in the droplets produced with surfactants
having diblock geometry can be attributed to the denser PEG
brush layer due to a reduced steric eﬀect as in comparison to
triblock geometry. However, for emulsion stability, it is
desirable to have a dense PFPE layer on the outside droplet
interface. The most eﬃcient layer against coalescence can be
provided by surfactants that contain two PFPE-tails (i.e.,
triblock geometry).29 Since droplet-based microﬂuidic applica-
tions require monodisperse droplets, further experiments were
performed with TRI2500 and TRI7000 surfactants. As shown
in Figure 2, improved retention for some of the ﬂuorophores
was achieved in the droplets produced with longer surfactants.
Figure 1. Fluorophores retention in the droplets (diameter (D) = 40
μm) having diﬀerent buﬀer/medium conditions. TRI2500 (10 mM)
surfactants were used to generate droplets for this experiment.
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This observation is straightforward since dyes have to pass a
higher energetic barrier due to a thicker surfactant layer.28
To further optimize the retention of ﬂuorophores within the
droplets, we investigated the optimal range of surfactant
concentrations required for stable monodisperse droplets
creation. The measurements were performed immediately
after droplet formation using a high-speed camera (see
Supporting Information, Section 5).
In agreement with previous studies,30 surfactant concen-
trations below 1 mM result in the droplets coalescence
immediately after creation. On the other hand, high surfactant
concentrations (C > 10 mM) lead to creation of small droplets
(D <5 μm), which can be easily observed with optical
microscopy during the droplets creation (see Supporting
Information, Section 5) and during the ﬂow in microchannels
where droplets experience high shear rates. On the basis of
these results and considering that molecular retention is
dependent on surfactants concentration, we investigated the
retention of the ﬂuorophores in the droplets produced with 2.5
and 10 mM surfactants concentration in the oil phase. It is
worth mentioning here that the diameter size of monodisperse
droplets (150 > D > 25 μm) and their formation speeds (30 > f
> 0.5 kHz) have no eﬀect on ﬂuorophores retention (see
Supporting Information, Section 6).
Figure 3 shows the retention summary of 12 ﬂuorophores
encapsulated in droplets made of 2.5 and 10 mM TRI7000 and
TRI2500 surfactants. In both cases, lower surfactant concen-
tration leads to improved ﬂuorophores retention. However, this
eﬀect was pronounced mainly in TRIS buﬀer and RPMI
medium. The decrease of free surfactants in the oil phase
reduces the formation of carriers for the solubilized
ﬂuorophores such as reverse micelles and small droplets. This
behavior is in agreement with previous observations in which a
decrease of the ﬂuorescence intensity of ﬂuorescein inside the
droplets was measured due to increased surfactant concen-
tration.25
We showed that the retention of most of the dyes can be
controlled eﬃciently by proper selection of the surfactant’s
physical properties such as concentration, geometry, and
molecular weight. However, it is also important to show if
the ﬂuorophore and surfactant selection will inﬂuence the
retention of labeled biomolecules within the droplets. Toward
this end, we investigated the inﬂuence of ﬂuorophores and
surfactants on the retention of highly hydrophilic biomolecules
such as antibodies and streptavidin and compared it to less
hydrophilic biomolecules such as tubulin.
For the retention experiments, TRIS buﬀer was used to
dissolve labeled streptavidin proteins and antibodies (see
Supporting Information, Section 2) to a ﬁnal concentration
of 0.2 μM. In the case of labeled tubulin, we used the PIPES
buﬀer (the most common buﬀer used for tubulin experiments)
for microtubule creation (1 μM) in a bulk condition and used it
as aqueous phase to create droplets (see Supporting
Information, Section 2.4).
Microtubule retention was found to be strongly dependent
on the hydrophilicity of the selected dye and on the surfactant
physical properties. Stable retention of ATTO 633-labeled
microtubules was observed in the droplets created with
TRI7000 surfactants. In the case of droplets made of
TRI2500 surfactants, the release of ATTO 633-labeled
microtubules into the oil phase was observed immediately
after the droplets creation (see Supporting Information, Video
S7 (ac504736e_si_008.avi)), whereas stable retention was
observed with microtubules labeled with highly hydrophilic
ATTO 488 (Figure 4). In contrast to experiments with labeled
Figure 2. Fluorophores retention in the droplets (D = 40 μm) as a
function of buﬀer/medium selection and surfactant physical proper-
ties. The droplets were generated using three diﬀerent surfactants
(TRI2500, TRI7000, and DI7000 (10 mM)).
Figure 3. Fluorophores retention in the droplets (D = 40 μm) as a
function of surfactant length and concentration. Fluorophores were
dissolved in TRIS, PIPES buﬀers, and RPMI medium. The oil phase
contained 2.5 or 10 mM of triblock surfactants.
Figure 4. Retention of labeled microtubules in the droplets strongly
depends on the degree of hydrophilicity of the dye and surfactant
selection. ATTO 633- and ATTO 488-labeled microtubules were
polymerized in PIPES buﬀer and used as an aqueous phase for
droplets creation. The oil phase contained 10 mM TRI7000 and
TRI2500 surfactants. Note: Similar results were observed with and
without addition of gold-linked surfactants.
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microtubules, independent of the hydrophilicity of the dye and
surfactant selection, stable retention for a period of 14 days was
observed for all diﬀerently labeled antibodies and streptavidin
proteins.
High hydrophilicity of antibodies and of streptavidin proteins
is a major reason for their dye independent stable retention
within the droplets. Even the most hydrophobic ATTO 647N
dye (LogD = +4.47), which showed no retention in the
droplets in a pure state, had no inﬂuence on the retention of
sheep antimouse antibodies or streptavidin. In contrast to
antibodies, tubulin is a less hydrophilic biomolecule and has
even been considered as an “amphipotential” protein, i.e., a
protein that can exist in both aqueous and lipid phases (like
membrane proteins). This was concluded from a signiﬁcant
fraction of tubulin (up to 8%) having distributed into the
detergent rich phase in some experiments.31 Therefore, in the
case of tubulin or other less hydrophilic proteins, the proper
dye for labeling has to be selected very carefully.
■ CONCLUSION
In many biochemical and biomedical droplet-based microﬂuidic
applications, stable retention of ﬂuorophores and labeled
biomolecules is pivotal for their successful implementation. In
this letter, we describe the physical and chemical key factors of
ﬂuorescent dyes, surfactants, and buﬀer conditions that have to
be considered for improved retention of labeled molecules and
ﬂuorophores within the emulsion droplets. For the retention
investigation, we dissolved 12 commercially available ATTO
and Alexa dyes in four diﬀerent buﬀers (TRIS, HEPES, PIPES,
and PBS) and two cell-culture mediums (RPMI and DMEM)
and used them as an aqueous phase for droplet creation. We
showed that retention is strongly dependent on the
physicochemical properties of the dyes. In particular, the
hydrophilicity level of the dye has been found to be a key factor
inﬂuencing the retention within the droplets. We demonstrated
that highly hydrophilic dyes (i.e., LogD < −7) showed stable
retention within the droplets, independent of buﬀer/medium
type. In the case of less hydrophilic dyes, we showed that stable
retention can be achieved by optimization of the surfactant
physical properties, such as geometry, molecular weight, and
concentration. Furthermore, we analyzed the encapsulation
stability of labeled biomolecules such as antibodies, streptavi-
din, and microtubules. In the case of “amphipotential” proteins,
such as tubulin, we showed that stable encapsulation can be
strongly dependent on dye and surfactant selection.
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1. Surfactants Synthesis and Analysis 
The used surfactants PFPE(2500)-PEG(600)-PFPE(2500) triblock-copolymer (5600 g/mol, 
TRI2500) and Gold-PEG(436)-PFPE(7000) were synthesized according to protocols reported 
earlier.
1
  
1.1. Perfluorpolypropylene-Polyethylene Glycol Monoethyl Ether Diblock-
Copolymer 7000 (DI7000) 
The synthesis of the perfluorpolypropylene-7000-polyethylene-750 glycol monoethyl ether 
diblock-copolymer (in the following referred to as DI7000) followed the procedure reported 
earlier
1
 but with several modifications as shown in Figure 1S. The synthesis was carried out 
under argon atmosphere in dry THF (Acros Organics, Germany) as solvent  in a heated 
Schlenk flask. PEG-OMe (750 mg, 1 mmol, molecular weight 750 g/mol, Fluka, Germany) 
was dissolved in 70mL dry THF and cooled to -78°C with isopropanol/dry ice. N-butyl 
lithium (0.4 mL of a 2.5 M solution in hexane, 1 mmol, Sigma-Aldrich, Germany) was added 
dropwise over a period of 45 minutes at -78°C to the PEG-OMe solution and stirred for 
additional 30 min at -78°C. While continuously stirred, the reaction was thawed slowly to 
room temperature and stirred for another 30 minutes. PFPE-carboxylic acid (7.0 g, 1 mmol, 
molecular weight 7000 g/mol, DuPont, Netherlands) was added dropwise over a period of 30 
minutes and stirred for another 2 hours. After the reaction was finished, the THF solvent with 
unreacted PEG-OMe was removed by separatory funnel. Two washing steps with dry THF 
were used to remove unreacted PEG-OMe. The product was dissolved in methanol (Carl Roth 
GmbH, Karlsruhe, Germany) to separate it from unreacted PFPE7000-carboxylic acid and 
thereby transferred to a clean flask. Methanol was removed with a rotary evaporator at 40 °C 
and the product was dried on the vacuum line. 
 
 
 
Figure 1S. Synthesis of PFPE(7000)-PEG(750) diblock-copolymer surfactants. 
1.2. Perfluorpolypropylene–Polyethylene glycol-Perfluorpolypropylene Triblock-
Copolymer PFPE(7000)- PEG(1400)-PFPE(7000) (TRI7000) 
The synthesis of PFPE-PEG-PFPE triblock-copolymer followed the procedure reported 
earlier1 but with several modifications as shown in Figure 2S. The synthesis was carried out 
under argon atmosphere in dry THF solvent (99.8%, Carl Roth, Germany) in a heated 
Schlenk-flask. PEG (1400 mg,  1 mmol, molecular weight 1400 g/mol, Sigma-Aldrich, 
Germany) was solved in 90 ml dry THF and cooled to -78 °C. N-butyl lithium (1.25 ml of a 
1.6 M solution in hexane, 2 mmol, Sigma-Aldrich, Germany) was added dropwise over a 
period of 60 min at -78 °C to the PEG solution and stirred for additional 30 min at -78 °C. 
Under continuous stirring the reaction was slowly heated to room temperature followed by an 
additional 30 min stirring. PFPE-carboxylic acid (Krytox FSH, 14 g, 2 mmol, molecular 
weight 7000g/mol, DuPont, Netherlands) was added dropwise over a period of 30 min and 
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stirred for another 2 hours. After the reaction was finished, the THF solvent with unreacted 
PEG was removed by separatory funnel. Two washing steps with dry THF were used to 
purify the crude product from the unreacted PEG. The product was dissolved in methanol 
(99.8 %, Carl Roth GmbH, Germany) to separate it from unreacted PFPE(7000)-carboxylic 
acid. The PFPE-PEG-PFPE product, soluble in methanol, was transferred to a clean flask and 
dried with a rotary evaporator at 40°C. Following the rotary evaporator the product was 
additionally dried on the vacuum line, the desired PFPE-PEG-PFPE surfactant was obtained 
(12.18 g, 87 %). The purity of the product was analysed by IR measurements (see following 
section). 
 
 
 
Figure 2S. Synthesis of PFPE(7000)-PEG(1400)-PFPE(7000) triblock-copolymer surfactants.  
 
1.3. FTIR Spectroscopy 
IR measurements were performed to confirm the success of the surfactant synthesis and 
evaluate the purity. The measurements were conducted on a Nicolet Nexus 870 Fourier 
transform infrared spectrophotometer (Thermo Electron GmbH, Dreieich, Germany) using a 
demountable pathlength cell for liquid FTIR (Thermo Scientific, USA) with KBr glasses and 
FC-40 perflourinated oil as solvent.  
Figure 3S (A) shows the representative FTIR spectra of the PFPE(7000)-carboxylic 
acid reactant and the triblock surfactant product PFPE(7000)-PEG(1400)-PFPE(7000) 
(TRI7000). This figure presents five major bands at 1701, 1775, 2848, 2956 and 3556 cm-1. 
The band at 1701 cm-1 is attributed to the ester (C=O) stretching mode. The band at 1775 cm-1 
is attributed to a stretching mode of the (C=O) bond of the PFPE-carboxylic acid which is 
strongly blueshifted (by ~ 50 cm-1) due to the electronegative fluor atoms in alpha position to 
the carboxylic group.2 The same blueshift of the carboxylic (C=O) band was observed 
previously in the studies measuring the FTIR spectrum of the trifluoroacetic acid.3,4 The 
bands at 2848 and 2956 cm-1 are assigned to symmetric and asymmetric stretching modes of 
the PEG (C-H) groups of the PFPE-PEG-PFPE product.2 The band at 3556 cm-1 is assigned to 
the asymmetric stretching (OH) vibrations.5  
Figure 3S (B) shows representative FTIR spectra of the DI7000 and PFPE(7000)-
carboxylic acid. This figure presents major bands at 1698, 1775, 2889, 2993 and 3556 cm-1. 
The band at 1698 cm-1 represents a stretching mode of the ester ν(C=O). The broad band at 
2889 and 2993 cm-1 represents the symmetric and asymmetric stretching of PEG νa(CH). The 
band at 3556 cm-1 is assigned to the asymmetric stretching (OH) vibrations.5 
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Figure 3S. FTIR spectra of the reactants and the products of the surfactant synthesis. FC-40 
perflourinated oil was used as a background solvent to obtain the spectra.  (A) Comparison between 
the PFPE(7000)-carboxylic acid (20 mM) as a reactant and the PFPE(7000)-PEG(1400)-PFPE(7000) 
triblock product (20 mM) as described in section 1. (B) Comparison between PFPE(7000)-carboxylic 
acid as a reactant (20 mM) and the PFPE(7000)-PEG-OMe(750) diblock product (20 mM) as 
described in section 1.  
1.4. Interfacial Tension Measurement via Pendant Drop 
The interfacial tension (IFT) measurements between the aqueous and the oil phase were 
performed using pendant drop shape analysis technique (OCAH 230, DataPhysics 
Instruments GmbH, Germany). Experiments were performed using a 0.8 mm flat-tipped 
needle were oil-surfactant solutions with different concentrations were extruded into a cuvette 
filled with deionised water and photographed. The Interfacial tension values were extracted 
by the OCAH 230 software using droplet radius, pressure and droplet form for the calculation. 
The critical micelle concentration (CMC) values of 0.01 and 0.05 mM for TRI2500 and 
TRI7000 surfactants, respectively were evaluated using a standard fit curve.6 
 
2. Fluorophores, Buffers, Cell Culture Media and Biomolecules  
2.1. Fluorophores 
ATTO 488 N-Hydroxysuccinimidyl ester (SE), ATTO 495 SE, ATTO 520 SE, ATTO 532 
SE, ATTO 565 SE, ATTO 590 SE, ATTO 647N SE and ATTO 655 SE were purchased from 
ATTO-TEC GmbH (Siegen, Germany). ATTO 532 SE, ATTO 565 SE, ATTO 590 SE and 
ATTO 647N SE were used to label sheep anti-mouse antibodies according to the protocol 
described in the section 2.3. Alexa Fluor® 488 C5 Maleimide (M), Alexa Fluor® 532 C5 M, 
Alexa Fluor® 647 SE, Alexa Fluor® 488 goat anti-mouse IgG and Alexa Fluor® 647 goat 
anti-mouse IgG were purchased from Thermo Fisher Scientific (Schwerte, Germany). ATTO 
647N-labeled streptavidin was purchased from Sigma–Aldrich, Germany.  
Pure fluorophores were dissolved in anhydrous DMSO at a concentration of 1 mM, 
stored at -20°C and further diluted with each of buffers and culture mediums (see the 
following section) to a final concentration of 5 µM and used as aqueous phase for droplet 
creation. To work with labeled antibodies the stock solutions (see section 2.3) were diluted 
with TRIS buffer to final concentrations of 200 nM.  
Hydrophilicity of fluorophores was analyzed using the distribution coefficient, LogD, 
which is a measure of the expected ratio of the sum of concentrations of all forms of the 
fluorophore (ionized plus un-ionized) in water and in a non-polar solvent (octanol). Negative 
LogD values correspond to hydrophilic fluorophores, positive values to hydrophobic ones. 
A B 
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Calculations for the fluorophores with a hydrolyzed SE and M reactive groups at pH 7.4 were 
performed by MarvinSketch version 14.10.20.0 (Chem Axon, Cambridge, MA), using the dye 
structures (Figure 4S). Three different calculation methods were used (VG, KLOP, PHYS) 
and weighted equally. Tautomerization and resonance were considered and electrolyte 
concentrations were adapted to: 
LogD (PBS):  141 mM Cl
-
,
   
141 mM Na
+
 & K
+
, pH7.4 
LogD (TRIS): 156 mM Cl
-
,
   
150 mM Na
+
 & K
+
,  pH7.7 
 
Table 1S Calculated LogD values and photophysical characteristics of the fluorophores used in this 
study.  
 
Fluorophore  LogD 
(PBS) 
LogD 
(TRIS) 
λabs 
[nm] 
λfl 
[nm] 
MW 
[g/mol] 
ηfl 
Alexa 488 M -9,47 -9,61 494 517 721 0.92 
Alexa 532 M -4,43 -4,54 530 555 813 0.61 
Alexa 647 M -7,75 -7,75 651 671 1250 0.33 
ATTO 488 SE -7,60 -7,60 501 523 981 0.80 
ATTO 495 SE -0.81 -0.71 495 527 549 0.20 
ATTO 520 SE 0.59 0.45 516 538 564 0.90 
ATTO 532 SE -4.49 -5.30 532 553 1081 0.90 
ATTO 565 SE -0,18 -0,18 563 592 708 0.90 
ATTO 590 SE +1,56 +1,56 594 624 788 0.80 
ATTO 633 SE n.a n.a. 629 657 749 0.64 
ATTO 647N SE +4,47 +4,47 644 669 843 0.65 
ATTO 655 SE -0.61 -1.46 663 684 887 0.30 
 
λabs:  maximum absorption wavelength 
λfl: maximum emission wavelength 
MW: Molecular weight  
ηfl:  Quantum yield: ratio of photons emitted and photons absorbed 
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Figure 4S. Structures of selected Alexa Fluor® and ATTO dyes used in this study.  
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2.2. Buffers and Cell Culture Media 
All buffers were prepared with ultra-pure (R ≥ 18 MΩ/cm, Millipore) water and stored at 4°C. 
Following buffers were used: 1) PBS pH 7.4 was prepared using PBS tablets (Sigma –
Aldrich, Germany); 2) TRIS buffer consisted of 50 mM TRIS, 150 mM NaCl, 2 mM MgCl2, 
1 mM MnCl2, pH 7,4; 3) 30 mM HEPES pH 7,4; 4) PIPES buffer consisted of 20 mM PIPES, 
7.25 mM MgCl2, 1 mM EGTA, 3 mM GTP, 1 mM 2-mercaptoethanol, 50 mM KCl, 1 μM 
paclitaxel, 31 mM glucose, 1 mg/ml glucose oxidase and 0.5 mg/ml catalase, 0.25 mg/ml 
beta-casein, pH 6.8.  
The pH values were adjusted using HCl and KOH solutions. Two cell culture media were 
used: 1) DMEM (Life technologies, USA) containing 4,5 g/l D-glucose, 1 mM L-glutamine, 
and 1% (v/v) penicillin/streptomycin (Gibco, Darmstadt, Germany); and 2) RPMI 1640 
supplemented with 2 mM L-glutamine, 10% FBS (Invitrogen, Darmstadt, Germany) and 1% 
(v/v) penicillin/streptomycin (Gibco, Darmstadt, Germany). 
2.3.  Antibody and Tubulin Labeling 
Labeling of anti-mouse antibodies with ATTO NHS dyes followed the protocols from ATTOtec 
with some modifications. The fluorophores were dissolved in DMF in a concentration of 10 mg/ml 
and used in a 15- to 20-fold molar excess. The AffiniPure Sheep anti-mouse (c = 2,4 mg/ml, 
IgG, Dianova (515-005-003)) was mixed with 10% (v/v) of 1 M NaHCO3 (pH 8,3 – 9,0) and 
stirred at RT. The fluorophore was added dropwise under constant stirring, the solution was 
protected from light and stirred for one hour at RT.  The crude product was purified by gel 
filtration with a Sephadex G25 (PD-10) gel filter (GE Healthcare GmbH, Solingen, 
Germany), equilibrated with 30 ml PBS pH 6.5. Following purification step, antibody-dye 
fractions of 500μl were collected and the protein content was determined with a Bradford 
Assay. The degree of labeling of 6 was determined by UV/VIS (Lambda 25 UV/VIS 
Spectrometer, PerkinElmer Precisely, USA). The labeled antibodies were stored at -20 °C. 
 Tubulin was purified from pig brain as described.7 It was then labeled using ATTO 
633-SE (Sigma) and ATTO 488-SE (Life Technologies) as described.8 Tubulin 
concentrations were measured using UV spectroscopy (λ = 280 nm; ε= 115000 M-1cm-1); they 
are expressed as tubulin heterodimer concentrations. The labelling ratio was determined by 
UV spectroscopy, using the appropriate extinction coefficients at 280 nm and at the 
absorbance maximum for the dyes. Labeling ratios of ATTO 633 and ATTO 488 labeled 
tubulin were 0.75 and 0.65 dye molecules per tubulin dimer respectively. 
2.4. Microtubule Polymerization 
Microtubules were polymerised by incubating 14.5 μM tubulin (10% labeled) in PIPES buffer 
(buffer 4 above) at 37 °C for 20 minutes. Then they were used for droplet formation. 
3. Microfluidic Device, Droplet Creation and Analysis 
Droplet-based microfluidic devices, made of PDMS (Sylgard 184, Dow Corning, Michigan, 
USA) were prepared by photo- and soft-lithography methods9 as previously described.1,10 
Water-in-oil emulsion droplets with an average diameter of 40 µm were created at a stable 
rate of 3 kHz by adjusting the flow rates of aqueous and oil phase to 240 µL/h and 320 µL/h, 
respectively. Surfactants (TRI2500, TRI7000 and DI7000) were dissolved in fluorinated oil 
(FC-40, Acros Organics, Germany) at different concentrations, ranging from 0.5 to 50 mM. In 
some experiments, the surfactants were mixed with 3µM gold-linked surfactants prior to 
droplets production. Figure 5S (A and B) shows an example for a microfluidic device and the 
flow focusing junction in which droplets are created. Blue and red colours indicate water and 
oil inlets and channels, respectively. The flow rates were controlled with precision syringe 
pumps (Aladdin-1000, World Precision Instruments, USA) connected to the inlets of the 
microfluidic device via polyethylene tubes (inner diameter 0.3 mm, Portex Fine Bore, Smiths 
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Medical Instruments Ltd., USA). Droplets were collected with a pipette tip at the outlet of the 
microfluidic device and transferred immediately to an analysis chamber10 (Figure 5S C and 
D) for further analysis and characterization. To create the chamber two stripes of double face 
sticky tape (thickness ≈ 80 µm, Tesa, Germany) were glued on the longer sides of a 24 x 60 
mm coverslip (Carl Roth, Germany), droplets were added in between the stripes and a 24 x 24 
mm glass (Carl Roth, Germany) was glued on top. The chamber was filled completely with 
FC-40 oil containing the same surfactant concentration as used for droplet creation. To avoid 
evaporations the open sides of the chamber were closed by two-component glue (Twinsil, 
Picodent GmbH, Germany). Droplets stored in these chambers remained stable for more than 
two weeks.  
 
 
 
Figure 5S. (A) Representation of the droplet-based microfluidic device. Red and blue colourings 
indicate the oil and the aqueous inlets, respectively.  (B) Shows the flow-focusing junction with 20 µm 
wide nozzle, where oil (red) and aqueous (blue) phases meet and the droplets are generated. (C) 
Schematic representation of an analysis chamber in which the droplets are stored for further analysis 
and characterization. (D) Representative phase contrast image of 40 µm diameter droplets in an 
analysis chamber. 
4. Fluorescence Microscopy 
All experiments were performed on an upright Leica DM6000B epifluorescence microscope 
(Leica Microsystems, Wetzlar, Germany) at 25°C. The droplets in an analysis chamber were 
excited via a 20x air objective (HC PLAN APO 20x/0.7; Leica Microsystems, Wetzlar, 
Germany). The field of sample excitation was limited using a rectangular aperture in the 
optical pathway. Brightfield and fluorescence images were taken every 15 sec for a period of 
10 minutes and additionally 24 hours after droplets insertion with the image acquisition LAS 
AF software (Leica Microsystems, Wetzlar, Germany) with 1392 x 1040 pixels (1 pix = 
0.46 µm) resolution. Analysis of fluorescence images was done using Fiji (ImageJ 2.0.0-rc-
14, Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2014) program (Figure 6S). 
To calibrate the emission intensity, fluorescence images of the aqueous phase 
(fluorophore solution) inside the microfluidic channels were taken. Illumination times were 
adjusted within the range of 10 to 50 ms to obtain the same fluorescence intensity value I0 for 
each buffer-dye-combination. These illumination times were used to analyse the droplets 
within the analysis chamber. Fluorescence intensities It0 and It24 correspond to the values 
obtained immediately and 24 hours after droplets insertion, respectively. Fluorophore 
retention was categorized according to the following criteria: (see also Figure 6S): 
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I0 ≈ It0 ≈ It24    Stable fluorophore retention         
I0 ≈ It0 > It24                    Moderate retention (slow release over 24h) 
I0 ≫ It0           No retention (immediate release) 
 
 
Figure 6S. Microfluidic droplets produced with 10 mM TRI7000. Droplets containing ATTO 
633 in TRIS (A), ATTO 655 in RPMI (B) and Alexa 488 in TRIS (C) were analyzed 
immediately after production (Intensity It0). Upper panel: Selected fluorescence images 
demonstrating different fluorescence retention in droplets. Middle panel: Intensity profiles of 
cross-sections marked in upper panel. Lower panel: Red, yellow and green blocks illustrate 
the color marking used in all tables. 
 
5. Droplets Stability 
To optimize the conditions for monodisperse droplets creation we investigated the optimal 
range of TRI2500 and TRI7000 surfactants concentrations. Videos of droplets, created in a 
microfluidic device, were recorded with a Phantom V7.2 camera at 10000 fps (Videos 
ac504736e_si_002.avi, ac504736e_si_003.avi, ac504736e_si_004.avi, ac504736e_si_005.avi, 
ac504736e_si_006.avi and ac504736e_si_007.avi). Representative images of droplets created 
using different surfactant conditions are shown in Figure 7S. 
green labeling 
yellow labeling 
red labeling 
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Figure 7S. Representative brightfield images of water-in oil droplets immediately after 
production. At low surfactant concentration (C < 1mM) coalescence of droplets is observed 
(left panel). At high surfactant concentration creation of small droplets occurs (right panel). 
Monodisperse and stable droplets are produced in a stable regime as it can be seen in the 
middle panel.  
 
6. Effect of  Droplet Sizes and Droplets Formation Speed on Retention Stability 
To assess if the moderately encapsulated fluorophores could be lost to the oil before a stable 
layer of the surfactant is formed we investigated the retention stability of the moderately 
encapsulated fluorophores at different formation speeds (0.5, 3, and 30 kHz). NOTE: in 
droplet-based microfluidic studies the common rates of droplets creation are between 1 to 30 
kHz. As can be observed in Figure 8S moderate retention was not affected by different rates 
of droplets formation. 
 
 
 
Figure 8S. Moderate retention of ATTO 590 SE fluorophores in the droplets does not 
depends on different rates of droplets formation. ATTO 590 SE fluorophores were dissolved 
in TRIS buffer and used as an aqueous phase for droplets creation. The oil phase contained 
2.5 mM of TRI7000 surfactants.   
TRI7000
2.5 mM
TRI2500
0.75 mM
TRI2500
2.5 mM
TRI2500
10 mM
TRI7000
0.75 mM
TRI7000
10 mM
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Moreover, we checked whether different droplet sizes (Diameter = 25, 40 and 150 µm) affect 
the retention stability of fluorophores (Figure 9S). NOTE: in the droplet-based microfluidics 
the most commonly used droplets are in the range of 10 to 100 µm in diameter. As can be 
observed in Figure S9 the droplet dimensions at the selected range do not affect the 
encapsulation stability.  
 
 
Figure 9S. Retention of fluorophores in the droplets does not depends on the droplets 
dimensions. ATTO 532 SE, ATTO 655 SE, ATTO 590 SE and ATTO 647N SE fluorophores 
were dissolved in TRIS buffer and used as an aqueous phase for droplets creation. The oil 
phase contained 2.5 mM of TRI7000 surfactants. 
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2.2 Spherical Network Contraction Forms Microtubule Asters in
Confinement
Juniper, M., Weiss, M., Platzman, I., Spatz, J.P., and Surrey, T.

Q1Spherical network contraction forms microtubule
asters in confinement†
Michael Juniper,a Marian Weiss,b Ilia Platzman,b Joachim P. Spatzb and
Thomas Surrey *a
Microtubules and motor proteins form active filament networks that are critical for a variety of functions
in living cells. Network topology and dynamics are the result of a self-organisation process that takes
place within the boundaries of the cell. Previous biochemical in vitro studies with biomimetic systems
consisting of purified motors and microtubules have demonstrated that confinement has an important
eﬀect on the outcome of the self-organisation process. However, the pathway of motor/microtubule
self-organisation under confinement and its eﬀects on network morphology are still poorly understood.
Here, we have investigated how minus-end directed microtubule cross-linking kinesins organise
microtubules inside polymer-stabilised microfluidic droplets of well-controlled size. We find that
confinement can impose a novel pathway of microtubule aster formation proceeding via the
constriction of an initially spherical motor/microtubule network. This mechanism illustrates the close
relationship between confinement, network contraction, and aster formation. The spherical constriction
pathway robustly produces single, well-centred asters with remarkable reproducibility across thousands
of droplets. These results show that the additional constraint of well-defined confinement can improve
the robustness of active network self-organisation, providing insight into the design principles of self-
organizing active networks in micro-scale confinement.
Introduction
The internal structure of living cells depends on the organisa-
tion of the cytoskeleton within the cell boundary. Microtubules
are dynamic tubular polymers of the cytoskeleton that interact
with a multitude of associated proteins. Among these are
several types of molecular motor that can form active cross-
links between microtubules to create a dynamic network, which
critically contributes to the overall organisation of the
cytoskeleton.1–5 Depending on the cellular state, the microtu-
bule cytoskeleton can re-organise into remarkably different
architectures with different biological functions.6,7 In the inter-
phase, the microtubule cytoskeleton is important for providing
a polar scaffold for intracellular cargo transport, and during
cell division it is essential for mitotic spindle assembly and
chromosome segregation.1,2,6,7 The molecular mechanisms
determining the dynamic organisation of the complex micro-
tubule network within the boundary of a eukaryotic cell are
however only poorly understood.
Biomimetic systems of purified cytoskeletal components
provide reduced complexity relative to their living counterparts.
This oﬀers the opportunity to gain insight into the mechanisms
underlying the basic behaviour of active cytoskeletal
networks,3,8 as well as addressing more fundamental questions
about the design principles of active matter systems. In
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previous work, in vitro experiments with microtubules and
motors led to the formation of large contracting networks or
multiple microtubule asters or vortices,9–12 or, in the additional
presence of depletion forces, to the generation of active gels or
nematic liquid crystals consisting of extensile microtubule
bundles.13–15 Related observations were also made for micro-
tubules organised by motors in more complex cell extracts.16,17
The role of physical confinement on self-organising motor/
microtubule systems is less studied, despite the importance
of this constraint for the organisation of the cytoskeleton
within cells, but some studies exist.
Pioneering work visualised individual dynamic microtu-
bules growing from purified tubulin in small unilamellar
vesicles.18,19 Later, microtubule asters nucleated from purified
centrosomes (microtubule nucleating organelles) were studied
in micro-fabricated chambers, investigating the conditions for
the centering of aster in these chambers.20–22 Recently
centrosome-nucleated asters were also encapsulated in lipid-
monolayered droplets in oil.23 In the absence of centrosomes,
and in the presence of motor proteins and a depletion force by
a non-adsorbing polymer, active nematics were observed at
the inner surface of large unilamellar liposomes formed by
short stabilised microtubules that were cross-linked and slid
relative to each other by molecular motors.24 Self-organisation
of microtubules and motors was also studied in the absence of
depletion forces in micro-fabricated chambers10 and in lipid
monolayer droplets surrounded by oil that ranged in size from
typically 5 to 50 mm in diameter.25 In these experiments,
microtubules nucleated and grew within their confined space,
followed by motor protein cross-linking, sliding and organisa-
tion. In micro-chambers, initially forming microtubule asters
transformed into vortices as more and/or longer microtubules
grew.10 In the much smaller droplets most microtubules
organised into bent bundles at the droplet boundary, whereas
in droplets larger than about 40 mm the motors were able to
cluster microtubule ends into a single focal point, leading to
the formation of a microtubule aster.25 The dependence of
aster formation on droplet size was explained by considering
that an aster with a distinct typical microtubule length will
only fit into droplets where the induced microtubule bending
is not too strong.10,25 This is in agreement with a study
performed using cell extract.26 In previous work with purified
motors and microtubules in droplets surrounded by oil, the
droplet size was not controlled and only some droplets were
large enough to allow aster formation having prevented a
detailed study of the pathway of aster self-organisation under
confinement.25
Here, we extend this previous work by producing relatively
large droplets of uniform size using microfluidic droplet for-
mation. Using polymer surfactants instead of phospholipids
allowed for improved tubulin activity compared to previous
experiments.25,27 We find that the mechanism of aster for-
mation is determined by both the biochemistry of the encap-
sulated solution and the chemistry of the droplet boundary.
Under optimal conditions, single asters form robustly in thou-
sands of droplets. We observe a novel pathway of aster
formation based on the contraction of a spherical network
which arises due to the imposed confinement.
Materials and methods
Protein biochemistry
Pig brain tubulin was purified and labelled with Alexa647-N-
hydroxy succinimidylester (Sigma) using standard
procedures,28,29 flash frozen in aliquots and stored in liquid
nitrogen. mCherry-labelled Xenopus laevis kinesin-14 XCTK230
was prepared as described previously,25 flash frozen in aliquots
and stored in liquid nitrogen.
Droplet-based microfluidics
Microfluidic devices for droplet production using a flow focus-
ing geometry31 were designed using QCADpro (RibbonSoft,
Switzerland). The corresponding photomasks were printed on
chrome-coated soda lime glass (JD-Photodata, UK). The photo-
lithography process was performed as described before:32,33 a
negative photoresist (SU8-3025, MicroChem, USA) was spin-
coated onto silicon wafers at 2500 rpm, resulting in uniform
coating of 30 mm thickness. Wafers were then transferred to a
hot plate for soft bake at 65 1C for five minutes, then ramped
slowly to 95 1C and held for 15 minutes. Following this, the
photoresist and the corresponding photomask were exposed
for 7.5 seconds to UV light in a mask aligner (MJB4, SU¨SS
MicroTec, Germany). For the post exposure bake, the wafers
were placed for 1 minute on a hot plate at 65 1C and 5 minutes
at 95 1C. The remaining resist was removed with mr-DEV 600
developer (MicroChemicals, Germany). The final hard bake was
carried out in an oven at 150 1C for 15 minutes.
Soft lithography was performed as described before:34,35
briefly, PDMS (polydimethylsiloxane, Sylgard 184, Dow Corn-
ing, USA) was prepared by mixing the polymerization catalyst
with the cross-linking oligomer in a 1 : 9 (w/w) ratio. The mixed
elastomer was degassed using vacuum, poured over the silicon
wafer and cured at 65 1C for 2 hours. After curing, the flexible
PDMS mold was cut oﬀ and peeled oﬀ the wafer. The injection
and outlet holes with a diameter of 0.75 mm were punched
using a biopsy puncher (World Precision Instruments, USA).
The device was cleaned with ethanol and activated together
with a 24  60 mm coverslip (#1, Carl Roth, Germany) in an
oxygen plasma (PVA TePla 100, PVA TePla, Germany) at 0.45
mbar, 200 W for 20 s. After activation, the PDMS device was
pressed on the coverslip and heated for 2 hours at 65 1C. In
order to make the device hydrophobic, Sigmacote (Sigma-
Aldrich, Germany) was flushed through the micro channels of
the device.
Internal droplet solution
The droplet solution was prepared by mixing on ice: 20 ml
SOB2x buﬀer (40 mM K-PIPES pH 6.8, 100 mM KCl, 67 mM
glucose, 10 mM ATP, 3 mM GTP, 4.5 mM MgCl2, 2 mM EGTA, 2
mM 2-mercaptoethanol, 0.5 mg ml1 b-casein), 1 ml antioxidant
mix (20 mg ml1 glucose oxidase, 10 mgml1 catalase in BRB80
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(80 mM PIPES pH 6.8, 1 mM MgCl2, 1 mM EGTA), pre-
centrifuged at 21 000g for 15 min), 9.76 ml tubulin mix (10.75
mg ml1 unlabelled tubulin, 5.57 mg ml1 Alexa647-labelled
tubulin (25% labelling ratio) in BRB80), 4 ml of motor mix (1
volume 1 mg ml1 mCherry-kinesin-14 mixed with 4 volumes
motor buﬀer (25 mM HEPES pH 7.2 250 mM KCl, 2 mM MgCl2,
1 mM 2-mercaptoethanol)), and 5.24 ml water (total volume 40
ml). The final mix was centrifuged at 17 000g for 5 min and kept
on ice until used (as internal phase) to make droplets. Final
protein concentrations were 40 mM tubulin dimer (final
Alexa647 labelling ratio B9%) and 200 nM mCherry-kinesin-
14 (monomer concentration). For experiments with 400 nM
motor protein, motor mix consisted of 2 volumes mCherry-
kinesin-14 and 3 volumes motor buﬀer.
Droplet production
For the surfactant/oil mixture, first, a 10% w/w stock solution of
RAN-008 fluorosurfactant (according to the manufacturer, a
non-ionic PFPE–PEG–PEPE triblock copolymer surfactant, RAN
Biotechnologies, USA) in HFE7500 (3M, USA) perfluorinated oil
was prepared. Then an 18% or 9% v/v dilution of this stock
solution in HFE7500 was made to generate a 1.8% or 0.9%
mixture of surfactant in oil, respectively. This mixture was
briefly vortexed before being used as the external phase in
droplet making. Droplets of about 145 mm diameter in the x/y
plane were produced in a cold room at 4 1C using the micro-
fluidic droplet maker and Aladdin AL-1000 (World Precision
Instruments, USA) precision syringe pumps with flow rates of
320 ml h1 for the external oil phase and 280 ml h1 for the
internal (aqueous) protein-containing solution. Droplets were
collected in 10 ml pipette tips in an Eppendorf tube and kept
on ice.
Fluorescence microscopy
To prepare flow chambers for microscopy, 25  75 mm glass
slides and 22 mm  22 mm glass cover slips (no. 1.5) were
sonicated in 20% ethanol, rinsed with MilliQ water, sonicated
in MilliQ water, dried and coated with Aquapel, which is a
fluorophilic and hydrophobic chemical which bonds covalently
to glass. A flow chamber of B15 ml volume was constructed
from a slide and coverslip using TESA double sided tape, placed
on a metal block on ice and filled with ice cold HFE7500.
Droplets were then drawn in using a tissue, followed by sealing
the chamber with clear nail varnish. Microtubule poly-
merisation was started by transferring the flow chamber to a
temperature controlled box heated to 30–34 1C around a 3i
Marianas spinning disk confocal fluorescence microscope. It is
based on a Zeiss Axio Observer Z1 and is equipped with a 20/
NA 0.8 plan apo objective, a Yokogawa CSU-X1 spinning disk
system and a Hamamatsu Orcaflash 4.0 CMOS camera con-
trolled by 3i SlideBook 6 software. Movies of the central droplet
plane parallel to the glass surface were recorded for 45 min at
two frames per min with 100 ms and 200 ms exposure times for
the 640 nm and 561 nm laser respectively.
For experiments where microtubules were depolymerised
and repolymerised by temperature shifts (Fig. 5), depolymer-
isation was induced by placing onto the flow chamber a North-
bridge cooler connected to a liquid circulating pump (Lauda
Eco RE 415) containing B5% ethanol in water at 2 1C. This
shifted the temperature in the flow chamber to 4 1C withinB2
min. Removing the cooler allowed the temperature in the
chamber to increase back to 30 1C within B6 min. For these
experiments, movies were recorded during the cooling phase
for 15 min at 12 frames per minute.
Three-dimensional images were created by making images
at multiple confocal planes separated by 1 mm, which were then
reconstructed in ImageJ to produce slices through the xz and yz
planes.
Kymograph analysis
Merged colour time series and kymographs were produced
using Fiji. To produce averaged diameter kymographs, a line
across the diameter of a droplet was drawn, and the ‘Radial
Reslice’ tool was used to generate a stack of 360 kymographs for
each diameter line rotated by 1 degree increments around the
droplet centre. ‘Z project’ averaged these kymographs into one
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Fig. 1 Schematic of confined active self-organising motor/microtubule system. (a) Schematic of a tri-block copolymer-stabilised protein containing
droplet. Encapsulated are tubulin, the motor kinesin-14, GTP (for microtubule polymerisation) and ATP (for motor activity). (b) Schematic view of kinesin-
14 cross-linking motor activity. Motor walks towards the minus ends of microtubules as it hydrolyses ATP, and transports other microtubules by binding
to them in a non-ATP dependent manner.
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image. Network constriction speed was manually extracted
from the initially approximately linear phase of constriction
in the five kymographs shown in Fig. 4c.
Droplet size
The droplet size distribution was analyzed using Fiji’s Analyze
Particle plugin. Recorded fluorescence images of the droplets
produced in the presence of 1.8% surfactant were converted
into binary images with optimized thresholds. The particle
analyzer was applied to this image and identified the Area A
of the single droplets, from which the diameter in the x/y plane
was calculated. A total amount of 343 droplets was detected,
resulting in a mean diameter of 145.3 mm a standard derivation
of 5.7 mm. The corresponding coeﬃcient of variation is 4%, in
good agreement with previous studies.36,37
Results and discussion
To study how confinement can influence the mechanism of
self-organisation of motors and microtubules, we further devel-
oped a recent realisation of an in vitro self-organisation assay in
which purified motors and tubulin were encapsulated in
phospholipid-based droplets surrounded by mineral oil.25 In
the new experimental set-up, we used droplet-based microflui-
dics to reproducibly generate monodisperse droplets with
about 145 mm diameter (Methods), a size expected to be
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Fig. 2 Microtubule structures in surfactant-stabilised droplets produced using microfluidic droplet generator. (a–c) Confocal fluorescence microscopy
time series of self-organising motors (green in merge) and dynamic microtubules (red in merge) at different surfactant and mCherry-kinesin-14
concentrations: (a) 0.9% surfactant in oil, 200 nMmotor; (b) 0.9% surfactant in oil, 400 nMmotor; (c) 1.8% surfactant in oil, 200 nMmotor. The Alexa647-
tubulin concentration was always 40 mM. Microtubule polymerisation was started by shifting the temperature to 34 1C. See also Movies 1–3 (ESI†).
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considerably larger than typical microtubule lengths under our
in vitro conditions and therefore optimal for our study here.25
We furthermore changed the chemistry of the droplet-
surrounding solution. We replaced mineral oil by perfluori-
nated oil, and phospholipids by a non-ionic PFPE–PEG-based
copolymer surfactant (Methods) that provides a polyethylene
glycol (PEG) layer on the inner surface of the droplet (Fig. 1a).
Such PEG layers are often used to minimise interactions of
proteins with surfaces in microscopy or microfluidics
experiments.38–41 The modified chemistry at the droplet bound-
ary allowed us to omit microtubule stabilising agents (taxol,
glycerol) from the encapsulated solution that were previously
required to stimulate efficient microtubule nucleation in
droplets25,42 (Methods). Omitting these stabilising agents is
expected to allow microtubules to remain dynamic throughout
the experiment.
Using our modified method of droplet generation, we
encapsulated purified mCherry-tagged Xenopus laevis
kinesin-14 (XCTK230) and Alexa647-labelled tubulin, together
with GTP and ATP (Methods). Nucleation of microtubules was
started by a temperature shift from 0 to 34 1C (t = 0 min)
allowing then the minus end-directed kinesin-149,43,44 to
cross-link and slide the growing microtubules relative to each
other9,45 (Fig. 1b). This can lead to large-scale organisation of
a dynamically interconnected network, as observed previously
for this motor in the absence and presence of confinement.9,25
At a surfactant concentration of 0.9% in the oil surrounding
the droplets and at 200 nM kinesin-14 inside the droplet we
observed, using confocal time-lapse fluorescence microscopy,
the development of a dynamic vortex-like organisation of
microtubules with the motor distributing along the microtu-
bules, eventually becoming enriched towards the centre of the
vortex (Fig. 2a and Movie 1, ESI†). This type of organisation is
reminiscent of previous vortices observed when microtubules
were organised by plus end directed motors, either in micro-
fabricated chambers similar in diameter to our droplets10 or
in the absence of confinement at low motor concentrations
where motors are thought to reach microtubule ends less
eﬃciently.11
To investigate whether vortex formation in our droplets has
geometrical or biochemical origins, we doubled the kinesin-14
concentration to 400 nM and observed now a self-organisation
process more resembling aster formation with a more concen-
trated motor accumulation in the centre of the aster (Fig. 2b).
However, many microtubules appeared bent, suggestive of a
potential geometrical eﬀect on the aster structure. This might
indicate that microtubules are very long, or that cross-linked
microtubule bundles are too long to fit into the droplet.
Individual microtubules are expected to be longer at lower
nucleation rates because the free tubulin concentration
decreases more slowly when fewer microtubules are growing,
and parallel microtubule bundles are also expected to be longer
at lower motor activities, because microtubule end-to-end slid-
ing may be less eﬃcient.
Next, we used a surfactant concentration of 1.8%, double the
value used above, in an attempt to increase the eﬃciency of
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Fig. 3 Robust formation of centred microtubule asters in surfactant-stabilised droplets. Conditions as in Fig. 2c: 1.8% surfactant, 200 nM mCherry-
kinesin-14 (green), 40 mM Alexa647-tubulin (red), 34 1C. (a) Confocal microscopy image of the central plane of individual isolated microtubule asters
formed inside several droplets. (b) Slices through a z-stack generated from confocal images, showing the three-dimensional nature of the aster structure.
(c) Montage of 95 images showing a region of the microscope slide 7.4  2.7 mm, and containing approximately 1400 droplets. Whole slide contains
approximately 10000 droplets.
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microtubule nucleation. With a kinesin-14 motor concentration
of 200 nM, we now observed relatively fast microtubule nucleation
locally at the droplet boundary (Fig. 2c, 3.5 min), possibly induced a
by PEG density dependent protein adsorption eﬀect.46 This was
followed by the appearance of an apparently structureless micro-
tubule/motor ring, indicative of a microtubule/motor shell in three
dimensions. Remarkably, rather than remaining stuck to the
boundary, this shell contracted, thereby dramatically reorganising
the microtubules. Eventually an aster formed with microtubule
minus ends focused into a single pole where the vast majority of
motors strongly accumulated, while the microtubules radiated
outward towards the droplet boundary as rather straight bundles
(Fig. 2c). This mechanism of aster formation by contraction of a
spherical network shell diﬀers markedly from motor-driven micro-
tubule aster formation pathways observed earlier9–11,25 and appears
to be a direct consequence of confinement in combination with the
more efficient microtubule nucleation at the droplet boundary
under our conditions. This mechanism of aster formation also
demonstrates that pole formation is a special case of three-
dimensional network contraction.
Aster formation was remarkably robust. In the vast majority
of observed cases, a single aster formed in each droplet, having
its focal point well centred with respect to the droplet bound-
ary, both in the x/y plane (Fig. 3a) and the z direction (Fig. 3b).
Thousands of droplets, almost all of them with well centred
self-organised microtubule asters could be reproducibly
observed on a single slide (Fig. 3c), indicating a very strong
preference for this configuration of our biochemical system
when under confinement. This suggests that a well-controlled
size of confinement can impose constraints on self-organising
motor/microtubule systems to promote robustness of organi-
sation, as is also required for the cytoskeleton in living
cells.
To elucidate the characteristic features of the network con-
striction mechanism, we produced kymographs (space-time
plots) showing the temporal development of motor and micro-
tubule densities measured along the droplet diameter (Fig. 4a,
Movie 4 and Methods, ESI†). Evidently, an initially uniform
distribution leads within a few minutes to local microtubule
nucleation at the boundary, followed by network constriction
towards the droplet centre (Fig. 4b). Constriction slows down
over time as the density of the spherical network increases,
finally leading to a pole with strong motor accumulation
(Fig. 4b), indicative of eﬃcient polarity sorting of the now
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Fig. 4 Kinetics of aster formation via contraction of a spherical network. (a) Illustration of the procedure for generating a radially averaged kymograph
(space-time plot) from a time-lapse movie, to reveal how the average density of motors and microtubules measured along the droplet diameter develops
over time. 360 kymographs are produced at 11 intervals, and averaged together (Methods and Movie 4, ESI†). (b) Typical averaged kymograph, showing
the main features of the pathway of aster formation by a constriction mechanism. Kinesin-14 in green, tubulin in red. t = 0 is at the top of the image. (c)
Selection of five kymographs from diﬀerent droplets at the same conditions (as in Fig. 2c and 3), showing that the essential features of the mechanism are
retained. Colour code as in (b). (d) Schematic model: (i) microtubules nucleate preferentially at the boundary; (ii) molecular motors cross-link
microtubules and slide them, causing contraction of the ring/shell; (iii) microtubule minus-ends sorted into a pole, stabilised by cross-linking motors.
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radiating microtubules. These characteristic features of the
pathway are remarkably reproducible, as kymographs showing
self-organisation in an arbitrary selection of five droplets show
(Fig. 4c). These kymographs revealed that initially constriction
caused the diameter of the network to shrink with 188 20 nm,
which is considerably faster than the typical kinesin-14 speed of
B20 nm s1,9 demonstrating that multiple local contraction
events are coupled leading to fast collective network constric-
tion. Taken together, these observations demonstrate a novel
and robust mechanism of motor-dependent microtubule aster
formation (Fig. 4d).
Finally, we investigated whether the constriction mecha-
nism was a consequence of the process of droplet formation
or an inherent property of the encapsulated biochemical
system. To address this question, we asked whether aster
formation via the shell contraction mechanism can be
repeated after aster disassembly. We first allowed asters to
form in droplets at 30 1C, showing again aster formation by
network constriction (Fig. 5a and Movie 5 – part 1, ESI†). We
then induced microtubules to depolymerise by cold treatment
(Methods), causing the asters to disappear, leaving only a
small remnant of the aster centre where the protein concen-
tration was highest, while most tubulin and motors redistrib-
uted throughout the droplet (Fig. 5b and Movie 5 – part 2,
ESI†). Reheating the flow chamber initiated microtubule
polymerisation again, and a second round of aster formation
began, again by the constriction mechanism (Fig. 5c and
Movie 5 – part 3, ESI†). This conclusion was confirmed by a
‘funnel’-shaped congression of high motor and microtubule
densities in the kymographs, indicative of spherical network
constriction and pole formation (Fig. 5d, left and right,
respectively). These observations demonstrate the dynamic
steady state nature of the self-organised aster, in contrast to
a static structure formed by an irreversible process. This
demonstrates also that the biochemical conditions here allow
the preservation of enzyme activities for well over an hour in
our droplet system. Moreover, the repeatability of aster for-
mation demonstrates that the constriction mechanism is an
intrinsic property of the system characterised by its (bio)chem-
ical composition and its geometrical properties, in contrast to
a history-dependent process retaining some memory from
droplet formation.
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Fig. 5 Repeatability of aster formation via the constriction mechanism. Surfactant and protein concentrations as in Fig. 2c–4. (a) Aster forms via network
contraction at 30 1C. (b) Depolymerisation of microtubules at 4 1C causes microtubule depolymerisation, leaving only a small aggregated remnant of the
aster pole which diffuses away from the droplet centre. Same slide, different droplet to (a). (c) When heated again to 30 1C, an aster rapidly forms again via
a contracting shell, and the original pole remnant joins the new pole. Same droplet as (b). (d) Averaged kymographs relating to panels (a) and (c), which
show characteristic contracting rings. Note the different time intervals between the images shown in (b). See Movie 5 (ESI†).
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Conclusions
We have developed a new and robust experimental system for
motor/microtubule self-organisation in surfactant-stabilised
droplets of well-defined size. The experimental system pre-
served protein activities well, allowing eﬃcient nucleation of
dynamic microtubules in the absence of artificial microtubule
stabilisers. Choosing a large droplet diameter of about 145 mm
allowed us to study the conditions of reproducible microtubule
aster formation in thousands of almost identical droplets. The
pathway of self-organisation depended on both the motor
concentration, as expected,9–11 as well as on the chemical
properties of the boundary. Under optimal conditions, single
asters formed robustly via spherical network constriction, a
mechanism that was notably different from previous aster
formations in unconfined geometries.9–11 The constriction
pathway illustrates the close relationship between active net-
work contraction and aster formation. It is particularly inter-
esting to note the continuous topological transition whereby a
spherical network of randomly oriented filaments is reorga-
nised by constriction to form a point from which polarity-sorted
bundles radiate.
Compared to previous biochemical self-organisation experi-
ments with purified motors and microtubules without
confinement9–11 or within droplets of uncontrolled size,25 the
pathway of aster formation was highly reproducible and the
size of the asters was uniform. The radial symmetry of asters
filling the entire droplet volume led to reliable concentration of
the vast majority of microtubule minus ends and minus-end-
directed motors in the droplet centre, demonstrating the ability
of the system to find its centre with high fidelity. The additional
constraint of imposing confinement of well-controlled size
confers robustness to the outcome of self-organisation, which
may well be of relevance for the self-organising cytoskeleton in
living cells.
It is also interesting to see that microtubules and cross-
linking kinesins can form a constricting network that resem-
bles to a certain extent the contraction of the cytokinetic ring
consisting of actin filaments and myosin motors that assem-
bles at the cell boundary to separate the two daughter cells
during cell division.47,48 The outcome of constriction is diﬀer-
ent in these cases due to diﬀerences in the properties of the
filaments and motors, with the cytokinetic ring collapsing
without a topological change to form a compact midbody,
whereas the microtubules in our experiments undergo a topo-
logical transition to form a large aster of bundles tethered to a
well-defined central pole. Despite the diﬀerent final structures
described, the use of symmetrical boundary conditions to
determine the eventual organisation of a dynamic system can
be seen as a fundamental design principle for micro-scale
active matter self-assembly.
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Sequential bottom-up assembly of mechanically
stabilized synthetic cells by microfluidics
MarianWeiss1,2†, Johannes Patrick Frohnmayer1,2†, Lucia Theresa Benk1,2†, Barbara Haller1,2,
Jan-Willi Janiesch1,2, Thomas Heitkamp3, Michael Börsch3, Rafael B. Lira4, Rumiana Dimova4,
Reinhard Lipowsky4, Eberhard Bodenschatz5, Jean-Christophe Baret6,7, Tanja Vidakovic-Koch8,
Kai Sundmacher8,9, Ilia Platzman1,2* and Joachim P. Spatz1,2*
Compartments for the spatially and temporally controlled assembly of biological processes are essential towards cellular life.
Synthetic mimics of cellular compartments based on lipid-based protocells lack the mechanical and chemical stability to allow
their manipulation into a complex and fully functional synthetic cell. Here, we present a high-throughput microfluidic method
to generate stable, defined sized liposomes termed ‘droplet-stabilized giant unilamellar vesicles (dsGUVs)’. The enhanced
stability of dsGUVs enables the sequential loading of these compartments with biomolecules, namely purified transmembrane
and cytoskeleton proteins by microfluidic pico-injection technology. This constitutes an experimental demonstration of a
successful bottom-up assembly of a compartment with contents that would not self-assemble to full functionality when
simply mixed together. Following assembly, the stabilizing oil phase and droplet shells are removed to release functional
self-supporting protocells to an aqueous phase, enabling them to interact with physiologically relevant matrices.
The formation of lipid membrane-based compartments is oneof the distinguishing features of eukaryotic cells. Compart-ments provide physical and chemical barriers that prevent
the uncontrolled diusion of molecular components to and from
the surrounding environment, thereby allowing independent and
self-contained metabolic, signalling, or synthesizing activities14.
Moreover, biological membranes allow for chemically selective
intra- and intercellular material transport and signal transduc-
tion by various transmembrane proteins, such as ion channels
and receptors5,6. In the context of synthetic biology, protocells
are synthetic, biomolecule-containing, lipid-based compartments.
These compartments can either be small, large or giant unilamellar
vesicles (SUVs, LUVs or GUVs)7,8. The chemical and mechanical
instabilities of phospholipids under high ionic strength conditions,
especially multivalent cations, and their sensitivity to pH changes
are considered to be the main challenges in utilizing protocells for
synthetic biology911. In addition, insertingmolecules into protocells
represents a particular challenge given their impermeability and
mechanical instability12.
Polymersomes made from amphiphilic block copolymers
constitute alternative compartments to protocells. They enclose and
are surrounded by an aqueous solution13. Some polymersomes can
be engineered with transmembrane proteins or synthetic channel
molecules that enable certain chemicals to pass the polymer
membrane14,15. They are both chemically and mechanically more
stable than protocells and are adjustable to certain environments
and functionalities13. In contrast to GUVs, where the manipulation
of chemical and physical properties bears limitations, the thickness,
bending and stretchingmoduli of the polymeric membrane is tuned
by changing the block-copolymer molecular properties. However,
the encapsulation of biomolecules and further manipulation of
traditional water-in-water polymersomes still represent challenges.
The uncontrolled permeability of the polymersomes16,17 and a lack
of technologies which allow for the precise and ecient delivery of
dierent biological components are the main drawbacks.
In contrast to polymersomes, copolymer-stabilized water-in-oil
droplet compartments can bemanipulated at high throughput using
automatedmicrofluidic technologies18,19. The biophysical properties
of droplet-based compartments, their ultra-fast generation (up to
1MHz), and the high degree to which this micro-environment is
controllable add up to a system that combines the necessary re-
quirements of various synthetic biology applications2022. Moreover,
it was shown that the continuous oil phase and its additives play an
important role not only in the stable separation of the droplets and
in preserving the bio-content23 but also in the combinatorial delivery
of biological materials exclusively into the droplets by means of
microfluidic pico-injection technology24. However, much like in
the case of polymersomes, the ability of the droplets to serve as
optimal cell-like compartments is mainly hindered by their inability
to imitate the biophysical properties of cellular lipidmembranes17,25.
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Figure 1 | Formation and analysis of droplet-stabilized GUVs. a, Lipid vesicles, either LUVs or GUVs, were encapsulated in water-in-oil
copolymer-stabilized droplets by means of microfluidics. To transform the encapsulated vesicles into a supported lipid bilayer at the copolymer-stabilized
droplets’ inner interface, 10mMMg2C was applied during droplet production or by means of pico-injection. b, Representative combined images of green
fluorescence from lipids (ATTO 488-labelled DOPE) and bright-field microscopy of the encapsulated LUVs and GUVs, and of the dsGUVs. The latter two
images show superimposed the fluorescence intensity profile. Scale bar, 10 µm. c, The microfluidic device designed to release the assembled lipid
compartments from the surrounding stabilizing polymer droplets into the aqueous phase. The left image shows the fluorescence images of the
monodisperse dsGUVs in the oil phase prior to release. After injection, droplets are separated from each other at a T-junction where a tributary oil flow
containing 20 vol% destabilizing surfactants merges with the droplet flow. Passive trapping structures within the microfluidic channel enable the draining
of the continuous oil phase into adjacent oil outlets and decelerate the droplets before they enter the aqueous phase. A comparison of dsGUVs and
released lipid compartments shows that they are comparable in size. Scale bars, 20 µm.
In this study, we present an approach that merges lipid vesicles
and copolymer-stabilized droplets to generate mechanically and
chemically stable cell-like compartments, which we have called
droplet-stabilized GUVs (dsGUVs). These compartments can be
sequentially loaded with biomolecules by means of pico-injection
technology and oer a well-defined micro-environment for a real
step-by-step bottom-up assembly of intracellular modules with
desired features. Moreover, the model systems were released from
the oil phase and stabilizing droplets after assembly, thus paving the
way towards interactions of these synthetic cells with physiologically
relevant environments such as extracellular matrices, cells or
signalling proteins.
Formation of dsGUVs and their analysis
Droplet-based microfluidics allows for high-throughput generation
of monodisperse droplets, thus enabling the precise estimation of
the lipid concentration required for the formation of a continuous
lipid bilayer at the droplets' inner interface of the polymer
shell (Supplementary Note 1 and Supplementary Fig. 1). The
determined optimal amount (800 µM) of various lipid compositions
in the form of LUVs or GUVs was dissolved in Milli-Q water
and encapsulated into copolymer-stabilized droplets of 40 µm
diameter (Supplementary Methods). The lipid-containing droplets
are shown in Fig. 1a,b. To transform the encapsulated vesicles into a
continuous supported lipid bilayer at the droplets' inner interface,
a solution with optimized MgCl2 concentration of 10mM was
introduced during droplet production or bymeans of pico-injection
(Supplementary Methods). In the case of droplets containing
LUVs, the formation of the continuous lipid bilayer was detected
within a few seconds. The formation of a dsGUV out of the
GUVs was considerably slower (in the range of 30min) due to
the slow diusion of the GUVs towards the droplets' interface
(Supplementary Note 2 and Supplementary Movie 1). Mg2C ions
are considered to be the most ecient mediators of lipid vesicle
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Table 1 | Lipid diusion coecients obtained by FRAP measurements.
Lipid composition D (µm2 s 1) Lipid-based compartment
DOPC:DOPE:DOPS(8:1:1), 1% ATTO488-DOPE 3.52 0.26 GUV formed by electroformation and encapsulated into droplet
Egg PC:Egg PG (1:1), 1% ATTO488-DOPE 3.96 0.51 GUV formed by electroformation and encapsulated into droplet
DOPC, 1% RhB-DOPE 4.42 0.65 GUV formed by electroformation and encapsulated into droplet
DOPC:DOPE:DOPS(8:1:1), 1% ATTO488-DOPE 3.31 0.77 dsGUV
Egg PC:Egg PG (1:1), 1% ATTO488-DOPE 2.88 0.06 dsGUV
DOPC, 1% RhB-DOPE 4.11 0.59 dsGUV
DOPC:Chol:DOPS(8:1:1), 1% ATTO488-DOPE 4.03 0.56 dsGUV
DOPC:Chol:DOPS(8:1:1), 1% ATTO488-DOPE 4.24 0.94 Released lipid compartment
DOPC:Chol:DOPS(8:1:1), 1% ATTO488-DOPE 4.43 1.23 GUV formed by electroformation
rupture, because they promote adhesion to a supporting surface10,26.
It is worth mentioning that neither the addition of Ca2C (10mM)
nor lower concentrations of Mg2C (1mM) as tested using the same
lipid concentration could obtain comprehensive vesicle fusion to the
droplets' inner surface (Supplementary Fig. 2).
To assess the formation process and the dynamics of the assem-
bled dsGUV lipid bilayer, fluorescence intensity analyses, fluores-
cence recovery after photobleaching (FRAP)measurements, and the
release of GUVs from the stabilizing droplet shell were performed.
The insets in Fig. 1b show representative fluorescence intensity
profiles of the encapsulatedGUVs and the dsGUVs (bothwith iden-
tical lipid compositions), evaluated with a laser scanning confocal
microscope using the same acquisition conditions (Methods). A fit
to the profile revealed similar integrated intensity values of 42 8
and 44 4 (arbitrary intensity units) for dsGUVs and encapsulated
GUVs, respectively. These findings may indicate a similar lipid
density for dsGUVs and GUVs.
FRAP measurements (Table 1) revealed slightly lower lipid mo-
bility in dsGUVs compared to encapsulated free-standing GUVs
(Supplementary Methods and Supplementary Note 3). This can be
attributed to the fact that the supported lipidmembrane is subject to
perturbations from the inner interface of the copolymer-stabilized
droplet. Previous reports found a similar or an even lower diusion
coecient for planar supported lipid membranes in comparison to
free-standing GUVs27,28.
Importantly, amicrofluidic release devicewas developed to trans-
fer the assembled lipid compartments into a physiologically relevant,
aqueous phase (Fig. 1c, Methods). The release of the assembled lipid
compartments (Methods) from the stabilizing polymer droplets
into the aqueous phase is shown in Fig. 1c. As can be observed
from the fluorescence images, the diameter of the released GUVs
(26.2 1.2 µm) in the aqueous phase is slightly smaller compared
to that of the dsGUV prior to release (28.3  0.6 µm). A slight
shrinkage of the released GUVs can be explained by the change
of the osmotic balance. FRAP measurements performed on the
released GUVs and on those formed by traditional electroformation
(consisting of the same lipid composition) revealed similar lipid
mobility (Table 1).
Biofunctionalization of dsGUVs
To test the ability of the dsGUVs to serve as anchoring points
for the immobilization of (His-tag) proteins, a lipid solution
consisting of 9:1 DOPC:DGS-NTA(Ni) (220 µM) and (His6)-
GFP was encapsulated into copolymer-stabilized droplet shells
(Methods). The analysis of the fluorescence images of the (His6)-
GFP inside the dsGUVs revealed the localization of the fluorescence
signal at the periphery of the dsGUVin other words, the same
place at which the anchor DGS-NTA(Ni2C) lipids are situated
(Supplementary Fig. 3a). In contrast, a homogeneously distributed
fluorescence signal was observed inside non-functionalized
dsGUVs (Supplementary Fig. 3b).
FRAP measurements were performed to assess the kinetics of
diusion within the GFP-linked copolymer-stabilized droplets21
and the GFP-linked dsGUVs (Supplementary Fig. 3c). Data
analysis revealed diusion coecients of 1.22  0.03 and
0.20 0.05 µm2 s 1 for proteins linked to the lipid bilayer or to the
polymer membrane, respectively.
Sequential assembly of sub-cellular units into the dsGUVs
To construct cellular modules by means of bottom-up assembly,
an automated microfluidic approach was adapted to allow for the
sequential loading of various sub-cellular functional units into
the dsGUVs. Towards this end, we incorporated transmembrane
proteins (integrin and ATP synthase) and cytoskeletal proteins
(G-actin and tubulin) into the dsGUVs (Fig. 2).
Following the formation of the dsGUVs, we used a pico-injection
system24 to inject and to fuse transmembrane protein-containing
proteoliposomes, that is, liposomes containing TAMRA-labelled
αIIbβ3 integrin or Alexa 488-labelled FoF1-ATP synthase (Methods),
with the dsGUVs composed of 8:1:1 DOPC:DOPE:DOPS. Lipid la-
belling was obtained by adding either 1%ATTO 488-labelled DOPE
or 1% Rhodamine B (RhB)-labelled DOPE. The co-localization of
the integrin or the FoF1-ATP synthasewith the lipid fluorescence sig-
nals is shown in Fig. 3a, indicating the successful fusion of the pro-
teoliposomes with the dsGUVs. As a control, we injected FoF1-ATP
synthase into copolymer-stabilized droplets without any dsGUVs,
and mixed these droplets with dsGUVs containing FoF1-ATP syn-
thase. It should be noted that only within the dsGUV was the
FoF1-ATP synthase fused with the periphery. In the case of droplets
without dsGUVs, FoF1-ATP synthases were distributed homoge-
neously within the entire droplet. Similar results were obtained for
integrin. This clearly indicates that transmembrane proteins such as
FoF1-ATP synthase or integrin need the formation of a dsGUV to
fuse with the lipid bilayer on the droplet periphery.
FRAP measurements of transmembrane proteins reconstituted
into dsGUVs revealed diusion coecients of 1.20  0.7 and
0.70 0.1 µm2 s 1 for FoF1-ATP synthase and integrin, respectively.
This value is in good agreement with previously published studies
on integrin αIIbβ3 mobility in planar supported lipid bilayers and
in cellular membranes2931. Moreover, to test the functionality of
the reconstituted integrin, RGD peptides anchored to gold-linked
surfactants21,32 (Methods) were used to provide binding sites for
integrin adhesion (Fig. 3b). In this case, the diusion coecient
of integrin dropped to 0.13  0.03 µm2 s 1, consistent with the
mobility of the copolymer surfactant layer that stabilizes the droplet.
Successful binding between the integrin and the RGDon the droplet
interface indicates the functional incorporation of integrin into the
lipid bilayer of the dsGUVs. It also reveals that at least some of
the integrin proteins are oriented correctly, with their extracellular
parts pointing towards the inner interface of the copolymer-
stabilized droplet. It should be mentioned that the establishment of
amethodology for integratingmembrane proteins into lipid bilayers
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Figure 2 | Sequential bottom-up assembly of dsGUV cell-like compartments. Schematic representation of the process for incorporating transmembrane
and cytoskeletal proteins into dsGUVs by means of high-throughput droplet-based pico-injection technology. Scale bar, 50 µm.
with a specific orientation is not in the scope of this work, but is an
important task for future studies.
For the activity assessment of the reconstituted FoF1-ATP
synthase in dsGUVs, an acidic FC-40 oil was added to the oil phase.
This addition resulted in the establishment of a transmembrane
pH gradient (1pH) as a driving force for ATP synthesis inside the
droplets (Methods and Fig. 3c). Following 2min incubation time,
the aqueous content of the dsGUVswas released and the synthesized
ATP concentration was determined by means of bioluminescence
luciferase in a plate reader (Methods). A total amount of 5 nM
ATP was measured in the released solution (Fig. 3c and Methods),
which indicates the functional reconstitution of the FoF1-ATP
synthases in the dsGUVs. It also reveals that at least some of the
FoF1-ATP synthases are oriented correctlythat is, the F1 portion is
pointing towards the inside of the dsGUV. The low concentration
of synthesized ATP can be attributed to the lack of a sucient
transmembrane electric potential gradient33. Moreover, the time
delay between generating the proton motive force for ATP synthesis
and the determination of the produced ATP was long so that
enzyme-catalysed and pH-dependent ATP hydrolysis could reduce
the amount of the remaining ATP. The drop of ATP over time as
measured in the plate reader is attributed to the kinetic instability of
ATP (Fig. 3c).
The same pico-injection approach was applied to obtain a
bottom-up reconstitution of the actin cytoskeleton or microtubules
within the dsGUVs (Methods). Towards this end, we proceeded
by the following two-step process: the formation of dsGUVs
(90% DOPC, 9% DOPS and 1% RhB-DOPE) in the presence of an
actin or tubulin polymerization buer; the pico-injection of G-actin
(10 µM final concentration, including 1% Alexa 488-labelled G-
actin) or tubulin (10 µM final concentration, including 10% ATTO
488-labelled tubulin) solution into the dsGUVs. Moreover, we
compared this pico-injection approach to the premixed (one-step)
approach, in which G-actin or tubulin proteins were mixed with
LUVs prior to droplet formation (Methods).
The successful reconstitution of the actin filaments and
microtubules within the dsGUVs could be obtained by sequential
pico-injection only (Fig. 3d, middle panel). When using the one-
step premixed approach, vesicle fusion to the droplets' inner surface
was suppressed. In the case of microtubules none, and in the case of
F-actin only partial fusion, was observed (Fig. 3d, top panel). The
inability to form dsGUVs in the presence of microtubules is related
to the fact that LUVs are subject to perturbations stemming from
the amphiphilic nature of tubulin34. The sequential pico-injection
approach enables the prior formation of stable dsGUVs with
appropriate ionic conditions followed by the injection of proteins
without perturbing the lipid bilayer of the dsGUVs.
Release of GUVs into physiological environments
To pave the way towards investigations of protocell interactions
with physiological environments, we developed both a bulk and a
microfluidic method to release assembled GUVs with or without
proteins from the oil phase and stabilizing droplet shell to the water
phase (Methods). By dissolving distinctive fluorophores in the oil
phase as well as the enclosed and continuous aqueous phase, we
could validate that the lipid membrane remains fully intact and
impervious during the release process and that no oil residue could
be detected in thewater phase or the releasedGUVs (Supplementary
Fig. 6). Moreover, to assess the purity of the GUVs, Raman spectra
were collected on released GUVs (Supplementary Methods and
Supplementary Fig. 7). As can be observed, no oil/surfactants were
detected in the Raman spectra of the released GUVs. Addition-
ally, by means of fluctuation analysis we calculated the bending
rigidity values (21.5  3.4kBT ) of released GUVs (Supplementary
Methods). This value lies in the range of typical values reported
for the bending rigidity of PC membranes35, suggesting that the
bilayers are clean of impurities. Moreover, these values correlate
strongly with the bending rigidity values (25.3 3.0kBT ) of the
GUVs, consisting of the same lipid composition and formed by a
standard electroformation method (Supplementary Methods).
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Figure 3 | Incorporation of transmembrane and cytoskeletal proteins into the dsGUV compartments by pico-injection technology. a, The left and right
pair of images show representative fluorescence images of the same areas of observation after pico-injection of integrin-containing liposomes
(ATTO 488-labelled DOPE lipids in green and TAMRA-labelled αIIbβ3 integrin in red) and of FoF1-ATP synthase-containing liposomes into the dsGUVs
(RhB-labelled DOPE lipids in yellow and Alexa 488-labelled FoF1-ATP synthase in green), respectively. Superimposed on the right pair of images is the
fluorescence intensity profile. Lipids and FoF1-ATP synthases clearly co-localize in dsGUVs. Without an inner dsGUV (white dashed circle), the signal from
the Alexa 488-labelled FoF1-ATP synthase is equally distributed within the droplet. Scale bars, 20 µm. b, Schematic illustration and representative results of
FRAP measurement of labelled integrin with (top row) and without (bottom row) immobilization to the gold-linked surfactants via RGD peptides. The focus
area of the light source is encircled in the pre-bleach frame and the timeline on top indicates when follow-up images were taken. Scale bar, 10 µm.
c, Schematic illustration of FoF1-ATP synthase-reconstituted dsGUVs and of the transmembrane pH gradient—the driving force of ATP synthesis—as
achieved by the addition of acidic FC-40 oil. The right graph shows the bioluminescence intensity response to the ATP content as a function of time. The
insert shows the representative bioluminescence intensity curves obtained from the aqueous content of dsGUVs activated (red) by a pH gradient and
dsGUVs without a pH gradient (black). The bioluminescence curve was calibrated by the addition of 100 nM ATP solution. d, Representative fluorescence
images of microtubules (10% ATTO 488-labelled tubulin, left panel) or the actin cytoskeleton (1% Alexa 488-labelled actin, right panel) in droplets
containing RhB-labelled DOPE lipids, as obtained by either the premixed (top) or the pico-injection approach (bottom). Scale bar, 20 µm.
To demonstrate the interactions of the released protocells with
physiological environments, Fig. 4 shows optical micrographs
of integrin αIIbβ3- or F-actin-containing dsGUVs and their
corresponding protocells in the aqueous phase after release. To
validate the functionality of the reconstituted integrin αIIbβ3, the
spreading behaviour of the released integrin αIIbβ3-functionalized
GUVs is investigated. While these integrin αIIbβ3-protocells do not
spread on BSA-coated interfaces, they spread well on fibrinogen
but less on fibronectin or collagen matrices as is expected
from the platelet adhesion receptor integrin αIIbβ3 (Fig. 4b and
Supplementary Methods and Supplementary Fig. 8; refs 32,36). The
dierential adhesion on the various matrices further demonstrates
that the protein reconstitution and release process does not aect
the biological functionality of the synthetic cells.
In conclusion, the developed technology overcomes fundamen-
tal limitations associated with the formation and manipulation of
currently existing protocells or polymersomes for the design of
complex synthetic cells. Recently developed microfluidic methods
showed remarkable success with the high-throughput formation
of monodisperse GUVs3739. Moreover, a control over the GUV
lipid composition and its asymmetry was achieved by microfluidic
methods such as layer-by-layer lipids assembly40, pulse-jet41 and
droplet shooting42. Despite the progress made in recent years in
designing protocells, the major drawback of all of these methods
is a lack of ability to suciently manipulate the protocell content
sequentially. The assembly of a cell-like compartment with dis-
tinct functionality requires the combination of dierent proteins,
molecules and buer conditions that are incompatible when applied
to the same spatial confinement all at once. The formation of ds-
GUVs enables the generation of mechanically and chemically stable
compartments which can be loaded sequentially with dierent pro-
teins andmolecules using pico-injection technology. This sequential
procedure allows for a combination of molecules and organized
molecular structures that would not occur spontaneously. These
system properties lay the groundwork for realizing a real bottom-up
assembly of rather complex combinations and functions in synthetic
compartments. Importantly, the ability to release functional proto-
cells from the stabilizing droplets into water phase paves the way to-
wards investigations of interactions of synthetic cells with physiolog-
ically relevant environments such as given by extracellular matrices,
cells, viruses or signalling molecules. Finally, it is worthwhile men-
tioning that the formation of synthetic cells by this technology is a
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Figure 4 | Release of actin- and integrin-reconstituted GUVs. a,b, Representative 3D reconstitution of confocal images of dsGUVs with reconstituted
integrin (a) and released lipid compartments with reconstituted integrin in contact with BSA- (left image) and fibrinogen-coated (right image)
glass surfaces (b). The merged fluorescence signals include both ATTO 488-labelled DOPE lipids and TAMRA-labelled αIIbβ3 integrin. c,d, Representative
fluorescence images of the actin cytoskeleton-containing dsGUVs (c) and of the released actin cytoskeleton-containing lipid compartments (d).
The fluorescence signals correspond to Alexa 488-labelled actin (red) and RhB-labelled DOPE lipids (green). Scale bar, 20 µm.
high-throughput method enabling the generation of up to 103 func-
tional compartments per second. As a result, it generates a vast num-
ber of synthetic cells of unique and precise composition, which can
be applied for follow-up scientific and technological applications.
Methods
Methods, including statements of data availability and any
associated accession codes and references, are available in the
online version of this paper.
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Methods
Fluorescence intensity analysis. To compare the lipid membrane fluorescence
intensity of encapsulated GUVs to that of dsGUVs with the same lipid composition
(1:1 Egg PC:Egg PG, including 0.5% ATTO488-DOPE), the droplets were
evaluated back-to-back, preserving identical settings with a Leica SP5 confocal
microscope (Supplementary Methods). More than twenty intensity profiles were
extracted for each droplet type using Fiji/ImageJ. Fluorescence analysis of the
encapsulated GUVs revealed a reduction in the amplitude and a broadening of the
fluorescence intensity profile peak in proximity to the copolymer-stabilized droplet
interface (Fig. 1b). This is due to refraction and diraction at the wateroil phase
barrier. To compare the fluorescence intensities, a Gaussian function with a
background correction was fitted to the intensity profile peaks using a nonlinear
least-squares fit (Matlab 2015 SP1).
Microfluidic release device. A high-throughput microfluidic device was developed
to release assembled lipid compartments from the stabilizing polymer droplet shells
into the aqueous phase (Fig. 1c). All flows inside the device were controlled by a
microfluidic flow control system (MFCS-EZ, Fluigent). To minimize shear forces,
the height of the channels was designed to exceed the droplet diameter, and the
pressure in the inlet channels was adjusted to a maximum of 20 mbar with minor
corrections for individual devices and experimental conditions. The dsGUVs were
injected into the inlet channel of the release device and isolated at the T-junction
where a tributary oil flow containing 20 vol% perfluoro-1-octanol destabilizing
surfactants (Sigma-Aldrich) joins. The total flow was adjusted to allow ecient
time for the destabilizing surfactants to replace and displace stabilizing surfactants
prior to reaching the release unit. In this unit, the dsGUVs encounter the aqueous
phase in a wide perpendicular channel. To minimize the mechanical impact on the
droplets at the oil/water junction, the droplets were decelerated using passive
trapping structures within the microfluidic channels (that is, rows of pillars
separated by distances smaller than the representative droplet dimensions), which
we designed for this purpose (Supplementary Movie 2)43.
To avoid oil penetrating into the aqueous channel whenever there were no
droplets in the trapping structures, the aqueous flow was adjusted to achieve a
zero-pressure gradient at the oil/water junction. As a result, the oil flows into the
adjacent oil outlet channels without droplets blocking the slits. Whenever a droplet
enters, it blocks the first slits on both sides, thereby increasing the pressure. As the
droplet flows along the passive trapping structures, it passes pairs of slits, opening
these up for oil flow to the oil outlet channels. With each pair of slits that opens up,
the channel cross section for the oil flow to the adjacent oil channels increases,
subsequently decreasing the pressure that is pushing the droplet along the channel.
The droplet decelerates as it approaches the oilwater interface. Upon contact with
the aqueous phase, the residual surfactant layer peels o the droplet's polymer shell,
which flows to the oil outlet channel. This releases the droplet's aqueous content
(including the lipid compartments) into the aqueous phase with the appropriate
ionic conditions.
Lipid composition for release. The release eciency of GUVs was found to be
dependent on the lipid composition. A few general key factors for the stability of
lipid bilayers have been identified. First, for better stability of self-supporting
released GUVs 1020 mol% cholesterol was included (C8667, Sigma-Aldrich) for
the release experiments. The lipid composition used for the results presented in
Fig. 1c, consisted of a molar ratio of 4:4:2 of DOPC, POPC and cholesterol,
respectively and included 0.5% Atto488-DOPE for observation. Second, in the case
of negatively charged GUVs, release eciency was aected when lipid
compositions exceeded a net concentration of 10 mol% of negatively charged lipids.
Therefore, the optimized lipid composition for the release experiments of
negatively charged GUVs consisted of a molar ratio of 1:8:1 of DOPG, DOPC and
cholesterol, respectively.
RGD-peptide immobilization to the gold-linked surfactants. To provide integrin
adhesion sites inside the gold-nanostructured droplets, a two-step method to
immobilize SN528 RGD peptides32 (kindly provided by Kessler's group from TU
Munich) on gold nanoparticles via its thiol linker was followed21. The freeze-dried
Au-PEG(436 gmol 1)-PFPE(7,000 gmol 1) diblock-copolymer surfactant was
dissolved in 100 µl fluorinated FC-40 oil. Next, the aqueous RGD-peptide solution
(50 µM, 100 µl) was added and everything was stirred for 1 h. To remove the
unbound RGD peptides, the crude product solution was centrifuged. The
supernatant solution was removed and the precipitant was freeze-dried for 24 h to
completely remove the remaining water. Finally, the product was dissolved in 1ml
of FC-40 oil and filtered with a hydrophobic filter (PTFE 0.2 µm) to remove traces
of unreacted peptide.
GFP immobilization. (His6)-GFP was a gift from S. Gardia, Addgene, plasmid
#29663. The protein was expressed in Escherichia coli using standard protocols and
purified by Ni-NTA chromatography. The linkage of (His6)-GFP to gold-linked
surfactants via Ni-NTA-thiol was performed as previously described21, with the
exception that purified Milli-Q water (Millipore filtered) was used as the aqueous
phase instead of PBS buer. To link (His6)-GFP to the lipid bilayer, the following
procedure was applied. NiCl2 (9 µl, 100mM, Fluka) was mixed with a water
solution of DGS-NTA lipids (300 µl, 1mM) and stirred for 20min. LUVs produced
from 9:1 DOPC:DGS-NTA(Ni) (220 µM) were encapsulated into
copolymer-stabilized droplet shells (100 µm diameter). Following encapsulation, a
water solution containing (His6)-GFP (10 µM) and MgCl2 (10mM) was
pico-injected into the droplets to form GFP-linked dsGUVs.
Integrin purification labelling and reconstitution. Integrin αIIbβ3 was purified
from outdated human blood platelets (Katharinenhospital Stuttgart) using TBS and
Triton X-100 according to a previously reported protocol32. Anity
chromatography over Concanavalin A and Heparin columns was followed by gel
filtration over a Superdex 200 Prep Grade column (GE Healthcare). The biological
activity of the purified integrin was analysed by an enzyme-linked immunosorbent
assay (ELISA) using AB1967 anti-integrin αIIb antibodies (Merck Millipore).
Following purification, integrin was stored at 80 C in TRIS storage buer,
consisting of 20mM TRIS/HCl pH 7.4, 150mM NaCl, 1mM CaCl2, 1mMMgCl2,
0.1% (w/v) Triton X-100, 0.02% (w/v) NaN3 and 2mgml 1 Aprotinin. Integrin
αIIbβ3 was labelled with 5-(and-6)-carboxytetramethylrhodamine, succinimidyl
ester, #C1171 TAMRA (Life Technologies) according to a previously published
protocol44. A dye/protein ratio of 1.0 to 1.2 was measured by molecular dye
extinction ("555D 80,000mol 1cm 1). Functionality was measured with an ELISA
binding assay.
Integrin reconstitution into the liposomes followed a previously published
protocol30. In brief, 50mol% of Egg PC and Egg PG were dried under a gentle
stream of nitrogen and then placed under vacuum conditions overnight. Dried
lipids were dissolved in 1ml of TRIS buer, consisting of 20mM TRIS/HCl, pH 7.4,
50mM NaCl, 0.5mM CaCl2 and 0.1% (w/v) Triton X-100, and integrin was added
to a final 1:1,000 integrinlipid ratio and incubated in the solution at 37 C for 2 h.
Triton X-100 was removed in two subsequent washing steps of 3.5 h each using
50mgml 1 BT Bio-Beads SM-2 (#152-8920, BIO-RAD). The size distribution of
the liposomes and integrin-reconstituted proteoliposomes was measured by
dynamic light scattering (DLS) in a Malvern Zetasizer (Nano ZS). Pico-injection
technology was used to inject the integrin liposomes into the dsGUVs, which
contained integrin activation buer (20mM TRIS/HCl, pH 7.4, 50mM NaCl,
0.5mM CaCl2, 1mMMnCl2 and 1mMMgCl2). Theoretical estimation of the
number of integrin proteins that might be reconstituted into dsGUVs is presented
in Supplementary Note 4.
For the release of integrin-reconstituted GUVs from the stabilizing droplet
shells, integrin was reconstituted into liposomes consisting of 100% EggPC. These
proteoliposomes were mixed at a ratio of 1:9 with liposomes containing 4:3:2
DOPC:POPC:cholesterol including 1% ATTO 488-labelled DOPE and used for
dsGUV formation.
FoF1-ATP synthase purification, labelling, reconstitution and activity
assessment. The purification of FoF1-ATP synthase from E. coli and subsequent
cysteine labelling at the C terminus of subunit a with Alexa 488 maleimide were
performed according to the protocols described in Zimmermann et al.45 and
Heitkamp and colleagues46. Labelled (or unlabelled) FoF1-ATP synthase was
reconstituted into preformed liposomes (120 nm diameter) as described in
Fischer and Gräber33 and stored at 80 C in tricine buer, consisting of 20mM
tricineNaOH (pH8.0), 20mM succinic acid, 0.6mM KCl, 50mM NaCl and
2.5mMMgCl2. Pico-injection technology was used to inject the FoF1-ATP synthase
liposomes into the dsGUVs, which contained FoF1-ATP activity buer, consisting
of 20mM tricineNaOH (pH7.5), 20mM succinic acid, 10mMMgCl2, 5mM
NaH2PO4 and 50 µM ultra-pure ADP (Cell Technology).
For the activity assessment of the reconstituted FoF1-ATP synthase in dsGUVs
the ATP synthase has to be energized by a transmembrane pH gradient established
between the FoF1-ATP synthase-containing dsGUVs and the surrounding oil. To
generate a pH gradient (1pH 3), 1µl of trifluoroacetic acid (TFA, 99%,
Sigma-Aldrich) was dissolved in 1ml FC-40 oil47 and an oil exchange was
performed. Following the application of the acidic oil, the change in the droplets'
internal pH through proton diusion was analysed by pyranine intensity detection
(Supplementary Movie 3 and Supplementary Fig. 10)48.
Following the reconstitution of the FoF1-ATP synthases in dsGUVs, 100 µl
oil/dsGUVs solution was transferred to a 500 µl Eppendorf tube and 20 µl of acidic
FC-40 oil was added by pipetting. The Eppendorf tube was carefully tilted and
slowly rotated for 2min. Then, 5 µl of perfluoro-1-octanol 20 vol% destabilizing
surfactants (Sigma-Aldrich) was added to release the content of the droplets. To
analyse the ATP content, 5 µl of the released aqueous solution was transferred to a
well on a non-transparent 96-well plate with a flat bottom, containing 180 µl tricine
buer and 20 µl of 10-fold concentrated luciferase reagent (ATP Bioluminescence
Kit CLS II, Sigma-Aldrich). A plate reader (Infinite M200, Tecan) was used to
detect the bioluminescence intensity corresponding to the synthesized ATP in the
aqueous solution. As a control, the same amount of aqueous solution was released
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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from the FoF1-ATP synthase-containing dsGUVs that were not energized by a
transmembrane pH gradient and analysed. To assess the amount of synthesized
ATP, a bioluminescence calibration curve was produced by the addition of 100 nM
ATP solution.
Actin polymerization within dsGUVs. Actin was purchased from Cytoskeleton.
Actin was stored in TRIS storage buer, consisting of 2.0mM TRIS/HCl pH 8,
0.2mM CaCl2, 0.2mM ATP, 0.005% NaN3 and 0.2mM DTT, at 80 C. Human
recombinant fascin was purchased from Novubio (Bio-Techne), aliquoted and
stored at 80 C. 1% of Alexa 488-labelled actin (Life Technologies) was added to
the non-labelled actin in all experiments to detect actin filament formation. To
polymerize actin inside the dsGUVs, two methods were tested:
Premixed approach: Lipid and G-actin solutions were introduced via a microfluidic
aqueous two-phase system (Supplementary Fig. 4C). To avoid polymerization prior
to droplet formation, one aqueous phase contained 10 µM actin (1% Alexa
488-labelled actin) in storage buer and the other aqueous phase contained the
polymerization buer (2.0mM TRIS/HCl pH 8, 20mMMgCl2 0.2mM CaCl2,
0.5mM ATP, 0.005% NaN3 and 0.2mM DTT), 0.5 µM fascin and LUV solution
consisting of 90% DOPC, 9% DOPS and 1% RhB-DOPE. The two aqueous phases
were mixed during droplet generation at a flow-focusing junction (Supplementary
Fig. 4).
Pico-injection approach: Two experimental steps were required for stable F-actin
creation in dsGUVs. The first step entailed the creation of dsGUVs (90% DOPC,
9% DOPS and 1% RhB-DOPE) that contain actin polymerization buer. The
second step was the pico-injection of storage buer containing G-actin (10 µM
final concentration) and fascin (0.5 µM final concentration) into these droplets.
For the release of F-actin-containing GUVs a lipid composition of
DOPC:cholesterol:DOPG (76mol% DOPC, 20mol% cholesterol, 3mol% DOPG
including 1mol% RhB-labelled DOPE) was used when creating the dsGUVs.
Microtubule formation within dsGUVs. Tubulin (kindly provided by Surrey's
group, the Francis Crick Institute) was purified from pig brain according to
previously described protocols49. It was then labelled with ATTO 488-SE (Life
Technologies) as described earlier50. Tubulin concentrations were measured using
UV spectroscopy ("280D115,000M 1cm 1). The labelling ratio of ATTO
488-labelled tubulin was 0.65 dye molecules per tubulin dimer. Labelled and
unlabelled tubulin were stored at 80 C in PIPES storage buer (20mM PIPES
pH6.8, 7.25mMMgCl2, 1mM EGTA, 1mM 2-mercaptoethanol, 50 mM KCl,
31mM glucose, 1mgml 1 glucose oxidase and 0.5mgml 1 catalase and
0.25mgml 1 beta-casein). To form microtubule networks inside the dsGUVs, two
methods were tested:
Premixed approach: Tubulin 14.5 µM (10% labelled with ATTO 488-SE) dissolved
in polymerization buer (20mM PIPES pH6.8, 7.25mMMgCl2, 1mM EGTA,
3mM GTP, 1mM 2-mercaptoethanol, 50mM KCl, 31mM glucose, 1mgml 1
glucose oxidase and 0.5mgml 1 catalase, 0.25mgml 1 beta-casein) was mixed
with the LUV solution (90% DOPC, 9% DOPS and 1% RhB-DOPE) and
introduced into the microfluidic device via an aqueous channel. To avoid tubulin
polymerization prior to droplet formation, droplets were produced at 4 C. After
droplet production, tubulin polymerization was triggered by transferring the
droplets to a 37 C observation chamber.
Pico-injection approach: Two experimental steps were required for producing
stable microtubules in dsGUVs. The first step entailed the creation of dsGUVs
(90% DOPC, 9% DOPS and 1% RhB-DOPE) that contain tubulin polymerization
buer. The second step was the pico-injection of the storage buer containing
tubulin (14.5 µM) into these droplets to get a 10 µM final concentration.
Bulk release approach. For the successful release of integrin αIIbβ3- or
F-actin-containing GUVs (Fig. 4a,b, respectively), the lipid compositions
of the dsGUVs were optimized in each case. More details are given in the
corresponding methods.
Following the formation of protein-containing dsGUVs, 100 µl
oil/dsGUV-containing solution was transferred into a 2ml Eppendorf tube
containing 1ml FC-40 oil/surfactant solution (identical to the FC-40 oil/surfactant
solution used for dsGUV production). Next, 100 µl of the appropriate buer (actin
polymerization buer or integrin activation buer) was pipetted on to the droplet
emulsion. To destabilize the polymer shell of the droplets, 100 µl of 20 vol%
perfluoro-1-octanol destabilizing surfactants (Sigma-Aldrich) dissolved in FC-40
oil was added. The Eppendorf tube was carefully tilted and slowly rotated until the
emulsion was broken. The released GUVs were studied in an observation chamber
made of BSA-coated glass slides and cover slips. The observation chambers were
prepared by incubating the glass with 10mgml 1 BSA in PBS for 2 h at room
temperature, followed by two 5min washing stepsone with PBS and one
with water.
Code availability.Matlab 2015 SP1 codes used for FRAP and intensity analyses are
available in the Supplementary Notes 5 and 6, respectively.
Data availability. Data supporting the findings of this study are available within
the article and its Supplementary Information files and from the corresponding
authors on reasonable request.
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Supplementary Text 
Supplementary Movie Legends 
Supplementary Movie 1 
The formation of a dsGUV out of the encapsulated GUVs.  
Representative time-lapse fluorescence microscopy of the process showing the transformation 
of the encapsulated GUVs (ATTO 488-labeled DOPE) into a continuous supported lipid bilayer 
at the droplet inner interface. To transform the encapsulated GUVs into a supported lipid bilayer 
at the copolymer-stabilized droplet inner interface, 10 mM Mg2+ was applied during droplet 
production or by means of pico-injection.  
Supplementary Movie 2 
Microfluidic release device. 
The video shows the dsGUVs encounter the aqueous phase in a wide perpendicular channel. 
To minimize the mechanical impact on the dsGUVs at the oil/water junction, the droplets were 
decelerated using passive trapping structures within the microfluidic channels (i.e., rows of 
pillars separated by distances smaller than the representative droplets dimensions), which we 
designed for the efficient release of GUVs. 
Supplementary Movie 3 
Pyranine as a pH sensor inside microfluidic droplets. 
 
The video shows water-in-oil droplets immobilized in a microfluidic trapping device. The pH-
sensitive fluorophore pyranine (concentration: 50µM) in ATP activity buffer was encapsulated 
into the droplets. To change the pH inside the droplets via the oil phase, acidic oil (containing 
1μL of trifluoroacetic acid per 1 ml FC40 oil) and basic oil (containing 1μL of propyl amine 
per 1 ml FC40 oil) were alternately flushed through the device. As a result, the pH inside the 
droplets changed accordingly from acidic to basic and vice versa. The encapsulated fluorophore 
pyranine was simultaneously excited at 405nm and 458nm wavelength and the corresponding 
emission signal was recorded. Dominant 405nm detection signal indicated by blue color 
corresponds to basic pH, dominant 458nm detection signal indicated by green color corresponds 
to acidic pH. 
 
Supplementary Methods 
 
Preparation of large unilamellar vesicles (LUVs) and free-standing giant unilamellar 
vesicles (GUVs).  
Lipids used in this study: 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
(DOPS), 1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid) 
succinyl] (DGS-NTA), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine 
rhodamine B sulfonyl) (RhB DOPE), 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate 
(Phosphatidic acid), L-α-phosphatidylcholine (Egg PC), L-α-phosphatidylglycerol (Egg PG) 
were purchased from Avanti (Avanti Polar Lipids, USA) and used without further purification. 
ATTO 488 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine was purchased from ATTO TEC 
(Siegen, Germany);  
To obtain the formation of dsGUVs, solutions of LUVs or GUVs, consisting of different lipid 
compositions, were generated according to previously reported protocols.1, 2 In brief, lipids 
were dissolved in pure chloroform, mixed at desired composition and concentration and dried 
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under a gentle stream of nitrogen. To remove traces of the solvent, lipids were kept under 
vacuum in desiccator for roughly 1 h. Dried lipids were then resuspended by addition of the 
desired buffer, followed by one hour of vortexing. LUV size was homogenized by extruding 
the solution 7 times through a polycarbonate filter (Whatman, Germany) with a pore size of 50 
nm using an extruder (Avanti Polar Lipids, USA). The mean LUV diameter distribution was 
determined to be 100 ±10 nm using DLS. Solutions containing LUVs were stored at 4°C for 
not longer than 48 h or used immediately after production.  
GUVs consisting of DOPC:DOPE:DOPS 8:1:1, including 1% ATTO 488-labeled DOPE were 
formed using the electroformation protocols as described previously.2 In brief, lipid mixtures 
at the desired concentration (from 1 to 5 mM) were dissolved in pure chloroform and spread 
onto two indium tin oxide (ITO) coated glasses (Sigma-Aldrich, Germany). Following 
chloroform evaporation, the electroformation cell was assembled. Towards this end, the two 
ITO coated glasses were faced to each other with the conductive sides. To avoid direct contact 
two Teflon spacers (1 mm) were used. Copper tape (3M, USA) was used to connect the 
conducting sides with a signal generator (RS Components, Germany). Subsequently, the 
chamber was filled with Milli-Q water (Millipore filtered) and sealed with two-component glue 
(Twinsil Picodent GmbH, Germany). An alternating electrical potential of 10 Hz at 1 V 
amplitude was applied for 2 h to form GUVs. Finally the GUVs were collected using a syringe.  
Following vesicles production, the solutions were used immediately for encapsulation into 
microfluidic water-in-oil copolymer-stabilized droplets.  
 
Block copolymer surfactant synthesis. Three types of block-copolymer surfactants were 
synthesized according to protocols reported earlier 3, 4 and used to produce droplets: Two 
triblock-copolymers PFPE(7000 g/mol)-PEG(1400 g/mol)-PFPE(7000 g/mol) (TRI7000) and 
PFPE(2500 g/mol)-PEG(600 g/mol)-PFPE(2500 g/mol) (TRI2500) and a gold-linked diblock-
copolymer surfactant Au-PEG(436 g/mol)-PFPE(7000 g/mol). Following synthesis, triblock 
surfactants were mixed separately with gold-linked surfactants and dissolved in FC-40 
fluorinated oil (3M, USA) to the final concentrations of 2.5 mM and 3 μM for triblock and 
gold-linked surfactants, respectively. NOTE: The two types of triblock copolymer surfactants 
(i.e. TRI7000 and TRI2500) mixed with gold-linked surfactants were tested and compared in 
all experiments. If not stated otherwise, the same results were observed. 
 
Droplet-based microfluidics. Droplet-based microfluidic devices made of PDMS (Sylgard 
184, Dow Corning, USA) were prepared by photo- and soft-lithography methods5, 6 as described 
previously.3 To control the droplet diameter during their creation, two different nozzle designs 
at the flow-focusing junction were implemented (Supplementary Figures 4 A and B).  Syringe 
pumps PUMP 11 ELITE (Harvard apparatus, USA) were used to control flow rates of 120 µL/h 
for the aqueous phase and 160 µL/h for the oil phase as required for stable droplet creation 
(diameter d = 40 μm) at the rate of 1 kHz.  In case of big droplets (d = 100 μm) the flow rates 
were adjusted to 650 and 850 µL/h for aqueous and oil phases, respectively to achieve a stable 
droplet creation at a rate of 1 kHz.  
Due to the variety of required cellular components in the droplets the microfluidic device was 
integrated with small and compact electrodes to apply an electric potential. Electrical fields 
allow destabilization (poration) of surfactants and lipid bilayers towards controlled injection 
(pico-injection) of different cellular components into the droplets. The design of the droplet-
based pico-injection unit was adapted from Abate et al.7 Droplets were introduced into the 
device using a MFCS-EZ flow control system (Fluigent, France). The spacing between the 
droplets was controlled through addition of oil via the second oil channel (Supplementary 
Figure 4F). Following separation step, isolated droplets passed an alternating electrical field 
(frequency 1kHz, potential 250 V) generated by HM 8150 signal generator (HAMEG, 
Germany) and amplified by 623B-H-CE amplifier (TREK, USA) and two electrodes made of 
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Indalloy 19 (51% indium, 32.5% bismuth, 16.5% tin, GPS Technologies, Germany). This 
process destabilizes the droplet copolymer shell and lipid bilayer and allows introduction of 
bio-reagents via a pressurized injection channel (Supplementary Figure 4G). The injection 
volume can be ranged between 1 to 100 pl, dependent on the applied pressure.  
For analysis, droplets were collected and transferred to the observation chamber 
(Supplementary Figure 5). The chamber was made of two single or sandwiched stripes of 
double face sticky tapes (Tesa, Germany. Thickness ≈ 80 µm or 160 µm for analysis of small 
and large droplets, respectively) as spacers, glued between two cover slips (Carl Roth, 
Germany). Finally, the chamber was filled with surfactant-containing oil and closed by two-
component glue (Twinsil, Picodent GmbH, Germany). 
 
Glass coatings for integrin-reconstituted GUVs adhesion experiments. To validate the 
biological functionality of the reconstituted integrin after the process of release, the adhesion 
of the integrin-reconstituted GUVs to fibrinogen-, fibronectin-, collagen-, and BSA-coated 
glass surfaces was examined and compared (Supplementary Figure 8). Therefore, dsGUVs with 
reconstituted αIIbβ3 integrin were formed and released as described in (Online Methods). For 
adhesion experiments integrin activation buffer (20 mM TRIS/HCl, pH 7.4, 50 mM NaCl, 0.5 
mM CaCl2, 1 mM MnCl2 and 1 mM MgCl2) was used inside and outside the GUVs. Following 
release the integrin-reconstituted GUVs were transferred to an observation chamber 
(Supplementary Figure 5) containing fibrinogen-, fibronectin-, collagen-, or BSA-coated glass 
slides. The adhesion was analyzed after 8 h incubation at 4°C to allow the integrin to interact 
with the different coatings. For these experiments fibronectin isolated from human plasma8 was 
dissolved in PBS, collagen Type I (calf skin, Sigma-Aldrich, Germany) was dissolved in 0.1 M 
acetic acid and fibrinogen (human plasma, Merck Millipore, Germany) was first dissolved in 
8.5% NaCl and for the incubation transferred to PBS.  
For coating the glass surface of the observation chamber, pretreated glass slides (O2 plasma, 
200 W, 30 s) were incubated with 0.1 mg/ml protein solution (8.5 µg/cm2) over night at 4°C 
(fibrinogen and collagen) or 1.5 h at room temperature (fibronectin). For the BSA coating the 
glasses were incubated with 10 mg/ml BSA in PBS for 2 h at room temperature, followed by a 
washing step with PBS and water for each 5 min. After incubation, the glass slides were air 
dried over night at 4°C. The coverslips for the observation chamber were passivated with BSA. 
 
Microscopy. All experiments were performed on a Leica SP5 confocal microscope (Leica 
Microsystems, Germany) equipped with an argon and a white light laser. The measurements 
were conducted at 25°C and in case of microtubule analysis at 37°C. Droplets, sealed in an 
analysis chamber, were observed via a 63x oil objective (HCX PL APO 63x/1.40-0.60; Leica 
Microsystems GmbH, Germany). Fluorophores were exited at 488, 550 and 555 nm and the 
detection windows were set at 498-540 and 560-620 nm and 565-625 nm in case of ATTO 488, 
Rhodamine B and TAMRA-labeling, respectively. The pinhole for data acquisition was set to 
1 Airy unit, which corresponds to an Airy disk diameter of 96 μm and 0.9 μm thickness of the 
optical slice. 
 
FRAP measurements. Due to the density differences between the aqueous droplets and the 
surrounding oil (1.0⨉103 vs. 1.9⨉103 kgm-3), the droplets ascend towards the upper slide of the 
observation chamber (Supplementary Figure 5). In this position, the droplets were scanned in 
z-direction until the bottom slice of the droplet was identified. The base of the droplet was 
chosen as a focal plane for FRAP measurements in order to exclude any influence from the 
cover slip at the chamber ceiling. A circular spot with a diameter of 5 µm was selected as the 
bleaching area. It should be noted that in case of FRAP measurements performed inside the 
droplets or on their periphery the actual bleaching area was measured and corrected for each 
measurement due to distortion of the optical path as a reason of diffraction/refraction at the 
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oil/water interface. Time course of each FRAP experiment included 10 pre-bleaching images, 
2 to 10 bleach cycles to eliminate the fluorescent signal and 50 to 200 post-bleaching images 
to record the fluorescence recovery. The bleaching time was adjusted to each fluorophore and 
laser used in the experiments, the acquisition frequency of post-bleaching images was adapted 
to the total recovery time. The average diffusion coefficient for each experiment and its standard 
error were calculated from at least 20 measurements. The analysis followed the protocols 
proposed by Axelrod et al.9 and Soumpasis10  as described in Supplementary Note 3. 
 
Raman spectroscopy. For Raman spectra collection released GUVs or dsGUVs were injected 
into the observation chamber (Supplementary Figure 5). GUVs or dsGUVs, sealed in an 
analysis chamber, were observed via a 100x oil objective (NA 1.2, Zeiss, Germany) using a 
confocal Raman microscope (Alpha300RA, WITec GmbH, Germany). To collect Raman 
scattered light, the same objective was used for focusing a 532 nm laser (20 mW, spot size 350 
nm) onto single GUVs or dsGUVs. The acquisition time was fixed to 2.14 seconds with five 
accumulations for each collection window. At the end of spectra collection the location of the 
observed subject was investigated and, in case the location was preserved the collected data 
was saved. The representative Raman spectra of the dsGUVs and of the released GUVs can be 
observed in Supplementary Figure 7. 
 
Fluctuation analysis. Fluctuation analysis was performed following the protocol described 
earlier.11 The GUVs were placed in a chamber made of two cover slips and a 2 mm-thick ring 
made of Teflon, and observed under phase contrast. The data was acquired at room temperature 
~23°C. The acquisition of five thousands of snapshots was done by high-resolution camera 
(pco.edge, PCO AG, Kelheim, Germany). More than 10 vesicles per type of sample were 
examined. 
The bending rigidity of vesicles released from droplets was measured and compared to that of 
vesicles prepared following the method of electrofromation12, 13 or gel-assisted swelling.14 The 
membrane composition was DOPC:POPC:Chol (4:4:2) in mole ratios and small amount of the 
ATTO 488 labeled DOPE was also added at concentration of 1 mol% of total lipid. The buffer 
composition used for fluctuation analysis of the released GUVs was adjusted to be similar to 
integrin activation buffer within the GUVs (20 mM TRIS/HCl, pH 7.4, 50 mM NaCl, 0.5 mM 
CaCl2, 1 mM MnCl2 and 1 mM MgCl2). The bending rigidity of the released vesicles was 
measured to be 21.5 ± 3.4 kBT (standard deviation). This value lies in the range of typical values 
reported for the bending rigidity of PC membranes,15 suggesting that the bilayers are clean of 
impurities. The methods of electroformation and gel-assisted swelling did not yield suitable 
vesicles (the vesicles were small and with defects or multilamellar) when grown in the buffer 
used for the preparation of dsGUVs. Therefore, we electroformed vesicles with the same 
membrane composition but in solution of 1 mM MgCl2. The bending rigidity values for these 
membranes were found to be 25.3 ± 3.0 kBT ideally corresponding to the data for released 
vesicles. 
 
 
Supplementary Notes 
 
Supplementary Note1. Calculation of minimal lipid concentration required to form a 
continuous lipid bilayer inside droplets - dsGUV: 
 
The following lipid concentration calculation is done for droplets with 75 µm radius. The 
volume 𝑉𝑉𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 and the surface area 𝐴𝐴𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 of a spherical droplet is given by 
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𝑉𝑉𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 =
4
3
𝜋𝜋𝑟𝑟3 = 1.8 × 106 𝜇𝜇𝑚𝑚3 =  1.8 𝑛𝑛𝑛𝑛 
and 
 
𝐴𝐴𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 = 4𝜋𝜋𝑟𝑟
2 = 7.1 × 1010 𝑛𝑛𝑚𝑚2. 
 
Assumption: Average area occupied by a single phospholipid in a lipid membrane equals16 
 
𝐴𝐴ℎ𝑑𝑑𝑒𝑒𝑑𝑑𝑒𝑒𝑑𝑑𝑑𝑑𝑒𝑒𝑑𝑑 = 0.7 𝑛𝑛𝑚𝑚
2. 
 
The amount of lipids per droplet needed to form a complete lipid bilayer is therefore: 
 
𝑁𝑁𝑑𝑑𝑙𝑙𝑑𝑑𝑙𝑙𝑑𝑑𝑙𝑙 = 2 ∗ 𝐴𝐴𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝐴𝐴ℎ𝑑𝑑𝑒𝑒𝑑𝑑𝑒𝑒𝑑𝑑𝑑𝑑𝑒𝑒𝑑𝑑⁄ = 2.3 × 10
11. 
 
Thus, the lipid concentration required to form a lipid bilayer inside droplets is 
 
𝑐𝑐 =
𝑁𝑁𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙
𝑉𝑉𝑙𝑙𝑑𝑑𝑑𝑑𝑙𝑙𝑙𝑙𝑑𝑑𝑑𝑑∗𝑁𝑁𝐴𝐴
=
6
𝑑𝑑∙𝑁𝑁𝐴𝐴∙𝐴𝐴ℎ𝑑𝑑𝑒𝑒𝑙𝑙𝑒𝑒𝑑𝑑𝑑𝑑𝑒𝑒𝑙𝑙
= 190 𝜇𝜇𝜇𝜇. 
 The concentration for droplets with different radii used in this study is c(r=50 µm) = 285 µM and c(r=20 µm) = 712 µM. 
For the experiments an excess of ≈15% in lipid concentration was used for the following two reasons: 1) to compensate for possible lipids loss during the production; and 2) to compensate for volume increase due to pico-injection. To validate experimentally the relevance of theoretically estimated lipid concentration, we systematically varied the amount of fluorescently-labeled lipids injected into monodisperse droplets and recorded their fluorescence intensity at the droplet interface. In case of minor lipid amount which would not cover the complete inner surface of the droplet we did not see the assembly of smaller GUVs than the size of the droplet itself. Instead we observed fusion of available lipids at the inner wall of the droplet.  A plot of the measured data is shown in Supplementary Figure 1. Considering the diameter of 
120μm of the droplets used in this experiment, a calculated concentration of 237 μM lipids is required for full bilayer coverage. As can be observed in Supplementary Figure 1, the intensity values are increasing approximately linear up to the theoretical estimated concentration. At elevated concentration the intensity reaches a plateau. It should be noted that at higher concentrations the excess lipids form aggregates of liposomes at the droplet interface. Inhomogeneous aggregation of liposomes on the droplet’s periphery affecting precise estimation of the intensity. Therefore, higher deviation in the recorded 
intensity at 500μM is attributed to this effect. 
 
 
Supplementary Note 2. Calculation of vesicle diffusion in microfluidic droplets 
 
Assuming 3D Brownian motion, the mean square displacement 〈𝑟𝑟2(𝑡𝑡)〉 of a particle in 
solution is 
 
〈𝑟𝑟2(𝑡𝑡)〉 = 6𝐷𝐷〈𝑡𝑡〉. 
 
The mean time 〈𝑡𝑡〉 needed for the particle to travel the distance √〈𝑟𝑟2(𝑡𝑡)〉 is therefore 
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〈𝑡𝑡〉 =  
〈𝑟𝑟2(𝑡𝑡)〉
6𝐷𝐷
. 
 
The diffusion coefficient 𝐷𝐷 of a spherical particle with radius 𝑅𝑅 in a solution with viscosity 𝜂𝜂 
for a given temperature 𝑇𝑇 is  
 
𝐷𝐷 =  
𝑘𝑘𝐵𝐵𝑇𝑇
6𝜋𝜋𝜂𝜂𝑅𝑅
. 
 
Therefore, the average time for a vesicle with radius R needed to diffuse from the center of the 
droplet to the periphery (√〈𝑟𝑟2(𝑡𝑡)〉 = 20 𝜇𝜇𝑚𝑚) is 
 
〈𝑡𝑡〉 =
〈𝑟𝑟2(𝑡𝑡)〉
6
6𝜋𝜋𝜂𝜂𝑅𝑅
𝑘𝑘𝐵𝐵𝑇𝑇
. 
 
Assuming an aqueous solution with 𝜂𝜂 = 0.1 𝑃𝑃𝑃𝑃 ∙ 𝑠𝑠 and a temperature𝑇𝑇 = 25°𝐶𝐶, the average 
time for all vesicle to diffuse from the centrum to the periphery of the droplet with diameter 40 
μm is 
 
〈𝑡𝑡(𝑅𝑅 = 50 𝑛𝑛𝑚𝑚)〉 ≈ 15 𝑠𝑠 
 
and 
 
〈𝑡𝑡(𝑅𝑅 = 5 𝜇𝜇𝑚𝑚)〉 ≈ 25 𝑚𝑚𝑚𝑚𝑛𝑛. 
 
 
Supplementary Note 3. Evaluation of FRAP data 
The analysis followed a protocol proposed by Axelrod et al.9 and Soumpasis.10 To correct the 
background noise Ibg, the detector signal was measured in the oil phase using the same settings 
as for the FRAP measurements. Ibg was subsequently subtracted from all the measured intensity 
values. Average intensity values of the bleaching spot, I(t), and as a reference of the whole 
droplet base, T(t), were extracted from the recorded images. I(t) and T(t) were normalized by 
the averages of the prebleaching values, Ipb and Tpb. To correct for photofading the intensities 
of the bleached spot were multiplied with the reciprocal, normalized intensities of the droplet 
base, T(t). Thus the normalized and corrected intensities, Inor, were calculated as  
 
𝐼𝐼𝑛𝑛𝑑𝑑𝑑𝑑 =
𝐼𝐼(𝑑𝑑)−𝐼𝐼𝑏𝑏𝑒𝑒
𝐼𝐼𝑙𝑙𝑏𝑏−𝐼𝐼𝑏𝑏𝑒𝑒
𝑇𝑇𝑙𝑙𝑏𝑏−𝐼𝐼𝑏𝑏𝑒𝑒
𝑇𝑇(𝑑𝑑)−𝐼𝐼𝑏𝑏𝑒𝑒
. 
 
A nonlinear least-square fit was then applied using MATLAB R2015a SP1 (Mathworks, 
USA) to fit an exponential function 𝑓𝑓(𝑡𝑡), 
 
𝑓𝑓(𝑡𝑡) = 𝑃𝑃(1 − 𝑒𝑒𝑒𝑒𝑒𝑒(𝜆𝜆 ∙ 𝑡𝑡)), 
 
to the normalized intensities, Inor. The resulting values of the coefficient λ were then used to 
calculate the half-recovery time τ1⁄2 for each bleaching experiment, 
 
𝜏𝜏1
2⁄
=
− log(0.5)
𝜆𝜆
. 
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The diffusion coefficient, D, is related to the half-recovery time τ1⁄2 via the square radius of the 
bleaching spot, assuming Gaussian bleaching profile, 
 
𝐷𝐷 =  0.32
𝑑𝑑2
 𝜏𝜏1
2⁄
. 
 
The average diffusion coefficient for each experiment and its standard error were 
calculated from at least 20 measurements (Supplementary Figure 9). 
 
Supplementary Note 4. Calculation of number of integrin proteins that might be 
reconstituted in dsGUVs. 
 
Droplet surface area: 
𝑆𝑆(𝑟𝑟 = 20µ𝑚𝑚) = 5026 µ𝑚𝑚2 
𝑆𝑆(𝑟𝑟 = 50µ𝑚𝑚) = 31416 µ𝑚𝑚2 
Area of a lipid in a membrane (from literature) 
𝐴𝐴𝑑𝑑𝑙𝑙𝑑𝑑 ≈ 0.7𝑛𝑛𝑚𝑚
2 
Cross-section of the transmembrane domain of integrin (two α helices).17  
𝐴𝐴𝑙𝑙𝑛𝑛𝑑𝑑 = 2𝑛𝑛𝑚𝑚
2 
Integrin/Lipid  
Ratio 
Surface area of lipid bilayer with one 
reconstituted integrin. 
𝑁𝑁𝑙𝑙𝑛𝑛𝑑𝑑 
(𝑟𝑟 = 20µ𝑚𝑚) 
𝑁𝑁𝑙𝑙𝑛𝑛𝑑𝑑 
(𝑟𝑟 = 50µ𝑚𝑚) 
1:1000 1000 ∗ 0.7𝑛𝑛𝑚𝑚2
2
+ 2𝑛𝑛𝑚𝑚 = 352𝑛𝑛𝑚𝑚2 
1.43 ∗ 107 8.92 ∗ 107 
1:10,000 10,000 ∗ 0.7𝑛𝑛𝑚𝑚2
2
+ 2𝑛𝑛𝑚𝑚 = 3502𝑛𝑛𝑚𝑚2 
1.44 ∗ 106 8.97 ∗ 106 
 
Supplementary Note 5. Matlab code for FRAP analysis 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% FRAP evaluation 
% version 5 20161010 
% Matlab-script for the evaluation of FRAP data. This script is designed to to evaluate '.csv' files 
exported 
% using the Leica Microscopy Software. For correct evaluation the files should contain 
% three columns, first the intensity values form the bleaching spot, second a reference spot 
% and a thrid a larger area containing the bleaching spot. The data sets can differ in time steps 
and total 
% number of datapoints. The script will output the computed diffusion coefficient for each dataset 
as well 
% the average diffusion coefficient and it's corresponding standard error. Optionally the script 
will draw 
% graphs of each evaluation step. 
  
%Program timer 
%tic 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% A set of parameters that control the evaluation of the results 
% Plotting switch. If value is true all intermediary results are plotted into 
% pdf files. This slows down script drastically 
plotall = true ; 
% Radius of the bleached spot in Âµm. Important for the evaluation of the 
% diffusion coefficient 
w = 2.5; 
% For good results its important, to correct the collected data points for background. 
bg=0; 
% The calculation is on standard done according to protocols published by Axelrod et al. (1976) and 
Soumpasis (1983). 
% Alternatively a model proposed by Kang et al. (2012) can be used, correcting for diffusion during 
the bleaching. 
% To derive the prefactor the script 'Frap radius evaluation.m' can be used. 
pf=0.32; 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Main body of code 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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%% Importing the data and removing rows with empty cells 
files = dir('*.csv'); 
for i=1:length(files) 
    data=importdata(files(i).name); 
    J=all(~isnan(data.data),2); 
    A{i}=data.data(J,:); 
    clear data J 
end 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Plotting of raw data 
if plotall == true 
for i=1:length(files) 
   figure('vis', 'off'); 
    plot1=plot(A{i}(:,1),A{i}(:,2:4),'LineStyle','none'); 
    set(plot1(1),'Marker','o','DisplayName','ROI1'); 
    set(plot1(2),'Marker','.','DisplayName','ROI2'); 
    set(plot1(3),'Marker','x','DisplayName','ROI3'); 
    xlabel('time [s]'); 
    ylabel('intensity'); 
    title(files(i).name) 
    print(sprintf('raw%02d',i) ,'-dpdf') 
end 
end 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Data correction and normalization 
% Each dataset is corrected for background, normalized by the prebleaching value 
% and corrected for photofading in this step 
for i=1:length(files) 
    B{i}=zeros(length(A{i}),2); 
    %% Mean intensity of focus point before bleach 
    Ipre=mean(A{i}(1:10,2)); 
    %% Mean intensity of the total cell before bleach 
    Tpre=mean(A{i}(1:10,4)); 
    %% Calculating normalized values (without background substration) 
    B{i}(:,1)=A{i}(:,1); 
    B{i}(:,2)=(A{i}(:,2)-bg)./(Ipre-bg) * (Tpre-bg) ./ (A{i}(:,4)-bg); 
end 
  
clear i j A Ipre Tpre bg 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Plotting normalized graphs 
if plotall == true 
for i=1:length(files) 
   figure('vis', 'off'); 
    plot(B{i}(:,1),B{i}(:,2),'Marker','o','LineStyle','none','DisplayName','B(:,1.6)'); 
    xlabel('time [s]'); 
    ylabel('intensity'); 
    title(files(i).name) 
    print(sprintf('normalized%02d',i) ,'-dpdf') 
end 
clear i 
end 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Initialization of the fitting model 
% As fitting function an exponential recovery curve is chosen. A robust, non-linear least square has 
proven to 
% show good results. The fit outputs information about the fit quality to allow debugging. 
    fo = fitoptions('method','NonlinearLeastSquares','Lower',[0 0],'Upper',[1 Inf], 
'Robust','Bisquare'); 
    st = [1 1]; %starting point 
    set(fo,'Startpoint',st); 
    ft = fittype('a*(1-exp(-t*b))',... 
              'dependent',{'y'},'independent',{'t'},... 
              'coefficients',{'a','b'}); 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% The normalized data is fitted to the previously initialized fitting model. The results are 
directly plotted. 
C=zeros(2,length(files)); 
for i=1:length(files) 
    [cf,gof] = fit(B{i}(11:length(B{i}),1)-B{i}(11,1),B{i}(11:length(B{i}),2)-B{i}(11,2),ft,fo); 
    C(:,i) =  transpose(coeffvalues(cf)); 
    if plotall == true 
        figure('vis', 'off') 
        hold on 
        ylim([-0.05 0.2]) 
        plot(B{i}(:,1)-B{i}(11,1),B{i}(:,2)-
B{i}(11,2),'Marker','o','LineStyle','none','DisplayName','B(:,1.6)'); 
        plot(cf); 
        xlabel('time [sec]','FontSize',20) 
        ylabel('normalized fluorescence Intensity','FontSize',20) 
        title(files(i).name) 
        print(sprintf('fitted%02d',i) ,'-dpdf') 
    end 
    clear cf gof 
end 
  
clear i st fo ft plotall B 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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%% Calculation of diffusion coefficients 
% The values are computed from the fitting results and the size of the bleaching spot. They are 
% first calculated for each dataset seperately and then the average and standard error is computed. 
% The calculation is on standard done according to protocols published by Axelrod et al. (1976) and 
Soumpasis (1983). 
% Alternatively a model proposed by Kang et al. (2012) can be used, correcting for diffusion during 
the bleaching 
tauh=-log(0.5)./C(2,:); 
C(3,:) = pf*w^2./tauh; 
D = [mean(C(3,:)), std(C(3,:))/sqrt(length(C(3,:)))]; 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Saving the results 
save coefficients.txt C -ASCII 
fid = fopen('diffusion_coefficient.txt', 'w'); 
fprintf(fid, 'diffusion_coefficient std_error [ÂµM^2/s]\n'); 
fprintf(fid, '%f    %f',D); 
close 
  
clear files w fid tauh pf 
  
%toc 
 
Supplementary Note 6. Matlab code for fluorescence intensity analysis 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Droplet intensity profile evaluation script 
% version 4 20161205 
% As there is refraction and defraction on the water oil interface of the droplets, 
% it is difficult to compare the fluorescence intensity of GUV and dsGUV. This script 
% tries to solve this problem by fitting and integrating the fluorescence 
% intensity profile. This script is designed to to evaluate '.csv' files exported 
% using the Leica Microscopy Software 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% A set of parameters that control the evaluation of the results 
% Plotting switch. If value is true all intermediary results are plotted into 
% pdf files. This slows down script drastically 
plotall = true; 
  
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Main body of code 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Importing the data and removing rows with empty cells 
files = dir('*.csv'); 
for i=1:length(files) 
    data=importdata(files(i).name); 
    J=all(~isnan(data.data),2); 
    A{i}=data.data(J,:); 
    clear data J 
end 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Plotting of raw data 
if plotall == true 
  for i=1:length(files) 
    figure('vis', 'off'); 
    hold on 
    plot1=plot(A{i}(:,3),A{i}(:,4)); 
    set(plot1(1),'Marker','o','DisplayName','ROI1'); 
    xlabel('position [Âµm]'); 
    ylabel('intensity'); 
    title(files(i).name,'FontSize',24) 
    print(sprintf('raw%02d',i) ,'-dpdf') 
   end 
end 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Fitting of Gaussian functions to the peaks 
% The data is split in two arrays around each peak and fitted with Gaussian functions 
B=zeros(length(files)*2,2); 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Finding good starting points 
% Searches for the position and values of two intensity peaks of a droplet crossection. 
for i=1:length(files) 
    j=round(length(A{i})/2); 
    [m1 p1]=max(A{i}(1:j,4)); 
    [m2 p2]=max(A{i}(j:length(A{i}),4)); 
    B(i*2-1,1)=m1; 
    B(i*2,1)=m2; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Fitting a Gaussian function to the data via a nonlinear least square to the 'left' peak 
% The fit uses the previously derived values as starting points 
    fo = fitoptions('method','NonlinearLeastSquares','Lower',[0 0 0 2],'Upper',[100 A{i}(j,3) 1e-4 
3], 'Robust','Bisquare'); 
    st = [m1 A{i}(p1,3) 1e-6 2.2]; %starting point 
    set(fo,'Startpoint',st); 
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    ft = fittype('a1*exp(-((x-b1)/c1)^2) +c3',... 
              'dependent',{'y'},'independent',{'x'},'coefficients',{'a1','b1','c1','c3'}); 
    x=A{i}(1:j,3); 
    y=A{i}(1:j,4); 
    f1=fit(x,y,ft,fo); 
    c=coeffvalues(f1); 
    B(i*2-1,2)=c(1)*c(3)*pi^.5; 
    clear c 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Fitting a Gaussian function to the data via a nonlinear least square to the 'right' peak 
% The fit uses the previously derived values as starting points 
    fo = fitoptions('method','NonlinearLeastSquares','Lower',[0 A{i}(j,3) 1e-10 2],'Upper',[100 
A{i}(length(A{i}),3) 1e-4 3], 'Robust','Bisquare'); 
    st = [m2 A{i}(p2+j,3) 1e-6 2.2]; 
    set(fo,'Startpoint',st); 
    x=A{i}(j:length(A{i}),3); 
    y=A{i}(j:length(A{i}),4); 
    f2=fit(x,y,ft,fo); 
    c=coeffvalues(f2); 
    B(i*2,2)=c(1)*c(3)*pi^.5; 
    clear c 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Plotting of data with fitting results 
        if plotall == true 
          figure('vis', 'off'); 
          hold on 
          plot(A{i}(:,3),A{i}(:,4)); 
          plot(f1); 
          plot(f2); 
          xlabel('position [µm]','FontSize',20) 
          ylabel('Intensity','FontSize',20) 
          title(files(i).name,'FontSize',24) 
          print(sprintf('fitted%02d',i) ,'-dpdf') 
    end 
    clear x y j m1 m2 p1 p2 fo ft f1 f2 i st c 
end 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Calculation of maximal intesity values and integrated intensity 
% The columns contain in order: the mean maximal values, the corresponding standard error, 
% the integrated intensity, and the corresponding standard error. 
C(1,1)=mean(B(:,1)); 
C(1,2)=std(B(:,1))%/sqrt(length(files)); 
C(1,3)=mean(B(:,2))*10^6; 
C(1,4)=std(B(:,2))*10^6%/sqrt(length(files)); 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Saving the results 
fid = fopen('intensitiy_values.txt', 'w'); 
fprintf(fid, 'max intensity [au] std error [au] integrated intensity [au*µm]  std error 
[au*µm]\n %f  %f  %f  %f',C); 
close 
  
clear plotall files ans plot1 fid  
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Supplementary Figures 
 
 
Supplementary Figure 1 
Fluorescence intensity of the lipids at the droplets interface as a function of encapsulated lipid 
concentration. 
 
To validate experimentally the relevance of theoretically estimated lipid concentration (237 μM, 
Supplementary Note 1), we systematically varied the amount of fluorescently-labeled lipids 
(egg PC:egg PG, 9:1, including 0. 5 % ATTO 488-labelled DOPE) encapsulated into 120 μm 
diameter monodisperse droplets and recorded their fluorescence intensity at the droplet 
interface. In case of lipid concentration lower than 237 μM no smaller GUVs than the size of 
the droplet itself were observed. Instead fusion of available lipids at the inner wall of the droplet 
was detected. As can be observed, the lipid fluorescence intensity values are increasing 
approximately linear up to the theoretical estimated concentration. At higher lipid concentration 
the intensity reaches a plateau. It should be noted that at higher concentrations the excess lipids 
form aggregates of liposomes at the droplet interface. Inhomogeneous aggregation of liposomes 
on the droplet’s periphery affecting precise estimation of the intensity. Therefore, higher 
deviation in the recorded intensity at 400μM lipid concentration is attributed to this effect. The 
mean integrated intensity values and their standard deviation, indicated by the error bars, were 
derived from intensity profiles taken from twenty individual droplets, each intersecting the 
membrane twice rectangularly.  
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Supplementary Figure 2 
Partial vesicle fusion due to 10 mM Ca2+ ions addition. 
 
Representative fluorescence image of lipid distribution (DOPC:DOPE:DOPS 8:1:1, including 
1% ATTO 488-labeled DOPE) within microfluidic water-in-oil droplets, containing 10 mM 
Ca2+ ions (CaCl2), measured 1 h after creation. 
 
 
 
Supplementary Figure 3  
Biofunctionalization of dsGUVs via DGS-NTA(Ni)lipids. 
 
In order to test the functionalization of dsGUVs, (His6)-GFP was pico-injected into droplets. 
(A) For droplets containing DOPC:DGS-NTA(Ni), 9:1 (220 μM), (His6)-GFP was linked to 
the dsGUVs at the droplets periphery. (B) An equally distributed fluorescence signal was 
observed when no anchoring points were present (here: dsGUVs consisting of DOPC lipids 
only). (C) Representative FRAP experiments on the mobility of (His6)-GFP immobilized to the 
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copolymer-stabilized droplet interface (upper trace) or the dsGUV (lower trace). The bleached 
area is encircled in the pre-bleach frame and the recovery time (seconds after bleaching) is 
indicated on top of the fluorescence recovery frames. Scale bar 10 µm. 
 
Supplementary Figure 4 Droplet-based microfluidic functional units.  Presentation of different droplet-based microfluidic operating units used in this research. (A) and (B) show representative images of the flow-focusing junctions for droplets production with a diameter of 40 and 100 μm, respectively. (D) shows a microfluidic droplet production device with two aqueous inlet channels (blue) and one oil channel (red). This device was implemented in actin-related experiments in order to avoid actin polymerization prior to droplet formation. Inset (C) and (E) show representative fluorescence images of the two phases for actin polymerization within the droplets. Bright phases represent the actin solution containing Alexa 488-labeled G-actin. The second phase contains all necessary bio-molecules for polymerization and bundling of actin. The solutions have a contact time in the millisecond range before getting encapsulated. Images (F) and (G) represent the pico-injection device for controlled introduction of different cellular components into droplets. (F) The spacing between the droplets carrying different biologically-active molecules is controlled through addition of oil via the second oil channel. (G) An alternating electric potential (1 kHz and 250 V) reduces the stability (poration) of the surfactants-lipid layer at the droplet interface for an aqueous injection of reagents from a pico-injection channel (injection volume can be ranged between 2 to 100 pl, dependent on the applied pressure). The injection process can be visualized by injection of ATTO 488-labeled F0F1-ATP synthase (H), using fluorescence microscopy.  
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Supplementary Figure 5 
Observation chamber and analysis setup.  
 
(A) Shows the design of an observation chamber for droplet analysis. (B) Magnified cross-
section representation of the analysis chamber. Due to the density differences, droplets rise to 
the top of the chamber. Confocal microscopy was used to scan the droplet in order to find the 
bottom plane. The lowest slice of the droplet was chosen as a focal plane for FRAP 
measurements in order to exclude any influence of stiff objects like in the case of the coverslip 
and the upper parts of the droplet. (C) Example of a FRAP experiment performed on dsGUV 
containing GFP-linked DGS lipids. The image shows a circular bleached spot with a 5 µm 
diameter. 
 
 
 
Supplementary Figure 6 
Release of dsGUVs, preservation of content and checking for oil residues. 
 
To evaluate if the lipid bilayer stayed intact during the release process the (A) oil phase (ATTO 
520, yellow), the (B) lipid bilayer (RhB DOPE, green), the (C) encapsulated (HyLite 405, blue) 
and (D) continuous water phase (Alexa 647, red) were labeled with distinctive fluorophores. 
(E)  A composite image of all channels. On the bottom left of each frame is the continuous oil 
phase containing multiple dsGUV encapsulating aqueous medium. The remainder of the frame 
is filled with a continuous aqueous phase containing a single released GUV. (A-D) The insets 
display a line profile intersecting the released GUV along the indicated white line for the 
respective fluorophore. (A) In the oil channel, no traces of remaining oil can be detected on the 
released GUV. (B) The fluorescent signal of the RhB DOPE is stronger compared to the dsGUV. 
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This is likely due to reduced diffraction and refraction. (C) and (D) show that no mixing 
between the aqueous phases was detected. 
 
 
 
Supplementary Figure 7 
 
Raman spectra of dsGUVs and the released GUVs. 
 
Raman microscope was used to perform Raman spectroscopy on released GUVs to provide a 
method for the detection of oil/surfactant residues in the released GUVs.  (A) Comparison of 
Raman spectra collected from the solution of surfactants in FC40 oil (brown) and from the 
SUVs (green), consisting of 4:4:2 of DOPC, POPC and cholesterol, respectively. Carbon-
hydrogen stretching vibration of lipid tails indicated by arrow between 2800 and 3000 cm-1.18 
The obtained FC40 oil spectrum in this study present similar peaks as published before.19  (B) 
Representative Raman spectra collected through the water oil interphase of the single dsGUV 
as indicated by the red line in the insert bright-field image. In sake of clarity of presentation the 
spectra collected from the oil and water phases were brown and blue colored, respectively. (C) 
Representative Raman spectra collected through the water-lipid interphase of the released GUV 
as indicated by the red line in the insert bright-field image. In sake of clarity of presentation the 
spectra collected from the water phases and the lipid bilayer were blue and green colored, 
respectively. Importantly, no characteristic peaks of the FC40 oil/surfactant were detected 
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within the collected spectra. Raman intensity of the carbon-hydrogen stretching vibration of 
lipid tails (indicated by arrow) was plotted over the screening distance.    
 
 
 
Supplementary Figure 8 
Release of integrin-reconstituted GUVs and their functionality assessment. 
 
Representative 3D reconstitution of confocal images of recovered integrin-reconstituted GUVs 
and their interactions with (A) fibrinogen- (C) fibronectin- (D) collagen- and (E) BSA-coated 
glass surfaces. The integrin-reconstituted GUVs show strong or moderate adhesion to 
fibrinogen- or fibronectin-coated glass surfaces, respectively. In comparison, only very weak 
to no interaction was detected for collagen or BSA-coated surfaces. The merged fluorescence 
signals consist of ATTO 488-labeled DOPE lipids and TAMRA-labeled αIIbβ3 integrin. (B) 
Shows the control experiment in which due to the absence of reconstituted integrin no 
interaction between the GUV and the fibrinogen-coated glass surface was observed.  
 
 
 
Supplementary Figure 9  
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Representative recovery curves. 
 
(A) Shows representative raw data acquired for a FRAP measurement on a dsGUV. The data 
consists of the average intensity values of the bleaching spot and of the whole droplet area in 
focus. A horizontal dotted line was added as a guide for the eye to indicate photo-fading. Before 
analysis, all data points were corrected for background. Furthermore, data points were 
normalized by the average pre-bleaching value and the inverse of the average intensity of the 
whole droplet in focus was multiplied to the values of the bleaching spot, to correct for photo-
fading. The resulting normalized intensity values of the fitting points and fitting curve are 
presented for the same dsGUV (B). Representative normalized fluorescence recovery curves 
obtained from the measurements performed on released and produced by electroformation 
GUVs are presented (C) and (D), respectively. In the FRAP measurements as presented in A-
D the same lipid composition containing 0.5 % ATTO 488-labeled DOPE was used as 
fluorescent marker. (E) and (F) show represented normalized fluorescence recovery curves 
obtained from the measurements performed on reconstituted TAMRA-labeled integrin proteins 
in dsGUVs with and without interaction with RGD peptides on the surfactant layer, respectively. 
 
 
Supplementary Figure 10 
Pyranine as a pH sensor within the dsGUVs. 
 
Pyranine was used as a sensor to monitor changes of the dsGUV internal pH. To calibrate the 
system, dsGUVs were produced with a given pH ranging from 5 to 10 with 1µM pyranine in 
the aqueous solution. These dsGUVs were then excited at 405 nm and 458 nm wavelength. The 
figure shows the variation of the fluorescence intensity ratios as a function of a given pH. 
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ABSTRACT: Fluorescence correlation spectroscopy (FCS) is a
sensitive technique commonly applied for studying the dynamics of
nanoscale-labeled objects in solution. Current analysis of FCS data is
largely based on the assumption that the labeled objects are
stochastically displaced due to Brownian motion. However, this
assumption is often invalid for microscale objects, since the motion
of these objects is dominated by Stokes drag and settling or rising
eﬀects, rather than stochastic Brownian motion. To utilize the power
of FCS for systems with nonstochastic displacements of objects, the
collection and analysis of FCS data have to be reconceptualized.
Here, we extended the applicability of FCS for the detection and
analysis of periodically passing objects. Toward this end, we
implemented droplet-based microﬂuidics, in which monodispersed
droplets containing ﬂuorescent marker are ﬂowing equally spaced
within microchannels. We show by simulations and experiments that FCS can sensitively quantify the ﬂow-rates, variability, and
content of rapidly passing droplets. This information can be derived at high temporal resolution, based on the intensity
ﬂuctuations generated by only 5−10 passing droplets. Moreover, by utilizing the periodicity of the ﬂowing droplets for noise
reduction by averaging, FCS can monitor accurately the droplets ﬂow even if their ﬂuorescence intensity is negligible. Hence,
extending FCS for periodically passing objects converts it into a powerful analytical tool for high-throughput droplet-based
microﬂuidics. Moreover, based on the principles described here, FCS can be straightforwardly applied for a variety of systems in
which the passing of objects is periodic rather than stochastic.
F luorescence correlation spectroscopy (FCS) derivesinformation from the temporal ﬂuctuations of ﬂuorescence
intensity.1−5 By sensitive high-rate sampling, typically >10
MHz, FCS records the intensity ﬂuctuations generated by
labeled particles passing through an observed confocal volume
within the sample. The fundamental analysis of FCS data is the
autocorrelation function G(τ)calculated as the correlation of
the recorded intensity trace with a delayed copy of itself as a
function of the delay, τ.1 FCS is commonly applied for studying
nanoscale objects (e.g., small molecules,6 proteins,1 quantum
dots,7 and liposomes8) passing the observed volume stochas-
tically due to diﬀusion and ﬂow.1,5,9 Accordingly, the
interpretations of G(τ) relies largely on the assumption that
the labeled particles are been stochastically displaced due to
Brownian motion.10 Such stochasticity implies that the number
of particles present in the confocal volume at the diﬀerent time
points distributes in a Poisson manner. Since for a Poisson
distribution the variance is equal to the mean, the concentration
of the labeled particles can be inferred from the amplitude of
the autocorrelation. Additionally, the stochastic particles
displacement implies that G(τ) decays as a function of τ,
gradually approaching a baseline corresponding to zero
correlation. The decay of G(τ) reﬂects the gradual and
independent entry and exit of labeled particles in the observed
volume. Accordingly, from this decay, the mobility mechanism
of the particles and its parameters, such as diﬀusion and ﬂow
speeds, can be inferred. However, while these implications are
based on the stochastic displacements of nanoscale objects in
solution, a large variety of ﬂuid dynamic processes involve
motion of microscale objects. For microscale objects, Brownian
motion is much less prominent, while nonstochastic displace-
ment mechanisms dominated by Stokes drag in a laminar ﬂow
and gravity are more prevailing. Moreover, acoustic waves and
electromagnetic ﬁelds can aﬀect the displacements of micro-
scale objects nonstochastically and arrange them in spatial
patterns. To extend the applicability of FCS for such
nonstochastic systems, its analysis has to be reconceptualized.
One type of nonstochastic displacements is a constant ﬂow
of equally spaced objects. Such a ﬂow mode is typical in
droplet-based microﬂuidics. This technology generates via
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microchannels picoliter-scale monodisperse emulsion droplets
at rates ranging from a slow drip to over 1 MHz.11−15 The
detection of droplets and their content is based mainly on
ﬂuorescence, due to the relatively high sampling rate and
sensitivity of photodetectors. Conventionally, this detection
relies on identifying the single droplets along the trace by
segmentation using intensity threshold and/or other object-
recognition criteria.16−19 This makes the monitoring of droplets
dependent on assumptions, manual tuning of parameters, and
dedicated segmentation algorithms. Additionally, accurate
segmentation of droplet depends on having a suﬃcient
ﬂuorescence signal of each droplet in comparison to the
background ﬂuorescence in the gaps between the droplets.
Therefore, despite the progress made in recent years, sensitive
and rapid monitoring tools are needed to further facilitate high-
throughput applications of droplet-based microﬂuidics.20,21
In this work, we extended the applicability of FCS for the
study of periodically passing objects. We demonstrate that this
extension converts FCS into a powerful detection method for
droplet-based microﬂuidics, enabling us to monitor rapidly and
sensitively the ﬂow and content of passing droplets.
■ MATERIALS AND METHODS
Production of Microﬂuidic Devices. The microﬂuidic
devices (Figure S1) were designed with QCAD-pro (Ribbon-
Soft, Switzerland). Photomasks were printed on chrome-coated
soda lime glass (JD-Photodata, U.K.). For the photolithography
process, a negative photoresist (SU8−3025, MicroChem,
U.S.A.) was spin-coated (Laurell Technologies Corp., U.S.A.)
onto silicon wafers at 2500 rpm in order to get a uniform
coating of 30 μm thickness. Wafers were then placed on a hot
plate for a 5 min soft bake at 65 °C, then ramped slowly to 95
°C and held for 15 min. Following this, the photoresist was
exposed for 7.5 s to UV light through the corresponding
photomask using a mask aligner (MJB4, SÜSS MicroTec,
Germany). For the post-exposure bake, the wafers were placed
for 1 min on a hot plate at 65 °C and 5 min at 95 °C. The
remaining resist was removed with mr-DEV 600 developer
(MicroChemicals, Germany). The hard bake was carried out in
an oven at 150 °C for 15 min. Soft lithography was performed
as previously described.22,23 Brieﬂy, polydimethylsiloxane
(PDMS; Sylgard 184, Dow Corning, U.S.A.) was prepared by
mixing the oligomer with the polymerization catalyst in a 9:1
(w/w) ratio. The mixed, degassed elastomer was poured over
the silicon wafer and cured at 65 °C for 2 h in the oven. After
curing, the ﬂexible PDMS mold was peeled oﬀ the wafer and
injection holes with a diameter of 0.75 mm were punched
(Biopsy Punch, World Precision Instruments, U.S.A.). The
device was cleaned with ethanol and activated together with a
24 × 60 mm coverslip (#1, Carl Roth, Germany) in an oxygen
plasma (PVA TePla 100, PVA TePla, Germany; 0.45 mbar, 200
W, 20 s).24 After activation, the PDMS device was pressed on
the coverslip and heated for at least 2 h at 65 °C. Sigmacote
(Sigma-Aldrich, Germany) was applied to the microchannels of
the device in order to make their surfaces hydrophobic.
Surfactant Synthesis. Following a previously published
protocol,25,26 the synthesis of the PFPE (7000 g/mol)-PEG
(1400 g/mol)-PFPE (7000 g/mol) triblock copolymer was
carried out under argon atmosphere in dry THF solvent
(tetrahydrofuran, 99.8%, Carl Roth, Germany) in a heated
Schlenk-ﬂask. First, 1 mmol PEG (1400 mg, 1400 g/mol
molecular weight, Sigma-Aldrich, Germany) was dissolved in 90
mL of dry THF and cooled to −78 °C. At this temperature,
1.25 mL of N-butyl lithium (1.6 M solution in hexane, 2 mmol,
Sigma-Aldrich, Germany) was added dropwise over 1 h and
stirred for additional 30 min. Under continuous stirring, the
reaction was slowly heated to room temperature and stirred for
another 30 min. Then, 14 g of Krytox FSH (PFPE-carboxylic
acid, 2 mmol, 7000 g/mol molecular weight, DuPont,
Netherlands) was added dropwise over 30 min and stirred
for 2 h. THF solvent with unreacted PEG was removed by a
separatory funnel. After two THF washing steps, the product
was dissolved in methanol (99.8%, Carl Roth GmbH,
Germany) and dried with a rotary evaporator at 40 °C. The
quality of the synthesized surfactant was analyzed by NMR and
FT-IR measurements.
Droplet Production. For stable production of water-in-oil
droplets,27−29 a 5 mM solution of PFPE (7000 g/mol)-PEG
(1400 g/mol)-PFPE (7000 g/mol) in HFE-7500 oil (3M,
U.S.A.) was used as the oil phase. The aqueous phase consisted
of PBS with 2 μM, 20 nM, or 2 nM Alexa Fluor 647 (C2-
maleimide, A20347, Molecular Probes) as indicated. Diﬀerent
droplet production frequencies, between ∼2−20 kHz, were
generated by adjusting the ﬂow rates of the aqueous and oil
phases ranging from 400 to 1000 μL/h and 800 to 3000 μL/h,
respectively (Supplementary Table S1). All ﬂuids were injected
into the microﬂuidic device using 1 mL syringes (Omniﬁx-F, B.
Braun Melsungen AG, Germany) connected by a cannula
(Sterican, 0.4 × 20 mm, BL/LB, B. Braun) and PTFE-tubing
(0.4 × 0.9 mm, Bola, Germany). For a ﬁne ﬂow-control, syringe
pumps (Pump11Elite, Harvard Apparatus, U.S.A.) were used.
High-speed camera (Phantom 7.2, Vision Research, U.S.A.) was
used for a visual quality assessment of droplets production.
Encapsulation of Cells. CHO suspension cells were
cultured in growth medium (EX-CELL ACF DHO Medium,
Sigma-Aldrich, Germany) enriched with 4 mM solution of L-
Glutamine (Gibco, ThermoFisher, U.S.A.). Prior to encapsu-
lation, the cells were centrifuged for 5 min at 700 rpm and
resuspended in PBS containing 8 μM Hoechst 33342
(Trihydrochloride, ThermoFisher, U.S.A.). Following an
incubation of 10 min, the cells were washed three times by
centrifugation and resuspension with PBS. Finally, the cells
were suspended in PBS containing 2 μM Alexa Fluor 647 (C2-
maleimide, A20347, Molecular Probes) to a concentration of 40
million cells per ml.
Microscopy. Fluorescence intensity measurements of
ﬂowing droplets were carried out on a LSM 880 confocal
microscope (Carl Zeiss, Germany), using a C-Apochromat 40
× /1.2 W water-immersion objective (Carl Zeiss, Germany).
Samples were excited with 405 and 633 nm laser lines, and
ﬂuorescence emission was detected within 419−615 nm and
within 650−695 nm for the green and red detection channel,
respectively. The pinhole was fully opened, to maximize photon
collection and minimize optical sectioning. Photon count rate
was detected and recorded at a sampling rate of 15 MHz.
Data Analysis. Autocorrelation curves of the acquired FCS
data were calculated using the LSM software (ZEN, Carl Zeiss,
Germany) in parallel with the data acquisition. For further
analyses, the ConfoCor3 raw data ﬁles, listing time intervals
between detected photons, were converted using a C++
program to ASCII ﬁles indicating the number of photons
detected during each time bin (here 1 μs) along the
measurementhence obtaining FD(t) and FC(t). Where
indicated, the single droplets were identiﬁed along FD(t) by
segmentation, as described in the text. To segment
encapsulated cells within each droplet, FC(t) fragments
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corresponding to passing droplets were subjected to a modiﬁed
one-dimensional watershed algorithm. The analyses of FD(t)
and FC(t), and the autocorrelation of simulated FD(t) traces,
were done with Matlab (Mathworks, U.S.A.).
Simulations. Simulations of intensity traces of ﬂowing
droplets were performed to systematically assess the derivation
of droplets ﬂow and content parameters from the autocorre-
lation curve. The input parameters for the simulation included
the average ﬂuorescence intensity level within a droplet (Fd)
and in the gap between droplets (Fg), the average passing time
of the droplets in the microﬂuidic channel (Ld), the average
passing time of the gap between each two sequential droplets
(Lg) and the variance of the droplet and gap passing times
(noise, Dn). The intensity value in each time point within a
droplet segment and within a gap segment was sampled from a
Poisson distribution having a mean value of Fd and Fg,
respectively. The time point at which a droplet segment ends,
in respect to its start point, was sampled from a normal
distribution having a mean value of Ld and a standard deviation
of Dn. Similarly, the time point at which a gap segment ends, in
respect to its start point, was sampled from a normal
distribution having a mean value of Lg and a standard deviation
of Dn. All simulations were done in Matlab (Mathworks,
U.S.A.).
■ RESULTS AND DISCUSSION
Interpreting the Autocorrelation of Periodically
Passing Objects. The autocorrelation function, G(τ), of the
recorded ﬂuorescence intensity ﬂuctuation trace F(t) can be
written as G(τ ) = ⟨δF(t)·δF(t + τ)⟩/⟨F(t)⟩2 + 1, where δF(t)
= F(t) − ⟨F(t)⟩. While the derivation of G(τ) from F(t) is a
straightforward calculation, the interpretation of G(τ) depends
on the mechanisms underlying the ﬂuorescence ﬂuctuations. In
the case of droplet ﬂow, ﬂuctuations along the intensity trace of
the droplet marker, FD(t), are caused mainly by the constant
ﬂow of periodically passing droplets (Figure 1A and Figure S2).
This periodicity in FD(t) is manifested by oscillations in GD(τ)
(Figure 1B).
We identiﬁed several important parameters concerning the
droplets ﬂow and content that can be derived from the
autocorrelation curve GD(τ) (Figure 1B):
(1) The τ value τfp, at which GD(τ) reaches the ﬁrst
oscillation peak, indicates the average time period that is
needed for a droplet and its subsequent gap to fully pass
the observed volume. Hence, 1/τfp equals the ﬂow rate of
the droplets (i.e., the number of droplets passing per
time interval).
(2) In the case of homogeneous droplets and gaps, GD(τfp)
should be equal to the amplitude of the autocorrelation
curve, GD(0). Variation in droplets or gap sizes would
cause damping of the GD(τ) oscillations, allowing the
quantiﬁcation of irregularities in the ﬂow of droplets, for
example as 1 − GD(τfp)/GD(0).
(3) The autocorrelation amplitude, GD(0), equals to
⟨FD(t)
2⟩/⟨FD(t)⟩
2 (Supplementary Note S1). This
implies that for homogeneously labeled droplets, GD(0)
= PD(1 − PD)(γ − 1)2/(1 + PD(γ − 1))2 + 1, where PD =
(mean droplet passing time)/τfp and γ is the ratio of
droplets intensity over the background ﬂuorescence
intensity in the gaps between droplets (Supplementary
Note S1). The partial derivative of GD(0) with respect to
γ is positive, hence for a given PD value, a higher
autocorrelation amplitude implies a higher droplets
intensity (Supplementary Note S1), given γ > 1. Thus,
the autocorrelation amplitude provides a handle to
monitor changes in droplets ﬂuorescence intensity due to
biological or chemical processes.
Simulation Assessments of Autocorrelation Re-
sponses to Droplet Parameters. We ﬁrst assessed by
simulations of droplet-marker intensity traces, FD(t), the eﬀects
of droplet ﬂow and intensity on the autocorrelation curve
GD(τ) (Figure 2). The results show that droplet ﬂow rates
ranging from 20 Hz−5 MHz were accurately inferred from the
1/τfp of the autocorrelation curve, given FD(t) with a temporal
resolution of 0.1 μs (Figure 2, left column, upper row). Hence,
autocorrelation can capture correctly the maximum theoret-
ically feasible frequency, the Nyquist frequency, for a given
sampling rate.
The large changes in droplet ﬂow rates, up to ∼2.5 MHz, did
not aﬀect the damping extent and the amplitude of GD(τ)-
(Figure 2, left column). At 5 MHz, the damping extent of
GD(τ) decreased, reﬂecting under-sampling of the passing-time
and intensity of each single droplet. Changing the standard
deviation of the passing times of the droplets and gaps from 0
to 0.3 caused linearly proportional changes in the damping
Figure 1. FCS-based monitoring of droplet ﬂow and content in high-
throughput microﬂuidics. (A) Schematic representation of a ﬂow-
focusing junction, where cell-containing droplets are generated, and of
the FCS-based detection setup. Intensity ﬂuctuations of a droplet
marker, FD(t), and a cell marker, FC(t), are recorded at high sampling
rates (15 MHz) at a spot along a droplet-carrying microchannel. (B)
The autocorrelation curve of the droplet marker, GD(τ), is calculated
instantaneously. From this curve, the following parameters can be
derived: (1) the period of GD(τ) oscillations, τfp equals to 1/(droplet
ﬂow rate), (2) the extent of damping in GD(τ) oscillations indicates
the variability of droplets size or speed, (3) the amplitude of GD(τ) can
indicate changes in the (mean droplets ﬂuorescence intensity)/(mean
gaps ﬂuorescence intensity) ratio.
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extent of GD(τ), without changing GD(0) or 1/τfp (Figure 2,
middle column).
Changing the ratio of the droplets intensity over the
background intensity in the gaps from 2 to 100 increased
GD(0) (Figure 2, right column, bottom row). As expected, at
high droplet/gap intensity ratio GD(0) converges to 1+(1 −
PD)/PD (here, equals to 2), where PD (here 0.5) equals (mean
droplet passing time)/(mean droplet + gap passing time)
(Supplementary Note S1). Increase of the droplet/gap intensity
ratio also enhanced the damping extent of GD(τ) but did not
aﬀect τfp (Figure 2, right column).
Conventionally, the monitoring of ﬂowing droplets in
microﬂuidics is performed in the time domain (i.e., by
recognizing each droplet as an object along the recorded
temporal intensity ﬂuctuation trace).16−19 Such recognition
requires to have a suﬃcient signal-to-noise ratio of the labeled
droplets to overcome stochastic ﬂuctuations of intensity.
Moreover, high droplet ﬂow rates reduce the sampling points
for each passing droplet, and hence reduce the statistical
conﬁdence in identifying and distinguishing the single droplets.
In contrast to time-domain based analyses, autocorrelation
captures and integrates the periodicity of a signal. Therefore,
even if the ﬂuorescence signal of the droplets is marginal,
autocorrelation can be expected to capture their ﬂow by
integrating a suﬃcient number of droplets. We ﬁrst assessed
this expectation by simulating intensity traces of droplets
ﬂowing at 500 kHz rate with diﬀerent (mean droplets
intensity)/(mean gap intensity) ratios (Figure 3). The intensity
of the droplets and gaps at each time bin was sampled from a
Poisson distribution around the mean droplets intensity and
the mean gaps intensity, respectively. At droplet/gap intensity
ratio ≤2, it is practically impossible to identify the single
droplets along the intensify traces (Figure 3, left column).
Remarkably, autocorrelation clearly detected the ﬂow of
droplets and accurately quantiﬁed its rate, even at droplet/
gap intensity ratio of 1.05 (Figure 3, right column). At droplet/
gap intensity ratio of 2, only 20 droplets were needed to be
integrated by autocorrelation for a clear quantiﬁcation of their
ﬂow rate. At the marginal droplet/gap intensity ratio of 1.05,
the integration power of autocorrelation utilized 100 000
droplets passing during 0.2 s to clearly capture their ﬂow rate.
To conclude, the simulation assessments indicate that the
autocorrelation curve GD(τ) can (1) quantify accurately fast
droplet ﬂow rates, up to the maximum theoretically possible for
a given sampling rate, (2) provide a quantitative measure for
changes in the variability of the droplets and gaps passing times,
and (3) provide a quantitative measure for changes in the
droplets’ intensity/gap intensity ratio, for a given droplet-ﬂow
condition. Given a suﬃcient ﬂuorescence intensity of droplets,
it is enough to use short intensity traces, spanning the mean
passing time of 5−10 droplets, to achieve accurately these
quantiﬁcations. Additionally, the simulations show that even
with a negligible droplets ﬂuorescence intensity, the autocorre-
lation can accurately monitor and characterize their ﬂow, by
integrating the signal over a larger number of droplets.
Figure 2. Simulation-based assessment of the eﬀects of droplet ﬂow
parameters on the autocorrelation curve GD(τ). Intensity ﬂuctuation
traces of ﬂowing droplets, FD(t), were simulated as described. The
default ﬂow parameters were the following: intensity trace time
resolution = 0.1 μs (corresponding to a sampling rate of 10 MHz),
mean droplet passing time = 1 μs, mean gap passing time = 1 μs
(resulting a ﬂow rate of 500 kHz), standard deviation (SD) of droplet
and gap passing time = 20% of the mean passing time, gap mean
ﬂuorescence intensity = 10 (a.u.), droplet mean ﬂuorescence intensity
= 100 (a.u.). The length of the simulated FD(t) spanned 5 passing
droplets for the left and middle columns, and 15 passing droplets for
the right column. Each column in the graph panel corresponds to a
given simulation parameter that was altered. The ratio between the
mean droplets intensity and mean gaps intensity was altered by
changing the former one. Each row in the graph panel corresponds to
a given parameter that was inferred from the autocorrelation curve
GD(τ). The damping of GD(τ) was calculated as 1 − GD(τfp)/GD(0).
Error bars indicate standard deviation (n = 300 simulation repeats).
Figure 3. Autocorrelation captures the ﬂow rates of droplets even with
marginal ﬂuorescence intensity. Intensity ﬂuctuation traces of ﬂowing
droplets, FD(t), were simulated as described. The ﬂow parameters
were the following: intensity trace time resolution = 0.1 μs, mean
droplet passing time = 1 μs, mean gap passing time = 1 μs (resulting a
ﬂow rate of 500 kHz), standard deviation of droplet and gap passing
time = 20% of the mean passing time, mean gap ﬂuorescence intensity
= 10. The mean droplets ﬂuorescence intensity was varied to achieve
diﬀerent ratios with the mean gap intensity, as indicated. The plots on
the left show the simulated FD(t) for the ﬁrst 10 μs, during which 4
droplets are fully passing. The plots on the right show the
autocorrelation curves, GD(τ), obtained from the corresponding
FD(t) spanning the indicated number of passing droplets (N).
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Experimental Assessment of Droplet Monitoring by
FCS. Following the assessment by simulations, we tested
experimentally the eﬀects of droplet ﬂow conditions on the
autocorrelation curve GD(τ). First, we produced droplets
containing 2 μM Alexa Fluor 647 at diﬀerent rates (Figure
4A and Figure S3) and measured their ﬂow rates by
autocorrelation (Figure 4B). FCS data acquisition of the
stream of droplets was performed at a spot adjacent to the ﬂow-
focusing junction (Figure 1A). Autocorrelation analysis of the
recorded intensity traces shows that the values of τfp get smaller
as the input ﬂow rates increase, hence indicating a higher
droplet ﬂow rate (Figure 4B). As a quantitative control, short
time-lapse movies (∼300 ms) were recorded using a high-speed
camera, and the number of passing droplets per time period
was counted (Figure S3 and Table S1). The droplet ﬂow rates
obtained from direct counting matched well those obtained
from autocorrelation analysis (Figure 4C). Hence, these results
conﬁrmed the capability of autocorrelation to monitor
accurately droplet ﬂow rates.
Next, we experimentally tested the eﬀect of inhomogeneity in
the droplet ﬂow on the autocorrelation curve GD(τ). By high-
speed camera imaging, we noticed that cell encapsulation aﬀects
the speed of the encapsulating droplets, hence increases the
variability of the distances between passing droplets (Figure
5A). Therefore, cell encapsulation provides an experimental
system to induce droplet-ﬂow inhomogeneity, which is relevant
for many potential microﬂuidic applications. In order to
generate ﬂow variability, we added Hoechst-labeled cells into
the input aqueous phase, leading to encapsulation of cells in the
forming droplets (Figure 1A). At the applied droplet
production rate (∼20 kHz), cell encapsulation aﬀected the
speed of cell-containing droplets (Figure 5A). To study the
eﬀect of induced inhomogeneous droplet ﬂow on GD(τ) the
density of cells was adjusted so that encapsulations were
occurring stochastically. As predicted, the damping of GD(τ)
oscillations was found to be much stronger for the sessions of
droplet production which included encapsulation of cells
(Figure 5B,C).
In order to experimentally assess the eﬀects of droplet/gap
intensity ratios on GD(τ), we produced droplets containing
diﬀerent concentrations of the ﬂuorescent marker. As expected,
the results show that for given ﬂow conditions and excitation
intensity, the autocorrelation amplitude GD(0) decreases as the
droplets intensity decreases (Figure 6A). Remarkably, the
autocorrelation provided an accurate measure of the droplet
ﬂow rates even if their ﬂuorescence intensity is marginal (Figure
6A, 2 nM marker concentration). Moreover, autocorrelation
captures the ﬂow of droplets and its rate even if the droplets are
unlabeled (Figure 6B). This sensitive detection is possible since
autocorrelation averages negligible, periodic, changes of
intensity levels generated as droplets are passing through the
observed volume. The intensity changes are due to
autoﬂuorescence of the oil phase, which is marginal but still
higher in comparison with the aqueous phase (Figure S4).
Since averaging reduces the random noise, but not the mean
ﬂuorescence diﬀerence between droplets and gaps, autocorre-
lation increases the signal-to-noise ratio. Of note, autoﬂuor-
escence of the oil phase is an important factor to account for, if
its level is comparable to, or higher than, the ﬂuorescence signal
of the droplets. Particularly, if the ﬂuorescence signal of the
droplets is lower than the oil autoﬂuorescence, GD(0) will be
lower than that of droplets with no ﬂuorescence signal.
Figure 4. Accurate quantiﬁcation of droplet ﬂow rates by
autocorrelation. Droplets were generated at diﬀerent rates by
modifying the input ﬂow rates of the aqueous and oil phases, as
indicated in Supplementary Table S1. (A) High-speed camera
transmission images of droplets generated at the lowest (Slow rate)
and highest (Fast rate) applied rates (Supplementary Table S1). Scale
bar, 30 μm. (B) The autocorrelation, GD(τ), curves obtained for
diﬀerent rates of droplet ﬂow. (C) A scatter plot comparing the
quantiﬁcations of droplet ﬂow rates by autocorrelation and direct
droplet counting. Dashed line indicates the line of equality. Error bars
indicate the standard deviation (n = 6 and n ≥ 3 for the horizontal and
vertical axes, respectively). The color-code matches each data point in
(C) with the corresponding example of autocorrelation curve in (B).
Figure 5. Quantifying the variability of droplet passing time by
autocorrelation. FD(t) was recorded for droplets produced with or
without cells encapsulation. (A) High-speed camera transmission
images of droplets generated with or without stochastic encapsulation
of cells. Scale bar, 30 μm. (B) Representative autocorrelation curves
obtained with or without cells encapsulation. (C) A plot showing the
mean ± standard deviation of the inferred level of periodicity noise,
calculated as 1 − GD(τfp)/GD(0). Error bars indicate standard
deviation (n ≥ 6).
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Therefore, when dealing with marginal ﬂuorescence signals it is
important to measure the GD(0) of droplets containing no
marker and calibrate accordingly.
Temporal Resolution of Droplet Monitoring by FCS.
To provide a real-time feedback for rapid changes in a periodic
ﬂow of objects, the autocorrelation analysis should enable to
derive information from short segments of the intensity trace
FD(t). The simulation analysis indicated that given suﬃcient
intensity, only few droplets are needed to be integrated to
enable their ﬂow-rate detection (Figure 3). To test this using
experimental data, we applied multiresolution FCS (mrFCS)7
analysis, scanning the recorded intensity ﬂuctuation traces with
diﬀerent temporal integration levels. Toward this end, we
partitioned FD(t) to short time periods (ranging from 200 to
2000 μs) and calculated GD(τ) for each period along the trace.
Analysis of a 500 μs period (5−10 droplets) was found to be
suﬃcient for detecting an inhomogeneity in the droplet ﬂow
(Figure S5). Thus, by scanning FD(t) with a sliding window,
and calculating GD(τ) per each window, it is possible to
monitor the cell-encapsulation frequency at a temporal
resolution of 500 μs, corresponding to 5−10 passing droplets
(Figure S5).
In addition to GD(τ), the amplitude of the cell-marker
autocorrelation, GC(τ), can be calculated for each short time
interval (Figure S5). In the absence of encapsulated cells the
amplitude of GC(τ), GC(0), is low, due to uncorrelated
intensity ﬂuctuations and weakly labeled small debris. In the
presence of one or more encapsulated cells GC(0) increases
considerably, since the cells are few in number, relatively big
and strongly labeled. Thus, GC(τ) and GD(τ) provide two
independent indicators for cell encapsulation.
Identifying Objects within Flowing Droplets via FCS
Data Acquisition. FCS relies on having fast sampling rates,
typically >10 MHz, in order to capture accurately the residence
time of diﬀusing particles in the confocal volume. This provides
high spatial resolution for resolving signals of encapsulated cells
or other objects within fast ﬂowing droplets (Figure 1A and
Figure S2). Segmentation of the droplets along FD(t) identiﬁes
the start and end of each droplet along the trace, hence enables
analyzing its content along the corresponding part of the cell-
marker intensity trace FC(t) (Figures S6 and S7). Thus,
encapsulated cells within each ﬂowing droplet can be detected
and counted by segmenting them along the corresponding
FC(t) fragment (Figure S8).
■ CONCLUSIONS
This study shows that FCS can be eﬀectively applied for the
study of periodically passing objects. To achieve this goal, we
reconﬁgured the manner by which the autocorrelation is
interpreted and analyzed. Moreover, we demonstrated that this
approach converts FCS into a sensitive analytical tool for
monitoring ﬂowing droplets and their content in microﬂuidic
devices. We showed that, in contrast to segmentation-based
methods, autocorrelation can monitor and quantify ultrafast
droplet ﬂow rates accurately, even with very faint ﬂuorescence
signals. Additionally, FCS can monitor the heterogeneity
among sequentially passing droplets at high temporal resolution
and sensitivity. Therefore, this approach paves a way toward
hitherto impossible feedback control for handling, processing,
and manipulating of droplets and their content in various high-
throughput microﬂuidic units.
Utilizing the power of FCS for the study of periodically
passing objects can facilitate and trigger a variety of additional
applications where microscale objects are spatially arranged in
solution due to ﬂow, gravity, acoustic waves, or electromagnetic
ﬁelds. Additionally, this approach enables the use of FCS for
detecting and analyzing immobilized nanoscale objects
patterned on a sliding specimen. Such a combination would
provide high-throughput molecular readouts for binding assays
and other in vitro analytical applications.
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Figure 6. Eﬀect of droplets relative ﬂuorescence intensity on their
autocorrelation curve. (A) Droplets were generated under the same
ﬂow conditions, with aqueous phase containing a ﬂuorescent marker
(Alexa 647) at 20 nM or 2 nM in PBS, as indicated. The
autocorrelation curves GD(τ) obtained for each measurement repeat
of 10 s (thin lines) and their average (thick line, n = 3) are shown. (B)
Autocorrelation curves and their averages (n = 3) of droplets
containing PBS alone, or of ﬂowing PBS without droplets formation
(due to lack of oil-phase ﬂow into the cross-junction). In (A) and (B)
samples were excited solely with laser line 633 nm, and with power
attenuator set to 0.3% power for (A) and to 30% power for (B). In the
case of high laser power, a marginal autoﬂuorescence of the oil phase
can be detected, enabling to monitor ﬂowing droplets containing no
ﬂuorescence marker. Thin and thick curves correspond to the
measurement repeats and their mean, respectively.
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Supplementary Figure S1 
Sketch of the microfluidic device used for the droplet production and cell encapsulation. Scale 
bar, 3 mm.  
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Supplementary Figure S2 
The importance of high sampling rate for robust monitoring of fast-flowing droplets and 
their content. (a) An example of droplet-marker and cell-marker intensity traces 
recorded for droplets flowing at a rate of 17 kHz (for clarity, a 3.5 ms segment from 
these traces is shown). (b) Plots of FD(t) and FC(t) along the first 350 !s part of the 
recorded period shown in (a) binned to a temporal resolution of 10 !s or 1 !s. 
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Supplementary Figure S3 
Representative images of the flow-focusing junction in which the droplets are generated with 
different inlet flow rates for the aqueous and oil phases (Qaq and Qoil, respectively). The 
obtained droplets production rates for the different inlet flow rates are listed in Supplementary 
Table S1. Scale bar 30 !m. 
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Supplementary Figure S4 
Marginal auto-fluorescence of the oil phase. (a) A transmission image of a representative 
droplet containing PBS as the aqueous phase and embedded in HFE-7500 as the oil phase. (b) 
Top, a fluorescence image taken using excitation at 633 nm, with laser attenuator set to 50 % 
power, and detection range between 641-695 nm. Bottom, the profile of the fluorescence 
intensity along a sampled line, as indicated on the image (dashed line). (c) Top, an image 
summing 40 consecutive images of the same droplet, each of which taken as described in (b). 
Bottom, the corresponding fluorescence intensity profile. Scale bar 10 !m. 
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Supplementary Figure S5 
Monitoring cell encapsulations and droplets inhomogeneity at high temporal resolution. 
Droplets were produced with cell encapsulation at droplets flow rate of 17 kHz. The recorded 
FD(t) was scanned with different window sizes, as indicated. For each window position GD(!) 
and  GC(!) were calculated. Left column, plots showing the mean GD(!) (solid line) ± standard 
deviation (dashed lines) and heatmaps showing the GD(!) for each window position. Second 
column from left, distributions of droplets per window and of percentage encapsulating 
droplets. Third and fourth columns from left, boxplots of the damping extents of GD(!) and of 
GC(!) amplitudes as a function of percentage encapsulating droplets.  
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Supplementary Figure S6 
A flowchart of the droplet segmentation algorithm. The algorithm scans the droplet-
marker intensity trace, FD(t), which lists the total number of photons detected within 
each time bin (here 1 !s) along the recorded period. In addition to FD(t), the input 
parameters include: (i) Ithr " an intensity threshold to distinguish gap background 
intensity from droplet intensity levels, (ii) Pthr " a persistency threshold defining how 
many sequential time bins have to be above or below Ithr in order to initiate or terminate 
a droplet mask, respectively, (iii) Wthr " a width threshold, defining the minimal passing 
time below which an identified droplet mask can be assumed to be related to noise rather 
than to an actual droplet. The output of the algorithm is a binary mask indicating the 
periods along FD(t), that correspond to the individual droplets.  
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Supplementary Figure S7 
Segmentation and analysis of single droplets. Droplets were produced for 10 seconds at 
rates of 1.8 kHz (left panel) and 17.4 kHz (right panel). For each production rate, the 
recorded FD(t) was subjected to the droplets-segmentation algorithm. (a) A fragment of 
FD(t) is shown (blue) overlaid with the obtained binary mask of the droplets segments 
(red). (b) histograms of the passing time and total intensity of the individual droplets. 
(c) The passing time of each droplet and of the gap between each two sequential droplets 
as a function of time along the droplet production session. (d) Heatmaps showing the 
intensity profile of each droplet.  
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Supplementary Figure S8 
Detection of encapsulated cells in the flowing droplets. Droplets were produced with 
cell encapsulation at droplet flow rate of 17 kHz. (a) An example of a short interval out 
of the recorded droplet-marker and cell-market intensity traces are shown. (b) Examples 
of droplets for which the watershed algorithm identified 0, 1, 2 and 3 cells (ordered 
clockwise from top-right). The dashed line in all plots indicates the masks of the droplets 
of the cells as generated by the respective segmentation algorithm.  
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SUPPLEMENTARY TABLES 
 
 
 
!
Input flow rates (!l/hr) Obtained Droplets flow rate 
(kHz) 
Qaq Qoil  
400 800 3.52 ± 0.02 
600 1200 5.59 ± 0.06 
800 1600 8.97 ± 0.14 
1000 2000 11.58 ± 0.05 
1200 2400 16.75 ± 0.46 
1000 3000 18.50 ± 0.50 
!
 
Supplementary Table S1  
Droplet production frequencies were determined by counting 20 " 32 sequential droplets 
at the beginning, middle and end of two videos from each experiment. Mean frequencies 
values and their standard deviation are shown.  
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Supplementary Note S1: Interpretation of GD(!) amplitude 
 
The amplitude of the auto-correlation curve of FD(t) at the origin (! = 0) can be calculated as: 
 !" # $ %&" ' (&")'* ( + , $ &" ' - &")'* (&")'* ( + , $ $ ./01/234 56 756)7* 8 + , $ 56 7 8 9 56)7* 856)7* 8 + , $ 56 7 856)7* 8  .    (1) 
 
 
 
For a flow of droplets that are homogenously labeled with intensity ID, the fraction PD of the 
time at which FD(t) equals ID is 
 
 :" $ ;0<=>47?=/@@12A?71B4;0<=>47CA/=?=/@@12A?71B4              (2) 
 
and the fraction of time at which FD(t) equals the gap intensity, IG, is 1-PD. Accordingly, the 
mean of the trace is 
 &")'* $ D":" + DE), - :"* .      (3)
          
Combining equations (1) and (3) gives 
 !" # $ 56 7 856)7* 8 $ F6G68C)H9F6*GI8G6F6CGI)H9F6* 8 .    (4) 
 
By defining the intensity in the droplets as its fold increase in respect to the background 
intensity in the gaps, ID = #$IG, we get: 
 
Period
Droplet passing time
Time
FD(t)
Droplets 
intensity
Gaps
intensity
Gap passing time
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   ?!" # $ F6 H9F6 J9H 8HCF6 J9H 8  +1    .    (5) 
The derivative of this GD(0) in respect to # is 
 
 ?KJ!" # $ ()J9H*)H9F6*F6)HC J9H F6*L      .    (6) 
 
By definition 0 < PD < 1. Therefore, given #  > 1, Equation 6 implies %# GD(0) > 0, meaning 
that for a given PD, the amplitude of the auto-correlation curve of FD(t) increases as the ratio 
between the droplets intensity and the background intensity increases. This increase is 
monotonous but not linear. If # = 1 (i.e. the droplets intensity is as the gaps intensity) then 
GD(0)=1, while for #&', GD(0) converges to (1-PD)/PD+1. Accordingly, flow conditions with 
lower PD’s enable a higher dynamic range for detecting changes in #. The figure below plots 
GD(0) as a function of #  for different values of PD, calculated based on Equation 5.  
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3.1 Discussion
The question ’What is Life’ asked at the beginning of this thesis is nowadays tackled
by researchers originating from a variety of different core disciplines, such as Physics,
Mathematics, Chemistry or Material Science [118]. The applications and combinations of
different methodological approaches and techniques towards Biology resulted in the de-
velopment of new research areas such as System Biology or Synthetic Biology. From these,
bottom-up synthetic biology strives for an experimental reconstruction of a living cell or
even a living organism, using engineering principles. The ultimate goal is to combine
either already existing molecular building units from a living cell or equivalent synthet-
ically produced components to a minimal system that is able to perform fundamental
tasks associated with a living system. Towards this end, the generation of compartments
for a controlled encapsulation and combination of these building units has become a re-
markable challenge. On the one hand such compartments should be bio-compatible as
well as mechanically and chemically stable. Bottom-up synthetic biology approaches on
the other hand require a sequential and controllable loading of these compartments with
bio-molecules under different buffer conditions. So far, these two contradictory require-
ments have not been met in a satisfying way.
This discussion points out the contributions of the thesis to new developments in bottom-
up synthetic biology, especially the formation of manipulatable compartments with tune-
able properties for a controlled assembly of biomolecules. The use of microfluidic water-
in-oil droplets as compartments and the associated microfluidic manipulation tools are
critically discussed. Furthermore, the newly-developed dsGUV compartment system
and the demonstrated applications and analysis methods are evaluated in regards to
future applications. Finally, this discussion gives an outlook to next possible research
questions.
3.1.1 Characterization of Microfluidic Droplets as Compartments
Every cell needs a shell in order to separate the interior processes from the outside. In
the past, most bottom-up synthetic cell approaches were based on lipid bilayer vesicles
or polymersomes as compartments [119]. This is intuitively understandable, since living
cells represent a water-in-water system, where interior and exterior are separated by a
biomembrane. However, the utilized compartments so far showed a limited stability and
even more importantly, technologies which allow for the precise and efficient delivery of
different biological components (see Section 1.2) into the compartments were still miss-
ing. Therefore, in this thesis, the use of microfluidic water-in-oil droplets (see Section
1.4.2) as compartments for a bottom-up synthetic cell approaches was investigated.
In a first step, the physical and chemical key factors for stable droplet production and the
reliable encapsulation of fluorescent dyes and bio-molecules into the droplets were inves-
tigated. It was shown, that the stability of microfluidic water-in-oil drop- lets depends on
the physical properties of the surfactants (see Section 1.4.3). Surfactants with triblock ge-
ometry have two PFPE-tails and can thus form a denser PFPE layer at the outside of the
droplet’s periphery in comparison to diblock surfactants. This provides a better shield
against coalescence of the droplets. Similar observations have been made by other groups
[120, 121]. Furthermore, the concentration of the surfactants influences the stability of the
droplets. Surfactant concentrations below 1 mM led to coalescence of the droplets, which
is in good agreement with previous studies [86, 121]. For concentrations above 10 mM
the creation of small daughter-droplets was observed, which can be attributed to a shift
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from dripping mode to tipstreaming mode (see [122]). These effects have now been ex-
perimentally assessed and have to be considered in future droplet-based microfluidic
applications, where the creation of stable and uniform droplets as compartments is de-
sired.
Following these investigations, the retention ability of different fluorescent dyes in mi-
crofluidic droplets was analyzed for various surfactant types, surfactant concentrations
and buffer conditions. Fluorescent dyes are crucial for many biochemical and biomedical
applications, since they allow the visualization and localization of labeled biomolecules.
Thus, different dyes covering the whole visible spectrum and therefore allowing for mul-
ticolor acquisitions were selected. It was shown, that the retention of these dyes for given
buffer conditions depends mainly on their hydrophilicity. By calculating the distribution
coefficient LogD, which is a measurement for the hydrophilicity, the probable retention
of the corresponding fluorophore can be estimated. However, the LogD value can not
be considered as an exclusive criterion for the retention ability of the dyes, since it could
be shown that also other factors such as the molecular weight and the three-dimensional
structure of the dyes influence the retention.
Additionally, the choice of surfactant types and concentrations has a strong influence on
the retention of the dyes. Surfactants with diblock geometry showed the best retention
ability for the fluorescent dyes. This can be explained with a denser hydrophilic PEG
layer at the inner periphery of the droplets in comparison to triblock surfactants [89].
Furthermore, surfactants with longer PEG and PFPE tails showed better retention ability
than short ones. This observation can be explained with a higher energetic barrier the
dyes have to pass in order to dissipate into the oil phase. Similar results for silicone-
based polymeric surfactants were found in [123].
Finally, the inevitability of choosing adjusted fluorescent dyes for the labeling of biomole-
cules was demonstrated with the bio-molecule tubulin (see Section 1.2.2). The amphiphilic
nature of tubulin in addition to the ’wrong’ choice of labeling dyes or surfactant types led
to a release of the corresponding microtubules out of the droplets into the oil phase. In
contrast, stable retention was achieved for adjusted surfactant types or adjusted fluores-
cent dyes.
The results presented here allow for the following statements, which should be consid-
ered in future applications based on microfluidic droplets:
 The mechanical stability of microfluidic water-in-oil droplets depends mainly on
the stabilizing surfactant type and the surfactant concentration.
 The key factors for stable retention of fluorophores inside droplet-compartments
depend on the physical and chemical structure of the dye, the buffer conditions, as
well as the surfactant type and concentration. A screening of the different condi-
tions allows for the creation of ’look-up tables’ for the choice of appropriate dyes
under specific conditions for future applications.
 Advanced retention of labeled (bio-) molecules inside microfluidic droplets can be
achieved by proper adjustment of the identified key factors, e.g by changing the
labeling dye or the surfactant type.
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3.1.2 Microtubule Self-organization inside Microfluidic Droplets
After optimizing the conditions for a stable creation of microfluidic droplets, the next step
was to investigate how these droplets can serve as compartments for the encapsulation
of bio-molecules under controlled conditions. Towards this end, the polymerization and
self-assembly of tubulin into microtubule structures (see Section 1.2.2) inside microfluidic
droplets was investigated. First experiments focused on optimizing the conditions for a
reproducible polymerization of tubulin inside microfluidic droplets (see Appendix A).
It was demonstrated, that the transfer from unconfined bulk conditions to compartments
with volumes in the range of living cells needs the adjustment of the utilized biochemical
components and concentrations. After optimizing these conditions, microtubule self-
assembly and the organization into different arrangements was observed. It is worth
mentioning here, that the microtubule polymerization and organization was achieved
without any stabilizing agent such as taxol or glycerol, which was necessary in previous
experiments [124]. In principle, this allows to study the dynamic behavior of micro-
tubules.
Furthermore, it could be demonstrated that growing microtubules can deform and elon-
gate their compartment by aligning into parallel bundles. This behavior remarkably re-
semble the mitotic spindle formation in living cells during mitosis (see Section 1.2.2).
In my research, this formation was observed for an increased tubulin concentration in-
side the droplets and without the involvement of any motor proteins. Similar observa-
tions have been made by other groups for microtubules encapsulated into lipid vesicles
[125, 126]. However, the exact mechanism behind the formation process could not be
explained, since the experiments were only to a limited extent reproducible and the in-
teractions of tubulin with the surfactant layer dominated in most of the cases (see Ap-
pendix A.1). Nevertheless, future studies might allow for the controlled creation of these
arrangements and could thus mimic cellular division by an induced droplet division.
During all the experiments mentioned above, the interactions of tubulin with the surfac-
tant layer at the periphery of the droplets dramatically limited the use of microfluidic
droplets as optimal compartments (see Appendix A.1). Therefore, long-term observa-
tions of microtubule organization and dynamic processes, which would involve the use
of motor proteins could not be investigated. In order to overcome this problem, two
approaches were taken. The first one involved the introduction of an additional lipid
bilayer at the droplet’s inner periphery with the ultimate goal to prevent interactions of
tubulin with the surfactant layer. This approach is demonstrated in Publication 3.
The second one addressed the surfactants and the surrounding oil. During experimental
work in my research it became clear, that the purification of the synthesized surfactants
was insufficient, thus leaving a small portion of unreacted Krytox (perfluoropolyether,
PFPE) in the surrounding oil-surfactant mix in the continuous phase. This led to an
acidification of the aqueous phase inside the droplets and thus to the observed depoly-
merization of the microtubule structures over time (see Appendix A.1). Based on these
findings, co-worker Michael Juniper investigated the polymerization of microtubules in
microfluidic droplets surrounded by HFE7500 oil (3M, USA) and 1.8 % RAN-008 fluoro-
surfactants (RAN Biotechnologies, USA), which are commercially available and have no
traces of Krytox. Under these conditions no interactions of tubulin with the surfactant
layer were observed and a dynamic, reversible arrangement of microtubules in combina-
tion with motor proteins was achieved. The results are published in Publication 2.
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In this context, the use of microfluidic technology allowed for a controlled creation of
monodisperse compartments with a well-defined size. Under these conditions, the self-
organization of microtubules into aster-like structure, mediated by the minus-end-direct-
ed motor protein Xenopus laevis kinesin-14 (XCTK2), was studied. The process of aster
formation was found to be dependent on the motor protein concentration as well as on
the chemical conditions of the boundary, i.e. the surfactant concentration. For optimized
conditions, robust aster formation was detected in hundreds of droplets. These find-
ings demonstrate one major advantage of microfluidic droplets as compartments, having
identical and controlled conditions in a high number of samples. This allows for sta-
tistically significant observations and statements of the behavior of a minimal synthetic
system.
Theoretical models [127] predict the formation of microtubule asters and vortices in the
presence of motor proteins such as kinesin or dynein for unconfined conditions. The sys-
tem developed here could be a suitable tool to experimentally study these results under
controlled conditions for compartments with different sizes and to investigate biological
pattern formation for a minimal system with reduced complexity.
Summarizing the above, the following conclusions for microfluidic water-in-oil droplets
as compartments for bottom-up synthetic cell approaches can be drawn:
 Microfluidic droplets do not provide entirely sealed and chemically inert compart-
ments, instead the physical and chemical properties of the surrounding oil and the
surfactants in particular have to be considered.
 After optimizing the external conditions, microfluidic droplets can serve as monodis-
perse compartments in a large quantity, showing uniform chemical conditions and
thus allowing for highly-reproducible experiments.
 The precise control over the biochemical micro-environment inside the compart-
ments allows for omitting artificial stabilizing agents and thus enables the investi-
gation of dynamic and reversible self-organization processes of tubulin and associ-
ated motor proteins.
 Even though the synthetic system described and developed here is very much re-
duced in complexity, it already exhibits attributes of living cells, notably parallel
microtubule organization and relating elongation of the microfluidic droplets.
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3.1.3 Droplet-stabilized Giant Unilamellar Vesicle (dsGUVs)
So far, the use of microfluidic droplets as compartments for studying the self-organi- za-
tion of proteins was demonstrated by the example of tubulin polymerization into micro-
tubule structures. In this system the microfluidic droplets serve as a stable and manip-
ulatable, three-dimensional confinement. However, the main limitation to realistically
mimic a living cell is the missing bio-membrane and the continuous oil phase around
the compartments. In order to overcome this problem, a fundamental new approach
was taken, namely the formation of an enclosed lipid bilayer at the inner periphery of
the droplets. This system was termed droplet-stabilized Giant Unilamellar Vesicle (dsGUVs)
and is presented in Publication 3.
Since this system represents a new type of compartments for bottom-up synthetic cell
approaches, the properties were characterized thoroughly. The investigation of the exact
nature of the created lipid arrangement was of particular importance. In a first step, the
formation mechanism of dsGUVs was investigated. It could be shown, that the transfer
from encapsulated lipid vesicles to an enclosed lipid bilayer at the periphery depends on
an optimized ion concentration of the interior aqueous phase. These findings are in good
agreement with previous studies on two-dimensional supported lipid bilayer systems
(see Section 1.3.2), where it could be shown that ions are necessary to promote the adhe-
sion between approaching vesicles and the supporting substrate [79, 128]. This leads to
the rupture of the vesicles and a subsequent fusion of the lipid patches, resulting finally in
a continuous lipid bilayer. In order to visualize the formation process in real time, GUVs
were formed by electroformation and were encapsulated into microfluidic droplets. This
allowed a quantification of the formation process. Additionally, the formation process
out of SUVs was analyzed by fluorescence intensity measurements of flowing droplets in
a microfluidic device shortly after droplet production (see Appendix A.4). The formation
times are in good agreement with theoretical considerations based on the mean diffusion
time of the vesicles inside the droplets. Knowing the temporal formation process of ds-
GUV is crucial for future applications, where an intact lipid bilayer has to be established
prior to other processes such as e.g. the polymerization of biomolecules inside the ds-
GUVs.
Furthermore, the physical properties of the created dsGUV system were analyzed. Flu-
orescence intensity measurements of dsGUVs and corresponding GUVs formed by elec-
troformation were performed and compared. The results indicate the formation of a
continuous, unilamellar lipid bilayer for adjusted lipid concentrations. Another inves-
tigation was the formation of a phase-separated dsGUV-system (see Appendix A.2 and
Section 1.2.1). However, the creation of phase-separated dsGUVs was not achieved in
this work, most probably due to perturbations from the supporting surfactant layer. On
the other hand, the occasional observation of defects inside dsGUVs might indicate the
lipid-bilayer like structure of the system (see Appendix A.2). Additionally, the mobility
of the lipids forming the dsGUVs was investigated by FRAP measurements. It could be
shown, that the diffusion coefficient of the lipids inside dsGUVs is slightly reduced com-
pared to free-standing GUVs, but in the same order of magnitude. This reduction can be
explained by perturbations of the supporting surfactant layer of the droplets, as it was
also observed for two-dimensional supported lipid bilayer systems [129, 130].
In order to definitively reveal the nature of the created system, different approaches were
developed and realized to release the assembled lipid bilayer compartments from the
stabilizing surfactant-oil phase into an aqueous environment (see Appendix A.3). All
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these approaches are based on bringing the dsGUVs in close contact with the continuous
aqueous phase and on subsequently breaking the stabilizing oil-surfactant layer with-
out destroying the lipid bilayer (see Figure A.8). This could be demonstrated in a "Bulk
Release" approach in an Eppendorf tube. In order to better understand and analyze the
release process, another approach was taken, using a flow chamber to bring dsGUVs and
the continuous aqueous phase together. This allowed the direct observation of the release
process. Furthermore, by labeling the aqueous phase inside the droplets, the continuous
aqueous phase as well as the oil phase with different fluorophores (using the results from
Publication 1) it could be shown that the content inside the droplets was conserved and
that there was no exchange during the release process. Finally, in order to integrate the
release process into a microfluidic droplet pipeline and therefore to aim for a real Lab-
on-Chip application, different microfluidic release devices were designed and tested (see
Section A.3). It could be shown, that adjusted microfluidic geometries allow for a re-
markable deceleration of the droplets before they come into contact with the continuous
aqueous phase (see Figure A.11). This enabled a gentle transition and a reduction of the
shear forces acting on the lipid bilayer. The release of the lipid compartments from the
stabilizing oil phase into an aqueous environment and their subsequent analysis indicate
strongly the unilamellar lipid bilayer structure of the dsGUV system. Furthermore it rep-
resents a new technique to create monodisperse GUVs in a controlled way.
However, in recent years, the controlled high-throughput formation of monodisperse
GUVs using other microfluidic methods such as pulse jets, droplet shooting or layer-by-
layer lipid assembly was achieved [76–78]. In order to point out the superior properties
of the system developed here, the ability of a sequentially loading with bio-molecules
was demonstrated. Towards this end, microfluidic pico-injection technology (see Section
1.4.4) was adopted for the precise delivery of bio-molecules into dsGUVs. A first demon-
stration was the injection of his-tagged GFP into dsGUVs, functionalized with NTA(Ni)
complexes. The functionalized lipid bilayer at the droplet’s inner interface presents an-
choring points for the injected his-tagged GFP bio-molecules. Indeed, it could be ob-
served, that the GFP binds to the lipid bilayer, indicating that both the lipid bilayer as
well as the bio-molecules are functionally not affected by the pico-injection process. Fur-
thermore, the mobility of the GFP molecules in the lipid bilayer was analyzed by FRAP
measurements. The resulting diffusion coefficient is in good agreement with previous
studies on SLB and indicates a successful binding of GFP to the lipid bilayer.
Following the success of applying pico-injection technology to dsGUVs, the incorpora-
tion of transmembrane proteins into the lipid bilayer was investigated. Therefore, the
transmembrane protein F0F1-ATPase (see Section 1.2.2) was reconstituted into proteoli-
posomes and injected into preformed dsGUVs via pico-injection. A successful fusion
of the ATPsynthase-containing proteoliposomes with the lipid bilayer was observed by
correlated fluorescence signals. Furthermore, the mobility of the incorporated ATPase
was analyzed by FRAP measurements and found to be in good agreement with previous
studies in pure GUV systems. Additionally the functionality of the incorporated trans-
membrane proteins was investigated. Towards this end, a transmembrane pH gradient
between the interior of the dsGUVs and the surrounding oil phase was applied by intro-
ducing acidic molecules via the oil phase. It could be demonstrated, that the energizing
force of the pH gradient is sufficiently enough to drive the ATPase to synthesize ATP
inside the dsGUVs. However, the total synthesized ATP amount is much lower than it
would be expected from theoretical calculations. This can be mainly attributed to the
missing transmembrane electric potential gradient (see Section 1.2.2). Furthermore, the
procedure to detect ATP is currently unsufficient, since the long time delay between ATP
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synthesis and ATP detection leads to the hydrolysis of ATP and therefore to a lower mea-
surable concentration. To overcome this problem, the direct observation of ATP inside
the dsGUV would be desirable. Therefore, an optical setup for the sensible detection of
bioluminescence, corresponding to synthesized ATP still has to be established in future
applications. Nevertheless, the principal functionality of the reconstituted ATPsynthase
was shown, demonstrating the successful reconstitution of a rather complex transmem-
brane protein, composed of various subunit with specific functions, into the dsGUV sys-
tem.
Additionally it was demonstrated, that the pico-injection technology enables the load-
ing of dsGUVs with cytoskeleton proteins, such as tubulin. This is of particular impor-
tance, since a direct mixing approach, where tubulin and lipids were introduced into the
droplets at the same time, did not result in the formation of a continuous lipid bilayer.
Additionally it was shown, that interactions of the microtubules with the surrounding
surfactant layer (see Appendix A.1) could be minimized in the case of dsGUVs. These
findings pave the road towards a sequentially assembly of a synthetic cytoskeleton, al-
lowing to study the self-organization with reduced complexity under controlled condi-
tions.
Summarizing the above, the combination of droplet-based microfluidic manipulation
methods and biologically relevant membrane properties allows to overcome limitations
of traditional compartments in synthetic cell biology. The sequential loading with dif-
ferent molecules, proteins and buffer conditions enables combinations, that would not
occur for a direct mixing of all at once. The enhanced mechanical and chemical stability
of the compartments pave the road for a bottom-up assembly of different bio-molecules
as it was exemplary demonstrated for the cytoskeleton protein tubulin and the trans-
membrane protein ATPsynthase.
The high-throughput microfluidic production methods allow for the creation of up to
103 compartments per second. Due to the sequential, controllable and adjustable load-
ing methods developed in this thesis, different compositions and concentrations of the
molecular components of the synthetic cells can be achieved, which will enable the screen-
ing and analysis of vast numbers of synthetic cells having different compositions within
short times. Additionally, the possibility of releasing the assembled lipid compartments
into an aqueous environment opens the door for investigations of the assembled proto-
cells under physiologically relevant conditions.
The characteristics of the new compartment type and applications for bottom-up syn-
thetic cell approaches developed in this thesis can be summarized as follows:
 The newly-developed dsGUV compartments combine the advantages of biologi-
cally relevant membrane properties and microfluidic manipulation methods such
as a sequential loading by pico-injection technology.
 The created lipid structure is a three-dimensional, intact and continuous lipid bi-
layer with full lipid mobility supported by the surfactant interface of the droplets.
 The applications of microfluidic manipulation tools towards dsGUVs were success-
fully demonstrated, in particular the use of pico-injection technology to sequen-
tially load dsGUVs with various bio-molecules.
 The preserved functionality of selected transmembrane and cytoskeleton proteins
was demonstrated, paving the road towards more sophisticated minimal synthetic
cells.
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 The release of the assembled lipid compartments into an aqueous environment
opens the door for investigations of the assembled protocells under physiologically
relevant conditions.
3.1.4 FCS for Analyzing Periodically Passing Droplets
The analysis of the formation process of dsGUVs out of fluorescently labeled SUVs was
performed using the point-spot excitation of a confocal microscope (see Appendix A.4
and Figure A.12, a). The confocal volume of the excitation spot was chosen to be in the
middle of a microfluidic channel, shortly after the droplet production unit and at distinct
positions in the subsequent channel. The velocity of the droplets and the known distance
between the production unit and the selected spots allowed to calculate the time after
droplet production and thus enabled an estimation of the temporal lipid bilayer forma-
tion process. Directly after the droplet production unit, the fluorescently labeled SUV are
assumed to be homogeneously distributed inside the microfluidic droplets, resulting in a
stepwise intensity function over time for passing droplets. After a sufficiently long time,
the SUVs diffuse to the periphery of the droplet, where they rupture and fuse to form a
lipid bilayer. This results in the formation of two intensity peaks per passing droplets.
While analyzing the fluorescence intensity traces of the periodically passing droplets, the
idea to perform FCS measurements using microfluidic droplets arose (see Publication 4).
Traditionally, FCS is based on fluorescence intensity fluctuations of labeled molecules due
to stochastic Brownian motion. In case of periodically passing droplets, the fluorescence
intensity fluctuations can be caused by fluorescent dyes, encapsulated into the droplets.
The fluorescence of monodispersed droplets, flowing equally spaced in the microfluidic
channels results in a square-wave intensity function over time. The corresponding auto-
correlation function has characteristic properties, which allow to draw conclusions for
the flow of the droplets:
1. The period of the oscillations of the auto-correlation function is the inverse flow
rate of the droplets.
2. The damping of the auto-correlation function is related to irregularities in the flow
of the droplets.
3. The initial amplitude of the auto-correlation function correlates to the fluorescence
intensity inside the droplets.
The method developed within this work overcomes fundamental limitations of microflu-
idic droplet flow monitoring: Conventionally, the investigation of the flow of microflu-
idic droplets is performed by recording the intensity trace over time and by subsequently
analyzing the trace by object recognition criteria. This procedure is on the one hand de-
pended on individual segmentation algorithms but also on an appropriate fluorescence
intensity inside the droplets. The use of FCS and the analysis of the auto-correlation
function allows for a precise detection of the flow properties mentioned above for low
fluorescence intensity. Additionally it could be shown, that a small number of droplets is
already enough to derive the auto-correlation function. Even for very low fluorescence
signals, e.g. for a droplet to gap intensity ratio of 1.05, a total amount of 100 000 droplets
was sufficient enough to derive the auto-correlation function. For a typical flow rate of
500 kHz, this corresponds to a recording time of 0.2 sec.
The advantage of producing vast numbers of droplet-based synthetic cells within short
times by microfluidics calls for adequate analysis tools. The method developed here is
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a first demonstration of such a new analysis tool for monitoring the flow of microflu-
idic droplets. In future microfluidic droplet-based synthetic cell applications this method
could possibly be used for monitoring the distribution and interactions of fluorescently
labeled (bio-) molecules inside the droplets.
To conclude, the application of FCS towards microfluidic droplets allows for the follow-
ing investigations:
 FCS can be adopted to serve as a sensitive analysis tool towards periodically pass-
ing microfluidic droplets, allowing for a fast detection of the flow-rates, the vari-
ability and the fluorescently labeled content of the droplets.
 The fast calculation of the auto-correlation function allows to monitor vast numbers
of droplets, making statistically significant statements possible in future microflu-
idic droplet-based synthetic cell applications.
3.2 Conclusion and Outlook
The results I achieved in my research can be considered as a meaningful contribution for
the experimental realization of bottom-up synthetic cells in the research field of synthetic
biology. The general use of microfluidic droplets to serve as compartments for the assem-
bly of bio-molecules was demonstrated. However I observed, that the droplets cannot be
considered as completely sealed containers. Instead the partitioning of fluorophores or
even bio-molecules into the surrounding oil phase (Publication 1) as well as interactions
of the encapsulated bio-molecules with the stabilizing surfactant layer (Appendix A.1)
were observed. In my research I could demonstrate, that these limitations can be over-
come by adjusting the physical and chemical properties of the surfactants (Publication 1
and Publication 2). Therefore, in future droplet-based applications, the properties of the
encapsulated components and the surfactants have to be considered and possible inter-
actions with the surfactant layer should be carefully monitored.
Driven by these results, a lipid bilayer was integrated inside the microfluidic droplets in
order to mimic the cellular bio-membrane and thus to extend and to improve the droplet-
based synthetic cell model system. In doing so, the results from Publication 1 and Publi-
cation 2 were included, especially by choosing adjusted fluorescent dyes for the labeling
of the lipids and the bio-molecules. The developed system can bridge the gap between a
functional bio-membrane, being essentially for most synthetic cell models and microflu-
idic droplet-based manipulation tools, especially pico-injection technology. The results I
achieved with the newly-developed dsGUV system are at an early stage of this research
direction. However, the successful reconstitution of the cytoskeleton protein tubulin in-
side dsGUV and the functional incorporation of the transmembrane protein ATPsynthase
already indicate the potential of the dsGUV system. Thanks to the ability of a sequential
loading of these compartments by pico-injection technology, combinations of different
bio-molecules can be assembled, which would not assemble in a direct mixing approach.
This might enable the synthetic reconstruction of independent functional units. One ex-
ample would be a controllable ATP-generating unit being composed of ATPsynthase and
bacteriorhodopsin. The latter is a protein that acts as a proton pump upon light illumi-
nation, thus creating a pH gradient, which in turn could be used by the ATPsynthase to
generate ATP. Such a unit could therefore be used to generate ATP locally and on demand
via an external light illumination. The ultimate goal would be the combination of several
of these functional units into an independent and controlled system that mimics certain
attributes or properties of a living cell. One example would be the combination of the
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ATP-generating unit with a synthetic mitotic spindle. Upon external light illumination,
ATP would be produced, providing the energy for molecular motor proteins to align mi-
crotubules and thus to initiate droplet division.
Furthermore, I achieved the release of the assembles lipid systems from the stabilizing
droplet shell into an aqueous environment. For these experiments, the results from Pub-
lication 1 were used again to find suitably fluorophores in order to label and visualize
the different phases. These findings show a great potential for future synthetic cell ap-
plications, since the behavior of the assembled synthetic cell can be investigated in a
physiological relevant environment after the release. This might enable to study the in-
teractions of synthetic cells with each other or with different substrates.
Up till now, the full potential of microfluidic droplet production and manipulation meth-
ods was not exploited. The production of monodispersed compartments with identical
chemical conditions in the kHz range enables the creation of thousands of droplet-based
synthetic cells per second. In combination with the reduced complexity of a minimal
synthetic cell, this allows for reproducible and statistically significant experiments as in
the case of microtubule aster formation (Publication 2). In future experiment these ad-
vantages can be further exhausted. Multiple pico-injectors in a row could be used to
create synthetic cells with adjusted and controlled concentration gradient of different
bio-molecules. This would allow to investigate the behavior of minimal synthetic cells
for different compositions and might enable to draw conclusions to the interactions of
the components. As an example, droplets with different tubulin and motor protein con-
centration could be produced and the resulting microtubule arrangements might provide
new insight into the interactions.
The possibility to create minimal synthetic cells in the kHz range also requires for the
development of new methods to monitor and analyses the production process. In this
context, Fluorescence Correlation Spectroscopy (FCS) was applied towards microfluidic
droplets, flowing periodically in a microfluidic channel (Publication 4). So far, the work-
ing principle of analyzing the auto-correlation function was demonstrated by fluorophores
encapsulated in microfluidic droplets. However, this method offers great potential in
monitoring also the production of microfluidic drop- let-based synthetic cells, especially
for the control of different concentration gradients as described in the section above.
Other future application might include the analysis of protein-protein interactions or
protein interaction with the lipid bilayer of dsGUVs by the use of fluorescence cross -
correlation.
All in all, the results and methods achieved in this work show new paths towards the
creation of minimal synthetic cells and therefore might provide one small piece of the
puzzle towards an answer to the original question ’What is Life?’

CHAPTER 4
Summary
134 Summary
The question ’What is life?’ is one of the questions that have always stirred and chal-
lenged humanity since the beginnings. Scientific explanatory approaches culminated in
the creation of a whole new scientific field, Biology (bios-logia), the ’study of life’, with the
aim to understand all facets of living organisms and the processes involved. In the begin-
ning, these studies were limited to direct descriptions and observations by eye. However,
the development of new technologies in other research fields, such as e.g. microscopy
techniques in optical Physics, allowed for an improved observation of living organisms,
resulting nowadays in the studies of single molecular building units and their functions.
Nevertheless, the pure observation of these processes so far has not led to a complete un-
derstanding of life. This is mainly due to the large number of players involved in living
organisms, but also due to the highly dynamic processes and the manifold pathways and
interplays. Consequently, interdisciplinary approaches arose to tackle these problems.
In this context, different methods and techniques from other disciplines such as Physics,
Mathematics, Chemistry or Engineering were applied, adopted and combined towards a
better understanding of the functional properties of living organisms. One branch of this
new research field is ’Synthetic Biology’.
Synthetic biology is characterized by not being limited to the observation and description
of the components of a living organism, instead it aims for a precise manipulation and
the application of engineering principles towards living organisms. The intended goal is
the creation of a minimal synthetic cell to understand the basic processes necessary for
life. In this context, the bottom-up approach aims for a controlled assembly of molec-
ular building blocks into functional units and eventually to an independent, self-reliant
system. In doing so, the compartment for the controlled assembly of the building blocks
plays a crucial role.
In this thesis, I focused on the investigation of new, cell-sized compartments for a sequen-
tial bottom-up assembly of minimal synthetic cells. In a first step, I studied the applica-
bility of microfluidic water-in-oil droplets stabilized by copolymer surfactants towards
such compartments. In doing so, key factors for stable droplet production were identi-
fied. In order to evaluate the retention ability of microfluidic droplets, different fluores-
cent dyes were encapsulated into the droplets. It turned out, that not only the physical
and chemical properties of the dyes can influence the retention ability, but also the buffer
composition inside the droplets as well as the physical properties of the surfactants and
their concentrations in the oil phase. The importance of these results was demonstrated
by labeling encapsulated bio-molecules with ’wrong’ combinations, which resulted in a
dissipation into the oil phase. In contrast, for optimized conditions, stable retention of the
labeled bio-molecules was achieved. Therefore, the outcomes of this research provided
crucial information for a reliable and stable encapsulation of bio-molecules.
Driven by these results, microfluidic droplets were used as compartments for the inves-
tigation of microtubule self-organization under confined and well-controlled conditions.
Different arrangements of microtubule networks were identified and an elongation of the
droplets for high tubulin concentration was observed. However, the reproducibility of
the experiments was limited because of strong interactions of tubulin with the copolymer
surfactants I used during my research. In order to overcome this issue, two approaches
were investigated. The first one comprised the addition of a lipid bilayer at the inner
interface of the droplets with the aim to shield the microtubule structures from the sur-
rounding surfactant layer. I could show, that the integration of such a shielding lipid
bilayer indeed minimized the interactions and led to an enhanced stability of the system.
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The second approach tackled the surfactants themselves, by replacing the TRI7000 sur-
factant with a commercial one. This led to the reproducible and reversible formation of
microtubule asters, mediated by the motor protein kinesin.
So far, microfluidic water-in-oil droplets stabilized by copolymer surfactants were used
as compartments. Even though these droplets provided stable and manipulatable com-
partments, the missing bio-membrane as well as the surrounding oil phase limited their
utilization as optimal compartments for synthetic cell approaches. Therefore, in a fun-
damental new approach, a novel compartment system was invented: The formation of
a lipid bilayer at the inner periphery of microfluidic droplets, so-called: droplet-stabilized
giant unilamellar vesicles (dsGUVs). Since dsGUVs represented a novel kind of compart-
ment systems, the underlying properties were characterized extensively. In a first step, I
could demonstrate that the formation process of dsGUVs depends on the presence of di-
valent ions such as MgCl2. The formation process was further analyzed by encapsulating
differently-sized vesicles into the droplets, allowing to observe the formation process for
different time scales.
Different analysis methods revealed that the lipid structure is indeed an enclosed, con-
tinuous lipid bilayer supported by the surfactant interface of the microfluidic droplets.
Furthermore, dsGUVs are accessible to different analytic methods. As an example, FRAP
measurements revealed the dynamic behavior of the lipid bilayer, similar to free-standing
equivalents. In order to ultimately explore the properties of the created system, I devel-
oped different approaches to release the assembled lipid compartments from the stabiliz-
ing surfactant shell into an aqueous environment. Towards this end, I demonstrated the
successful ’bulk release’ in an Eppendorf tube as well as in an observation chamber. The
latter allowed to observe the release process in real time and to evaluate the stability of
the lipid compartments and the retention ability of encapsulated fluorophores during the
release process. Finally, I designed and tested different microfluidic devices to allow for
a fully automated release process with the ultimate goal to create future droplet-based
synthetic cells on a single device (lab-on-chip application).
The superior features of the developed system in comparison to other microfluidic GUV
production methods were demonstrated by applying microfluidic droplet manipulation
tools towards dsGUVs. In particular, the successful loading of dsGUVs with different bio-
molecules using ’pico-injection’ technology was achieved. It could be exemplary shown,
that both the loading with cytoskeleton proteins as well as transmembrane proteins was
possible, remarkably without reducing their functionality. In this context I could demon-
strate the successful polymerization of tubulin within dsGUVs, as well as the incorpora-
tion of ATPsynthase into the lipid bilayer of dsGUVs. For the latter, I could additionally
demonstrate full functionality after the incorporation, which means that I could detect
ATP synthesized by ATPsynthase inside energized dsGUVs.
The production of dsGUV-based synthetic cells in the kHz regime by microfluidics re-
quires adequate analysis tools, which can match the high production rates. Therefore,
while performing the analysis of the dsGUV formation process, the idea to perform Flu-
orescence Correlation Spectroscopy (FCS) measurements on microfluidic droplets was
born. Towards this end, the fluorescence intensity fluctuations of fluorophores inside
microfluidic droplets, passing periodically through a channel, were measured and ana-
lyzed. The resulting auto-correlation function allows for a fast determination of the flow-
rates, the variability and the fluorescently labeled content of the rapidly passing droplets.
This enables to monitor and analyze the formation process of microfluidic droplet-based
synthetic cells in the kHz regime.
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The results and methods achieved and developed in this thesis might pave the road to-
wards a new level of development in bottom-up synthetic cell biology. The results of the
experiments, especially related to dsGUVs, demonstrate the basic functionality of the de-
veloped system and the applicability towards a real bottom-up synthetic cell assembly.
Future applications might exploit the full potential of the generation and the manipu-
lation of these compartments by high-throughput microfluidic technology. This might
lead to the construction of more complex minimal synthetic cells in an engineering-like
manner, allowing to mimic, study and better understand fundamental processes of life.
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The following sections provide additional data and methods, which were not or only
partially documented in the Publications.
A.1 Microtubule Polymerization in Microfluidic Droplets
Publication 2 was based on preliminary experiments, which I performed in the context
of my research. The following section provides an overview of these results.
In living cells, the internal structure depends on the cytoskeleton, which consists mainly
of actin filaments, intermediate filaments and microtubules. In combination with associ-
ated motor proteins the latter create a highly dynamic network, which is altered to spe-
cific cellular tasks and functions (see Section 1.2.2). The molecular mechanism behind the
adaptability of the microtubule network is still only poorly understood. Beside various
biochemical components, which can influence the formation of microtubule networks,
the confined space and the boundary conditions play a similar role. Since microtubules
are rather rigid structures, they can either deform the confinement or are bent themselves,
depending on the stiffness and the geometry of the compartments.
In this context, I studied the polymerization of tubulin into microtubule structures in
confined microfluidic water-in-oil droplets of controlled and adjustable size. Based on
these results, the influence of motor proteins (mCherry-labelled Xenopus laevis kinesin-
14, XCTK2) on the microtubule networks was analyzed and the results were published
in Publication 2.
Microtubule polymerization inside microfluidic droplets
In order to produce microtubule networks and to observe self-organization of micro-
tubules inside microfluidic water-in-oil droplets, the polymerization of tubulin into mi-
crotubules has to be controlled and should be triggered only after droplet production
and encapsulation. Therefore, droplets containing the protein solution with all polymer-
ization agents were produced at a temperature of 4C, at which polymerization is sup-
pressed. For the production, a standard microfluidic droplet production device with one
aqueous channel was used. The size of the droplets was controlled by adjusting the ratio
of aqueous- to oil-phase and in the case of droplets with a diameter > 75 m a device with
an adopted geometry was used. This allowed for the control of droplet sizes in a range
of roughly 10-150 m in diameter, which mimics the size of somatic metazoan cells [131].
In order to observe the self-assembly process of tubulin into microtubules, the produced
droplets with the encapsulated, fluorescently labeled tubulin solution were transferred
to an observation chamber and observed with a confocal microscope at 34C. The tem-
perature shift triggered the polymerization of tubulin, thus allowing for the observation
of the microtubule self-organization over time (see Figure A.2).
In a first step, the biochemical conditions for in vitro polymerization of tubulin inside
confined droplets were investigated and adopted from bulk experiments.
Figure A.1, a) shows microfluidic droplets with encapsulated tubulin labeled with ATTO-
488 45 min after the transfer to 34C. In this case, the biochemical conditions were the
same as in bulk experiments with a tubulin concentration of 14:5M, a GTP concentra-
tion of 1.5 mM and the stabilizing agent taxol at 3M. In case of corresponding bulk
experiments, tubulin polymerized into microtubules for the given conditions, however
in droplets no polymerization was observed. Therefore, in an attempt to increase the effi-
ciency of tubulin polymerization, the concentration of tubulin and GTP was increased to
20M and 3 mM, respectively. This led to a visible nucleation of microtubules within the
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Figure A.1 – Representative fluorescence images of tubulin labeled with
ATTO 488 and encapsulated into microfluidic droplets after transfer to
34C. a) For low tubulin concentration, no polymerization is observed af-
ter 45 min. b) Increased tubulin and GTP concentration led to microtubule
aggregates. c) Time series of tubulin aggregation after omitting taxol.
droplets, as shown in Figure A.1, b). However, the microtubules formed thick aggregates
and clustered together. In order to overcome this problem and to move to physiologi-
cally more relevant conditions, the use of taxol was omitted. A representative time series
is shown in Figure A.1, c). In this case, tubulin formed aggregates, which however did
not polymerize into microtubules and which interacted strongly with the droplets’ pe-
riphery. This behavior was prevented by additionally omitting the oxygen scavenger
system, i.e. the omission of glucose oxidase, catalase and -casein. These conditions led
to a reproducible polymerization of tubulin into microtubules inside microfluidic water-
in-oil droplets.
Importantly, the final polymerization was even possible without any additional stabi-
lizer, such as taxol or glycerol, which have been used in most other studies to allow for
microtubule polymerization. This enabled to mimic cellular processes much better, since
the dynamic behavior of tubulin is conserved.
After adopting the biochemical conditions for tubulin polymerization inside microfluidic
droplets, the polymerization of microtubules triggered by a temperature increase was
observed over time. Figure A.2 shows different time series of fluorescently labeled tubu-
lin inside microfluidic droplets. At t = 0 min, the droplets were transferred to the heat
chamber. Therefore, tubulin is not polymerized and thus distributed equally inside the
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Figure A.2 – Fluorescence images of tubulin polymerization inside mi-
crofluidic droplets. Red color indicates labeling with Alexa 647, green
color labeling with ATTO 488 dyes. a) represents the formation process of
cortical structures and b) the formation of aster-like structures in droplets
with a diameter of 40 m. c) shows the formation process of aster-like
structures in droplets with a diameter of 150 m.
droplets. As the temperature is increased, polymerization of tubulin into microtubules
is initiated and filaments start to grow. These filaments move around freely until the
microtubule network is to dense and motion comes to halt. After roughly 30-40 min the
microtubule self-assembly process is completed.
Following the formation process, the influence of the droplet size on the microtubule
self-organization was analyzed. Therefore, in a first step, droplets with a diameter of
d  40m were produced.
Figure A.3, a) and b) show the equatorial confocal plane of typical arrangements for the
microtubule networks. Mainly four configurations were observed, namely a ’centered’
arrangement, a ’ring-like’ arrangement, a ’wide cortical’ arrangement and a ’narrow cor-
tical’ arrangement (see Figure A.3, b). The most frequently occurring arrangement of
microtubule networks inside microfluidic droplets with 40 m diameter was a cortical
arrangement (see Figure A.3, a) Note: Similar observations have been made earlier for
microtubule organization in confined lipid-monolayered droplets [124]. However, the
findings in [124] were performed with stabilizing agents (both taxol and glycerol) and
without the control of the droplet size.
In a second step, the microtubule organization for droplets with a diameter of d  150m
was analyzed. The majority of the droplets showed a aster-like microtubule arrangement
with individual microtubules growing from the droplet’s center to its periphery (see A.3,
c). Only in minor cases (<10%) an even distribution of microtubules inside the droplets
was observed (see A.3, d).
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Figure A.3 – Fluorescence images of microtubule arrangements inside mi-
crofluidic droplets. a) Overview for droplets with a diameter of 40 m. b)
Different microtubule arrangements identified for 40 m droplets. c) and
d) Microtubule arrangements for 150 m droplets.
Elongation of microfluidic droplets by growing microtubules
The dynamic nature of microtubules in living cells allows for the adaptation of the cel-
lular cytoskeleton to perform different tasks and functions. During cellular division, the
microtubule network has the ability to deform the whole cell into two polar halves by
mitotic spindle assembly. This finding has been demonstrated in vitro for lipid bilayer
compartments [125, 126]. In this study, the ability of microtubules to deform water-in-oil
droplets was demonstrated.
Figure A.4 a) shows fluorescence and corresponding brighfield images of microfluidic
droplets with encapsulated microtubules after polymerization. In contrast to the pre-
vious section, a lower surfactant concentration for droplet stabilization was used and
the tubulin concentration was increased to 50 M. It can be observed, that tubulin accu-
mulates mainly at the periphery and occasionally forms single or multiple microtubule
poles, as indicated by bright spots in the fluorescence image. At these points, the droplet’s
periphery is curved and deformed. In case of two opposite poles, this behavior leads to
an elongation of the droplet into a ’rugbyball’-like shape, which can be observed both in
fluorescence and in brightfield images. Figure A.4, b) represents a closer look at one of
the elongated droplets with one pole. The projection of a stack scan in z-direction (right
image) indicates, that the microtubules arrange in a radial geometry from the pole at the
droplet interface, thus aligning in parallel bundles between the pole and the opposite side
of the droplet. This formation enables a deformation and elongation of the droplet. Most
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Figure A.4 – a): Representative fluorescence and corresponding bright-
field image of microfluidic droplets, being deformed by growing micro-
tubules. b): Detailed representation of a deformed droplet with corre-
sponding brightfield image. Right image shows the two-dimensional pro-
jection of a z-stack, indicating a parallel arrangement of the microtubules.
probably the enhanced tubulin concentration leads to a higher polymerization-force, act-
ing on the oil-water interface and ultimately leading to the observed deformations.
Interaction of microtubules with surfactants
Even though the results from the previous sections were promising, the use of microflu-
idic water-in-oil droplets as compartments to study microtubule self - organization in
confinements was limited. This can be mainly traced back to long-term observations,
which are demonstrated in Figure A.5.
For most microtubule experiments performed in water-in-oil droplets, the microtubule
structures depolymerized shortly after the final arrangement and interacted strongly
with the surfactant layer. This led to a complete destruction of both the microtubles
and the droplets. As it can be seen in the brightfield channel of Figure A.5 b), the sur-
factant layer at the oil-water interface shows concavities and deformations. In case of
droplets with a diameter > 100 m (see Figure A.5, c)), small fluorescent dots appeared,
which can be attributed to depolymerized and destroyed microtubules. Additionally, the
droplets’ boundaries became less stiff, leading to a deformation into a hexagonal pattern
of squeezed droplets. Interestingly, this geometrical deformation was stable, even when
the droplets were isolated (see Figure A.5, d)).
In order to investigate the origin of this behavior, the interactions of polymerized mi-
crotubules and the oil/surfactant phase were investigated in bulk conditions. Towards
this end, a flow chamber was constructed, allowing to introduce FC-40 oil with 2.5mM
TRI7000 surfactants from one side and tubulin in polymerization buffer from the other
side. Figure A.6 shows the temporal development and interactions at the boundary layer.
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Figure A.5 – a) shows fluorescence and corresponding brightfield im-
age of microfluidic droplets with encapsulated microtubules shortly after
complete microtubule polymerization. b) shows the same droplets as in
a), after 60 minutes observation time. c) shows droplets with a diame-
ter of roughly 100 m, 45 minutes after production. The deformation of
the droplets into a hexagonal pattern stays intact even after isolating the
droplets from the bulk arrangement, as demonstrated in d).
As it can be observed, the microtubules interact strongly with the oil/surfactant layer,
resulting in a depolymerization of microtubules close to the boundary as well as a de-
formation of the boundary itself. The breakage of intact microtubule structures might be
explained by the influence of labeling dyes and irradiation of excitation light, as it was
demonstrated in [132]. Under light illumination, the labeling fluorescent dyes can create
reactive oxygen species such as singlet oxygen, which can cause damage to bio-molecules
like microtubules. Therefore, the intact microtubules can break and depolymerize. The
amphipotential behavior of tubulin might lead to interactions with the surfactant layer
and thus to an aggregation at the boundary layer.
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Figure A.6 – Time lapse series of micrutubules interacting with the
oil/surfactant layer. Fluorescently labeled microtubules are shown in
red, whereas the oil/surfactant phase is unlabeled. A deformation of the
boundary layer can be observed over time. Lower panel shows the cor-
responding brightfield images. Time between the fluorescence images: 5
min.
A.2 Phase Separation and Lipid Defects
This part provides additional data, which was obtained in order to characterize the lipid
bilayer-like structure of the dsGUVs system. Towards this end, the creation of dsGUVs
showing lipid phase separation behavior was investigated. For an increased tempera-
ture, lipids undergo a transition from the liquid-phase to the gel-phase. The transition
temperature TT depends on the physical properties of the lipids, like e.g. the length of
the hydrophobic tails and the packing density (See Section 1.2.1). A lipid bilayer, con-
sisting of a mixture of lipids with different TT, shows macroscopic domains of coexisting
liquid- and gel-phases. The formation of these domains is considered to be an indicator
for an unilamellar lipid bilayer-like structure. Therefore, this part aimed for the creation
of dsGUVs, showing lipid phase separation behavior.
The formation of phase-separated GUVs was performed at temperatures higher than the
maximum TT of the lipids. In this state all lipid species are in the liquid-phase. When
the vesicles were cooled down, lipids with a high TT were transferred to the gel phase,
whereas lipids with low TT remained in the liquid-phase. This phase separation was vi-
sualized with fluorescently labeled lipids, which only partition into one specific phase
[128].
Figure A.7 a) shows phase-separated GUVs formed by electroformation as described
above and encapsulated into microfluidic droplets, as indicated by a dashed circle line.
The macroscopic domains of the different phases, one labeled with a fluorescent dye, the
other unlabeled, are clearly visible. To achieve the formation of dsGUVs an optimized
solution of MgCl2 was subsequently injected into these droplets by pico-injection tech-
nology to a final concentration of 10 mM. However, as it can be observed in Figure A.7,
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Figure A.7 – a) shows fluorescence image of phase-separated GUVs en-
capsulated inside a microfluidic droplet, as indicated by a white circle.
After addition of ions via picoinjection, the GUVs fuse to the periphery,
however the phase separation is not conserved, as demonstrated in b). c)
and d) show the appearance of lipid bilayer defects in dsGUVs, as indi-
cated by black holes in the fluorescently labeled lipid layer.
b), the resulting dsGUVs showed no phase separation. Perturbations from the dynamic
droplet interface like friction or attractive forces could be an explanation for this observa-
tion, as it was found for SLB [59]. Furthermore, the formation of dsGUVs at high temper-
atures above the maximum TT by transferring the whole droplet production setup into
an oven and a subsequent cooling did likewise not result in a phase-separation of the
lipids. Summarizing these findings, the issue of phase separation in the dsGUV mem-
branes remains an open question for further studies.
Even though the phase separation in dsGUVs membranes was not successful, another
observation might indicate the lipid bilayer-like structure of the dsGUVs. Occasionally,
dsGUVs formed by only one lipid species, showed the appearance of black ’holes’ or
better ’defects’, as it can be seen in Figure A.7, c) and d). This phenomenon has been
reported in literature before for SLB systems [133] and can be attributed to mobile re-
gions devoid of any lipids. Even though the exact conditions and the formation process
of these defects remained unclear, it strongly supports the lipid bilayer-like structure of
the dsGUVs, since a multilayer would not lead to completely dark regions.
146 Additional Data and Methods
A.3 Release of dsGUVs
This part provides more detailed information on methods, which I developed in order to
release the assembled lipid bilayer compartments from their stabilizing surfactant shell
into an aqueous environment (see Publication 3). The general underlying principle is
sketched in Figure A.8.
Figure A.8 – Schematic representation of dsGUV release into an aqueous
environment. dsGUVs have to come into close contact with the continu-
ous aqueous phase. Subsequently, the separating oil-surfactant layer has
to be broken without damaging the lipid bilayer. This leads to a release of
the GUV into the continuous aqueous phase.
The release of dsGUVs into an aqueous environments provides better analytic access
for the characterization of the assembled lipid system and is also crucial for future ap-
plications, where protocells are first assembled by microfluidic technology and finally
released. The latter will allow the investigation of protocell-protocell interactions and
protocell-environment interactions and obviously mimics living cells much better than
the dsGUV system. In the following sections, several approaches and their realizations
for dsGUV release into an aqueous phase are presented. The crucial factor for all ap-
proaches is to bring the dsGUVs in the oil phase into close contact with a continuous
aqueous phase. After destabilizing the surfactant layer the GUV might be released into
the connected aqueous phase. In doing so, shear stress on the lipid bilayer has to be
avoided in order to preserve the fragile GUV structure.
Bulk Release Approach
One possibility to bring the droplet in the oil phase close to a continuous aqueous en-
vironment was achieved with a bulk release approach. In this case, thousands of ds-
GUVs were produced and transferred to an Eppendorf tube. After addition of a sufficient
amount of the continuous aqueous phase, droplets were align at the oil-water interface,
being still separated by a remaining oil-surfactant layer. In order to remove the latter,
destabilizing surfactants were added and the droplets’ interior including the lipid bi-
layer was released into the continuous aqueous phase.
In order to investigate the potential of this approach, in a first step free-standing GUVs
were formed by electroformation and subsequently encapsulated into microfluidic drop-
lets in MilliQ water (see Figure A.9, a). Following this process, the bulk release approach
was applied to recover the encapsulated GUVs into a continuous aqueous phase. As it
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can be seen in Figure A.9, b), the released GUVs stayed intact and showed roughly the
same size distribution as the encapsulated GUVs prior to the release process.
Figure A.9 – Bulk release approaches. a) shows fluorescently labeled
GUVs formed by electroformation and encapsulated into microfluidic
droplets as indicated by the white circle. After the bulk release process,
GUVs with similar size distribution as in a) can be observed in the contin-
uous aqueous phase, b). The same approach was applied to fluorescently
labeled dsGUVs, depicted in c). After the release process, lipid patches
on the cover-slip of the observation chamber can be observed, as demon-
strated in d). e) shows a three-dimensional representation of the released
GUVs, indicating a semi-fusion with the cover-slip.
Driven by these results, the release of dsGUVs into a continuous aqueous phase was stud-
ied. Figure A.9, c) shows dsGUVs surrounded by a continuous oil phase. After applying
the bulk release method, the continuous aqueous phase containing the released GUVs
was transferred to an observation chamber and the resulting lipid formations were ob-
served, as exemplary shown in Figure A.9, d) and e). It can be seen that the released
GUVs settled down to the bottom of the observation chamber and ruptured into mem-
brane patterns due to interactions with the glass slide. However, the size of the mem-
brane patterns resembles the original size of the dsGUVs, indicating a successful release
process. Frequently, three-dimensional structure as in Figure A.9, e) (three-dimensional
representation of a z-stack) were observed, showing a semi-fusion of the released GUVs
with the glass slide.
These results demonstrate a successful release of GUVs from their supporting surfactant
layer. After the realization of the bulk release concept achieved here, co-worker Lucia
Benk optimized the conditions for the bulk release method by screening different lipid
compositions and by functionalizing the glass slides of the observation chambers in or-
der to reduce GUV rupture.
In order to directly visualize the release process, another bulk release approach was in-
vestigated by using an open flow-cell chamber for the observation. The results are pre-
sented in Publication 3, Supplementary Figure 6. This method also enabled to monitor
molecular exchange between the internal and the external aqueous phase by dissolving
adjusted fluorescent dyes, based on the results from Publication 1. During the release
process, no molecular exchange of the fluorophores between the two phasese was ob-
servable, indicating the successful release of intact lipid compartments.
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Microfluidic Release Approach
In addition to the bulk release methods, microfluidic devices for a controllable release
of GUVs from the stabilizing surfactant layer were developed. The motivation for a mi-
crofluidic release device was on the one hand to better observe the release process. On the
other hand such a device could be implemented as a part of a synthetic cell production
pipeline, or in other words as a part of a lab-on-chip device, allowing for the generation
of dsGUVs, their manipulation and analysis and finally the release of the assembles pro-
tocells into an aqueous environment with one single device. A first prototype of such an
microfluidic release device is shown in Figure A.10.
Figure A.10 – This Figure shows the first design for the automated release
of the content of microfluidic droplets. Produced droplets are reintro-
duced into the device and separated by an additional oil channel. The
latter also serves to introduce destabilizing surfactants. In the fusion unit,
droplets flow parallel to the continuous aqueous phase. By applying an
electrical AC field, fusion is achieved, as indicated by the inserts. The
lower panel shows a time series of the fusion process in more detail. The
content of the droplets is visualized by black ink. Time between the im-
ages: 0.5 ms.
The two inlet channels allow for a parallel flow of droplets in the oil phase and the con-
tinuous aqueous phase. Due to the low Reynolds Numbers in microfluidic devices and
the resulting laminar flow, the steam lines of the two phases do not mix (see Section 1.4).
Therefore, two outlet channels allow for a separation of the continuous oil phase and the
continuous aqueous phase. As shown in Figure A.10, the surfactant-stabilized droplets
do not fuse with the attached aqueous phase. However, fusion can be induced by electri-
cal fields, imposed by the microelectrodes. Similar like in the case of pico-injection, these
electrical fields induce electroporation of the stabilizing surfactant layer, thus enabling
the fusion of the aqueous content of the droplets with the continuous aqueous phase (see
inlet in Figure A.10). However, in the case of dsGUVs, the lipid bilayer is also subject
to the electroporation and thus the created lipid bilayer structure would be destroyed by
the electrical fields.
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In an attempt to omit the use of strong electrical fields, a destabilizing surfactant as in the
case of bulk release was introduced. This was done by the separation channel, actually al-
lowing for the separation of the reintroduced droplets (see Figure A.10). The subsequent
channel length was adjusted to be long enough to allow for an exchange of stabilizing
surfactant with the destabilizing one. Droplets reaching the fusion unit directly merged
with the continuous aqueous phase. This process is illustrated in the time series in Fig-
ure A.10, where the droplets inner aqueous phase is labeled with dark ink. However, the
shear forces on the released content of the droplets are very strong, leading to a dissolv-
ing of the content. Consequently, these forces would be to high to allow for a successful
release of GUVs form the stabilizing surfactant layer as in the case of dsGUVs.
In order to overcome this problem, a new device was designed with the aim to apply as
little forces as possible to the released GUVs. Figure A.11 shows the microfluidic release
device, which I designed during my research.
Figure A.11 – Final design for the automated release of GUVs using a
microfluidic device. dsGUVs are reintroduced and separated by a T-
junction. The separation channel also allows for the introduction of desta-
bilizing surfactants. In the fusion-unit, droplets are decelerated due to
passive trapping structures. These structures additionally serve as out-
lets for the oil phase. This enables a gentle transition of the dsGUV with
the continuous aqueous phase, thus making the release of GUVs possi-
ble. The lower panel shows a time series of the deceleration process of the
droplets. Time between the images: 1.0 ms
The first part of the device consists of a channel for the reintroduction of droplets and a
second, rectangular-connected oil channel. The latter serves two functions. Firstly, the
additional oil separates the droplets in a way that they sequentially flow spatially sep-
arated by consistent and uniform distances. Secondly, the oil in the separation channel
contains destabilizing surfactants. Thus, the stabilizing surfactant of the droplets is re-
placed by the short destabilizing one inside the subsequent channel section.
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The second part of the device is the actual release unit. The passive trapping structures
again fulfill two purposes. Firstly, they allow the flow of the oil phase out into the con-
nected oil outlet channels. Secondly, they decelerate the approaching droplets before they
come into contact with the continuous aqueous phase, which is connected to the end of
the trapping structures. This allows a smooth and gentle transition of single dsGUVs into
the aqueous phase.
The time series in Figure A.11 (lower panel) shows a droplet approaching the passive
trapping structure. After entering the rows of pillars, excessive oil is pushed into the oil
outlet channels, resulting in a pressure drop in the main channel. Therefore, the droplet
is decelerated until it comes to halt shortly before the oil-water interface. The subse-
quent droplet arriving in the main channel gives the ultimate push to induce fusion of
the droplet with the continuous aqueous phase, allowing a gentle release of the droplet’s
content. This release process can be performed at rates up to 300 droplets per second.
In the context of this thesis, I designed and produced the microfluidic release device and
performed first experiments with microfluidic droplets. Based on these achievements,
co-worker Johannes Frohnmayer improved the handling of the device and demonstrated
successful release of dsGUVs into the continuous aqueous phase.
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A.4 Formation Process of dsGUVs
In an attempt to understand the properties of dsGUVs, the formation mechanism was
studied in detail. Towards this end, lipid vesicles with different sizes were encapsulated
into microfluidic droplets under ionic conditions of 10 mM MgCl2. As it was shown in
Publication 3, the time for a complete formation of dsGUVs, tc depends on the size of the
vesicles and the corresponding mean diffusion time. In case of encapsulated GUVs, tc is
in the order of minutes, whereas in the case of SUVs, tc is in the order of seconds. In most
cases, dsGUVs were produced using SUVs, since for this situation the total lipid concen-
tration inside the droplets could be controlled precisely. The knowledge of the dsGUV
formation time is of particular interest for the design of microfluidic devices consisting
of several manipulation units. As an example, it would be desirable to form complete
dsGUV before using the pico-injection unit. Towards this goal, fluorescence intensity
analysis of flowing microfluidic droplets was performed.
The optical setup, which was implemented into a LSM 880 microscope (Zeiss, Ober-
kochen, Germany), is schematically shown in Figure A.12, a).
Figure A.12 – a) shows a schematic representation of the fluorescence
detection setup. The two pinholes allow for a defined confocal detec-
tion volume. b) shows the microfluidic device for the detection of the
dsGUV formation process. Fluorescence intensity traces were measured
at the indicated positions. c) shows the average fluorescence intensity
(a.u.) and corresponding standard derivation of labeled lipids in 120
by-passing, length-normalized droplets at different positions. The corre-
sponding time after creation is indicated in the Figure. The inserts show
the fluorescence intensity distribution inside droplets before and after the
introduction of MgCl2.
The two pinholes serve to provide a defined confocal excitation volume inside a microflu-
idic channel. Such a spot-like excitation of fluorescent dyes allows for a fast detection of
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the emission signals in the MHz-range, using a PMT.
In order to evaluate the formation process of dsGUVs, droplets with encapsulated SUVs,
labeled with ATTO-488 in 10 mM MgCl2 were produced. The device, shown in Figure
A.12, b) enables the observation of the droplets for different distances after the produc-
tion, as indicated in the figure. With the velocity of the droplets, known by observations
with a high-speed camera at 10Mhz, the corresponding time after production could be
evaluated, as indicated in c). The fluorescence intensity traces at the different positions
were recorded for 120 droplets in each case. Following acquisition, the traces of single
droplets in the intensity profiles were identified and the lengths of the droplets were
normalized. Figure A.12, c) shows the resulting mean intensity values for the three dif-
ferent positions. The transformation from a homogeneous fluorescence distribution (cor-
responding to homogeneously distributed SUVs) to two distinguishable intensity peaks
after roughly 10 seconds (corresponding to an established lipid bilayer at the droplets
periphery) can be observed. This value is in good agreement with theoretical consid-
erations, see Publication 3, Supplementary Note 2 and allows for an estimation of the
lengths and geometry of microfluidic devices to achieve full dsGUV formation.
In the context of this observations, the idea arose to use fluorescence correlation spec-
troscopy (FCS) for periodically passing droplets. It turned out, that the resulting auto-
correlation curve can be used to draw precise conclusions to the droplet production fre-
quency, to irregularities in the flow of the droplets as well as to the fluorescence intensity
inside the droplets. These results are presented in Publication 4.
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